Pancras Hogendoorn
Professor Pathology
- Name
- Prof.dr. P.C.W. Hogendoorn
- Telephone
- +31 622800 166
- p.c.w.hogendoorn@lumc.nl
- ORCID iD
- 0000-0002-1513-8104
Pancras C.W. Hogendoorn is a professor of pathology at the Leiden University Medical Center (LUMC). Apart from that he is guest professor at Oxford University and the Free University of Brussels (FUB). He is chairman of the Netherlands Committee for Bone Tumours and a member of the Supervisory Board of the Royal Academy of Arts/Conservatoire. He is also a member of the Royal Netherlands Academy of Arts and Sciences (KNAW) and the Academia Europea.
More information about Pancras Hogendoorn
News
Pancras C.W. Hogendoorn is a professor of pathology at the Leiden University Medical Center (LUMC). Apart from that he is guest professor at Oxford University and the Free University of Brussels (FUB). He is chairman of the Netherlands Committee for Bone Tumours and a member of the Supervisory Board of the Royal Academy of Arts/Conservatoire. He is also a member of the Royal Netherlands Academy of Arts and Sciences (KNAW) and the Academia Europea.
Pathology
Pathology is an insightful profession. Various signs and symptoms of disease such as abdominal pain, forgetfulness and fever can be correlated with changes at a cellular level. My profession creates a certain awareness, demystification. Many patients with bone and soft tissue tumours are referred to our hospital. The patients first present to the general practitioner their pain, often around a joint. Following the clinical work up - blood analysis, scans etc - I eventually get to see the tumour cells under the microscope or even smaller at the DNA-level. From the growth pattern and the cytonuclear features one can tell whether the lesion is benign or malignant, crucial for the appropriate treatment. Clinical symptomatology alone is insufficient for diagnostic accuracy. This is what probably attracts me to the microscope and laboratory: the desire, the urge to know something at the scientific level with certainty. As few uncertainties as possible: these are the facts.
Academic career
Pancras C.W. Hogendoorn absolved Medical School and his doctoral research at Leiden University. The title of his doctoral thesis (1990) reads ‘Immunopathogenetic mechanisms in experimental glomerulonephritis’. Subsequently Prof. Hogendoorn further specialised in oncologic pathology at the Netherlands Cancer Institute (NKI) in Amsterdam and the Memorial Sloan Kettering Cancer Center in New York. In March 1999 he was appointed Professor in Pathology of the Leiden University Medical Center. The title of his inaugural lecture was ‘Form Follows Function’.
For more than 30 years, Prof. Hogendoorn has carried out research into molecular pathogenesis and diagnostics of bone and soft-tissue tumours. He has over 400 scientific publications and various influential reviews and more than 30 chapters of books to his name. Prof. Hogendoorn has held a number of national and international offices at scientific organisations. Currently he is chairman of the Netherlands Committee for Bone Tumours, a member of the knowledge coalition for the Dutch National Research Agenda, Chief Scientific Officer of the topteam Lifescience and Health, member of Education and Training (O&O) at the Netherlands Federation of University Medical Centres (NFU), and chairman of the League of European Research Universities (LERU) Policy Group in Biomedicine.
In the past he was, among other things, chairman of the sub-committee of Pathology and Biology of the EORTC Soft tissue and Bone Sarcoma Group, the European Osteosarcoma Intergroup, the EuroEwing consortium, chairman of Eurolife, and a board member of the Connective Tissue Oncology Society, the European Musculoskeletal Oncology Society and chairman of the Bone and Soft Tissue working group European Society of Pathology
Prof. Hogendoorn was a member of the editorial board of the prestigious Journal of Pathology. He held the same post for Diagnostic Histopathology and Hereditary Cancer in Clinical Practice. Prof. Hogendoorn is still an active member of the working group of bone and soft-tissue tumours of the European Society for Pathology. Because of his research and diagnostic work in the field of bone and soft-tissue tumours, the World Health Organisation (WHO) asked him in 2002 to join the working group for the classification of these tumours. As such he was a co-author of the WHO classification for bone and soft-tissue tumours and was in 2013 appointed editor of the most recent edition.
Prizes and honourable appointments
Pancras C.W. Hogendoorn is an honorary member of the Belgium Society of Pathology. He received the European Oswald Vander Vekenprijs (2008), the Corrine Farrel Award of the International Skeletal Society both in 1994 and in 1998, and the Jeremy Jass Prize for excellent research in the field of pathology in 2011 and 2015. In 2019 he received a doctorate honoris of Semmelweis University and was elected as member of the European Academy of Sciences (Academia Europaea) and the Royal Netherlands Academy of Arts and Sciences (KNAW).
Professor Pathology
- Faculteit Geneeskunde
- Divisie 4
- Pathologie
- Mustokoweni, S.; Mahyudin, F.; Setiawati, R.; Nugrahenny, D.; Hidayat, M.; Kalim, H.; Mintaroem, K.; Fitri, L.E. & Hogendoorn, P.C.W. (2024), Correlation of high-grade osteosarcoma response to chemotherapy with enhanced tissue immunological response, Virchows Archiv.
- Kemps, P.G.; Kester, L.; Scheijde-Vermeulen, M.A.; Noesel, C.J.M. van; Verdijk, R.M.; Diepstra, A.; Marion, A.M.W. van; Dors, N.; Bos, C. van den; Bruggink, A.H.; Hogendoorn, P.C.W. & Halteren, A.G.S. van (2024), Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms, Histopathology 84(5): 837-846.
- Dorst, M.M.A.R. van; Pyuza, J.J.; Nkurunungi, G.; Kullaya, V.I.; Smits, H.H.; Hogendoorn, P.C.W.; Wammes, L.J.; Everts, B.; Elliott, A.M.; Jochems, S.P. & Yazdanbakhsh, M. (2023), Immunological factors linked to geographical variation in vaccine responses, Nature Reviews Immunology.
- Santoso, D.; Thaha, M.; Empitu, M.A.; Kadariswantiningsih, I.N.; Suryantoro, S.D.; Haryati, M.R.; Hertanto, D.M.; Pramudya, D.; Bintoro, S.U.Y.; Nasronudin, N.; Alsagaff, M.Y.; Susilo, H.; Wungu, C.D.K.; Budhiparama, N.C. & Hogendoorn, P.C.W. (2023), Brown tumour in chronic kidney disease: revisiting an old disease with a new perspective, Cancers 15(16).
- Khalil, R.; Bonnemaijer, J.D.D.; Kreutz, R.; Spaink, H.P.; Hogendoorn, P.C.W. & Baelde, H.J. (2023), Transmembrane protein 14A protects glomerular filtration barrier integrity, Physiological Reports 11(23).
- Santoso, D.; Thaha, M.; Empitu, M.A.; Kadariswantiningsih, I.N.; Suryantoro, S.D.; Haryati, M.R.; Hertanto, D.M.; Pramudya, D.; Bintoro, S.U.Y.; Nasronudin, N.; Alsagaff, M.Y.; Susilo, H.; Wungu, C.D.K.; Budhiparama, N.C. & Hogendoorn, P.C.W. (2023), Brown tumour in chronic kidney disease: revisiting an old disease with a new perspective, Cancers 15(16).
- Aldo A Acosta-Medina, Paul G Kemps, Timo C E Zondag, Jithma P Abeykoon, Jelske Forma-Borst, Eline C Steenwijk, Elizabeth A M Feijen, Jop C Teepen, N Nora Bennani, Susan M Schram, Mithun V Shah, Caroline Davidge-Pitts, Matthew J Koster, Jay H Ryu, Robert Vassallo, W Oliver Tobin, Jason R Young, Surendra Dasari, Karen Rech, Aishwarya Ravindran, Arjen H G Cleven, Robert M Verdijk, Carel J M van Noesel, Brian V Balgobind, Gerrit Joan Bouma, Peerooz Saeed, Jos A M Bramer, Ruben A L de Groen, Joost S P Vermaat, Michiel A J van de Sande, Egbert F Smit, Anton W Langerak, Tom van Wezel, Sanne H Tonino, Cor van den Bos, Jan A M van Laar, Ronald S Go, Gaurav Goyal & Astrid G S van Halteren (2023), BRAFV600E is associated with higher incidence of second cancers in adults with Langerhans cell histiocytosis, Blood 142(18).
- Venneker, S.; Eenige, R. van; Kruisselbrink, A.B.; Palubeckaite, I.; Taliento, A.E.; Briaire-de Bruijn, I.H.; Hogendoorn, P.C.W.; Sande, M.A.J. van de; Gelderblom, H.; Mei, H.L.; Bovee, J.V.M.G. & Szuhai, K. (2022), Histone deacetylase inhibitors as a therapeutic strategy to eliminate neoplastic "stromal" cells from giant cell tumors of bone, Cancers 14(19).
- Barnes, D.J.; Dutton, P.; Bruland, O.; Gelderblom, H.; Faleti, A.; Buhnemann, C.; Maldegem, A. van; Johnson, H.; Poulton, L.; Love, S.; Tiemeier, G.; Beelen, E. van; Herbschleb, K.; Haddon, C.; Billingham, L.; Bradley, K.; Ferrari, S.; Palmerini, E.; Picci, P.; Dirksen, U.; Strauss, S.J.; Hogendoorn, P.C.W.; Buddingh, E.; Blay, J.Y.; Cleton-Jansen, A.M. & Hassan, A.B. (2022), Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial), BMC Cancer 22(1).
- Khalil, R.; Boels, M.G.S.; Group, P.; Berg, B.M. van den; Bruijn, J.A.; Rabelink, T.J.; Hogendoorn, P.C.W. & Baelde, H.J. (2022), Mutations in the heparan sulfate backbone elongating enzymes EXT1 and EXT2 have no major effect on endothelial glycocalyx and the glomerular filtration barrier, Molecular Genetics and Genomics 297.
- Yang, L.; Zhang, H.J.; Zhang, X.H.; Tang, Y.Q.; Wu, Z.G.; Wang, Y.M.; Huang, H.; Fu, X.; Liu, J.Y.; Hogendoorn, P.C.W. & Cheng, H. (2022), Clinicopathologic and molecular features of denosumab-treated giant cell tumour of bone (GCTB), Annals of Diagnostic Pathology 57.
- Kemps, P.G.; Picarsic, J.; Durham, B.H.; Helias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; Bos, C. van den; Wetering, M.D. van de; Noesel, C.J.M. van; Laar, J.A.M. van; Verdijk, R.M.; Flucke, U.E.; Hogendoorn, P.C.W.; Woei-A-Jin, F.J.S.H.; Sciot, R.; Beilken, A.; Feuerhake, F.; Ebinger, M.; Mohle, R.; Fend, F.; Bornemann, A.; Wiegering, V.; Ernestus, K.; Mery, T.; Gryniewicz-Kwiatkowska, O.; Dembowska-Baginska, B.; Evseev, D.A.; Potapenko, V.; Baykov, V.V.; Gaspari, S.; Rossi, S.; Gessi, M.; Tamburrini, G.; Heritier, S.; Donadieu, J.; Bonneau-Lagacherie, J.; Lamaison, C.; Farnault, L.; Fraitag, S.; Jullie, M.L.; Haroche, J.; Collin, M.; Allotey, J.; Madni, M.; Turner, K.; Picton, S.; Barbaro, P.M.; Poulin, A.; Tam, I.S.; Demellawy, D. el; Empringham, B.; Whitlock, J.A.; Raghunathan, A.; Swanson, A.A.; Suchi, M.; Brandt, J.M.; Yaseen, N.R.; Weinstein, J.L.; Eldem, I.; Sisk, B.A.; Sridhar, V.; Atkinson, M.; Massoth, L.R.; Hornick, J.L.; Alexandrescu, S.; Yeo, K.K.; Petrova-Drus, K.; Peeke, S.Z.; Munoz-Arcos, L.S.; Leino, D.G.; Grier, D.D.; Lorsbach, R.; Roy, S.; Kumar, A.R.; Garg, S.; Tiwari, N.; Schafernak, K.T.; Henry, M.M.; Halteren, A.G.S. van; Abla, O.; Diamond, E.L. & Emile, J.F. (2022), ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition, Blood 139(2): 256-280.
- Kemps, P.G.; Hebeda, K.M.; Pals, S.T.; Verdijk, R.M.; Lam, K.H.; Bruggink, A.H.; Lil, H.S. de; Ruiterkamp, B.; Heer, K. de; Laar, J.A.M. van; Valk, P.J.M.; Mutsaers, P.; Levin, M.D.; Hogendoorn, P.C.W. & Halteren, A.G.S. van (2021), Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation, Journal of Pathology: Clinical Research 7(1): 10-26.
- Kemps, P.G.; Hebeda, K.M.; Pals, S.T.; Verdijk, R.M.; Lam, K.H.; Bruggink, A.H.; Lil, H.S. de; Ruiterkamp, B.; Heer, K. de; Laar, J.A.M. van; Valk, P.J.M.; Mutsaers, P.; Levin, M.D.; Hogendoorn, P.C.W. & Halteren, A.G.S. van (2021), Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation, Journal of Pathology: Clinical Research 7(1): 10-26.
- Hosseini, R.; Lamers, G.E.M.; Bos, E.; Hogendoorn, P.C.W.; Koster, A.J.; Meijer, A.H.; Spaink, H.P. & Schaaf, M.J.M. (2021), The adapter protein Myd88 plays an important role in limiting mycobacterial growth in a zebrafish model for tuberculosis, Virchows Archiv 479.
- Groen, R.A.L. de; Eijk, R. van; Bohringer, S.; Wezel, T. van; Raghoo, R.; Ruano, D.; Jansen, P.M.; Briaire-De Bruijn, I.; Groot, F.A. de; Kleiverda, K.; Boome, L. te; Terpstra, V.; Levenga, H.; Nicolae, A.; Posthuma, E.F.M.; Focke-Snieders, I.; Hardi, L.; Hartog, W.C.E. den; Bohmer, L.H.; Hogendoorn, P.C.W.; Berg, A. van den; Diepstra, A.; Nijland, M.; Lugtenburg, P.J.; Kersten, M.J.; Pals, S.T.; Veelken, H.; Bovee, J.V.M.G.; Cleven, A.H.G. & Vermaat, J.S.P. (2021), Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotype, Blood Advances 5(19): 3760-3775.
- Mremi, A.; Pyuza, J.J.; Ahmad, B.; Andongolile, A.A.; Sadiq, A.; Yahaya, J.J.; Szuhai, K. & Hogendoorn, P.C.W. (2021), Non-Hodgkin lymphoma of bone of the femur and humerus: a case report and review of the literature, Oxford Medical Case Reports: 150-152.
- Kravtsov, V.Y., Gaivoronskii, I.V., Academy named SM Kirov, St.Petersbrug & Russian Federation (2021), Dutch cultural heritage of Fredrik Ruijsch and Herman Boerhaave in the Military Medical Academy named SM Kirov, Vestnik Saint Petersburg University. Medicine. 16(14).
- Forsyth, R.G.; Krenacs, T.; Athanasou, N. & Hogendoorn, P.C.W. (2021), Cell Biology of Giant Cell Tumour of Bone: Crosstalk between m/wt Nucleosome H3.3, Telomeres and Osteoclastogenesis, Cancers 13(20).
- Yastrebinskii GB., State Museum Hermitage, St. Petersburg, Russian Federation Zhuravlev DA., Military Medical Museum, St. Petersburg, Russian Federation Gaivoronskii IV., S.M. Kirov Military Medical Academy, St. Petersburg & Russian Federation (2021), Medical instruments in Imperial Russia, Journal of Anatomy and Histopathology 10(2).
- Lam, S.W.; Bruijn, I.H.B.D.; Wezel, T. van; Cleven, A.H.G.; Hogendoorn, P.C.W.; Cleton-Jansen, A.M. & Bovee, J.V.M.G. (2021), NTRK fusions are extremely rare in bone tumours, Histopathology 79(5): 880-885.
- Kemps, P.G.; Picarsic, J.; Durham, B.H.; Helias-Rodzewicz, Z.; Hiemcke-Jiwa, L.; Bos, C. van den; Wetering, M.D. van de; Noesel, C.J.M. van; Laar, J.A.M. van; Verdijk, R.M.; Flucke, U.E.; Hogendoorn, P.C.W.; Woei-A-Jin, F.J.S.H.; Sciot, R.; Beilken, A.; Feuerhake, F.; Ebinger, M.; Mohle, R.; Fend, F.; Bornemann, A.; Wiegering, V.; Ernestus, K.; Mery, T.; Gryniewicz-Kwiatkowska, O.; Dembowska-Baginska, B.; Evseev, D.A.; Potapenko, V.; Baykov, V.V.; Gaspari, S.; Rossi, S.; Gessi, M.; Tamburrini, G.; Heritier, S.; Donadieu, J.; Bonneau-Lagacherie, J.; Lamaison, C.; Farnault, L.; Fraitag, S.; Jullie, M.L.; Haroche, J.; Collin, M.; Allotey, J.; Madni, M.; Turner, K.; Picton, S.; Barbaro, P.M.; Poulin, A.; Tam, I.S.; Demellawy, D. el; Empringham, B.; Whitlock, J.A.; Raghunathan, A.; Swanson, A.A.; Suchi, M.; Brandt, J.M.; Yaseen, N.R.; Weinstein, J.L.; Eldem, I.; Sisk, B.A.; Sridhar, V.; Atkinson, M.; Massoth, L.R.; Hornick, J.L.; Alexandrescu, S.; Yeo, K.K.; Petrova-Drus, K.; Peeke, S.Z.; Munoz-Arcos, L.S.; Leino, D.G.; Grier, D.D.; Lorsbach, R.; Roy, S.; Kumar, A.R.; Garg, S.; Tiwari, N.; Schafernak, K.T.; Henry, M.M.; Halteren, A.G.S. van; Abla, O.; Diamond, E.L. & Emile, J.F. (2021), ALK-positive histiocytosis, Blood 139(2).
- Hernugrahanto, K.D.; Utomo, D.N.; Hariman, H.; Budhiparama, N.C.; Hertanto, D.M.; Santoso, D. & Hogendoorn, P.C.W. (2021), Thromboembolic involvement and its possible pathogenesis in COVID-19 mortality: lesson from post-mortem reports, European Review for Medical and Pharmacological Sciences 25(3): 1670-1679.
- Kemps, P.; Hebeda, K.; Pals, S.; Verdijk, R.; Lam, K.; Bruggink, A.; Lil, H. de; Ruiterkamp, B.; Heer, K. de; Laar, J. van; Valk, P.; Mutsaers, P.; Levin, M.D.; Hogendoorn, P. & Halteren, A. van (2021), SPECTRUM OF HISTIOCYTIC NEOPLASMS ASSOCIATED WITH DIVERSE HEMATOLOGICAL MALIGNANCIES BEARING THE SAME ONCOGENIC MUTATION, Pediatric Blood & Cancer 68.
- Hendriks, I.F.; Zhuravlev, D.A.; Bovill, J.G.; Boer, F.; Gaivoronskii, I.V.; Hogendoorn, P.C.W. & DeRuiter, M.C. (2020), Nikolay Ivanovich Pirogov (1810-1881), Clinical Anatomy 33(5): 714-730.
- Goriacheva, I.A., Military Medical Academy named S.M. Kirov, ul. Akademika Lebedeva 37, 194044 St.Petersburg, Russian Federation Gaivoronskii, I.V., Military Medical Academy named S.M. Kirov, ul. Akademika Lebedeva 37, 194044 St.Petersburg & Russian Federation (2020), The Dutchman Herman Boerhaave and the Russian Nikolay Ivanovich Pirogov are brilliant medical scientists, whose remembrance will be eternal., Vestnik Saint Petersburg University. Medicine. 15(2).
- D. A. Zhuravlev, Military Medical Museum, Lazeretniy pr. 2, St. Petersburg, 191180, Russian Federation. E. S. Houwaart, University of Maastricht, Peter Debyeplein 1, Postbus 616, 6200 MD Maastricht & the Netherlands. (2020), Nikolay Ivanovich Pirogov, Vestnik Saint Petersburg University. Medicine. 15(1).
- D. A. Zhuravlev, Military Medical Museum, St. Petersburg, Russian Federation. I. V. Gaivoronskii, Military Medical Academy named S.M. Kirov, St. Petersburg & Russian Federation (2020), Nikolay Ivanovich Pirogov as an innovator in anatomy, surgery, and anaesthesiology, Journal of Anatomy and Histopathology 9(3).
- D. A. Zhuravlev, Military Medical Museum, St. Petersburg, Russian Federation. E. S. Houwaart, University of Maastricht, Maastricht, the Netherlands. I. V. Gaivoronskii, Military Medical Academy named S.M Kirov, St. Petersburg & Russian Federation (2020), Highlights of the professional activities of Nikolay Ivanovich Pirogov before and after his professoriate in Saint Petersburg (1841–1860). Part I, Journal of Anatomy and Histopathology 9(2).
- Schutgens, E.M.; Picci, P.; Baumhoer, D.; Pollock, R.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Dijkstra, P.D.S.; Rueten-Budde, A.J.; Jutte, P.C.; Traub, F.; Leithner, A.; Tunn, P.U.; Funovics, P.; Sys, G.; San-Julian, M.; Schaap, G.R.; Durr, H.R.; Hardes, J.; Healey, J.; Capanna, R.; Biau, D.; Gomez-Brouchet, A.; Wunder, J.; Cosker, T.D.A.; Laitinen, M.K.; Niu, X.; Kostiuk, V.; Sande, M.A.J. van de & Adamantinoma Res Grp (2020), Surgical outcome and oncological survival of osteofibrous dysplasia-like and classic adamantinomas an international multicenter study of 318 cases, Journal of Bone and Joint Surgery 102(19): 1703-1713.
- Schutgens, E.M.; Picci, P.; Baumhoer, D.; Pollock, R.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Dijkstra, P.D.S.; Rueten-Budde, A.J.; Jutte, P.C.; Traub, F.; Leithner, A.; Tunn, P.U.; Funovics, P.; Sys, G.; San-Julian, M.; Schaap, G.R.; Durr, H.R.; Hardes, J.; Healey, J.; Capanna, R.; Biau, D.; Gomez-Brouchet, A.; Wunder, J.; Cosker, T.D.A.; Laitinen, M.K.; Niu, X.; Kostiuk, V.; Sande, M.A.J. van de & Adamantinoma Res Grp (2020), Surgical outcome and oncological survival of osteofibrous dysplasia-like and classic adamantinomas an international multicenter study of 318 cases, Journal of Bone and Joint Surgery 102(19): 1703-1713.
- Wang, X.D.; Zhang, X.H.; Pan, W.L.; Han, Y.D.; Li, Y.W.; Sun, H.B.; Hogendoorn, P.C.W. & Cheng, H. (2020), Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease, Virchows Archiv 479.
- Wang, X.D.; Zhang, X.H.; Pan, W.L.; Han, Y.D.; Li, Y.W.; Sun, H.B.; Hogendoorn, P.C.W. & Cheng, H. (2020), Co-existence of lung carcinoma metastasis and enchondroma in the femur of a patient with Ollier disease, Virchows Archiv 479.
- Lipplaa, A.; Kroep, J.R.; Heijden, L. van der; Jutte, P.C.; Hogendoorn, P.C.W.; Dijkstra, S. & Gelderblom, H. (2019), Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial, Oncologist 24(7): 889-+.
- D.A. Zhuravlev, Military Medical Museum, Lazeretniy 2, St.Petersburg, 191180, Russian Federation I.V. Gaivoronskii, Military Medical Academy S.M. Kirov, Ul. Akademika Lebedeva 6, St.Petersburg, 194044 & Russian Federation (2019), The development of Russian Medicine in the Petrine era and the role of Dutch doctors in this process., Vestnik Saint Petersburg University. Medicine. 14(2).
- Hendriks, I.F.; Zhuravlev, D.A.; Bovill, J.G.; Boer, F.; Gaivoronskii, I.V.; Hogendoorn, P.C.W. & DeRuiter, M.C. (2019), Nikolay Ivanovich Pirogov (1810–1881):Anatomical Research to Develop Surgery, Clinical Anatomy 00(0).
- Venneker, S.; Szuhai, K.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2019), Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma, Virchows Archiv.
- Edmunds, L.D.; Gluderer, S.; Ovseiko, P.V.; Kamerling, R.; Ton, J.; Vis, L.; Jenni, M.; Tutton, G.; Lawton-Smith, H.; Nadaban, M.V.; Rab, M.; Rees, J.; Anson, J.; Rushforth, A.D.; Allen, M.; Buchan, A.M.; Vendrell, M.; Casta, A.; Mehes, G.; Hogendoorn, P.C.W.; Hafen, E. & Hassan, A.B. (2019), New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project, Health Research Policy and Systems 17.
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2019), Non-ossifying fibroma: A RAS-MAPK driven benign bone neoplasm, Journal of Pathology 248(2): 127-130.
- Smeland, S.; Bielack, S.S.; Whelan, J.; Bernstein, M.; Hogendoorn, P.; Krailo, M.D.; Gorlick, R.; Janeway, K.A.; Ingleby, F.C.; Anninga, J.; Antal, I.; Arndt, C.; Brown, K.L.B.; Butterfass-Bahloul, T.; Calaminus, G.; Capra, M.; Dhooge, C.; Eriksson, M.; Flanagan, A.M.; Friedel, G.; Gebhardt, M.C.; Gelderblom, H.; Goldsby, R.; Grier, H.E.; Grimer, R.; Hawkins, D.S.; Hecker-Nolting, S.; Hall, K.S.; Isakoff, M.S.; Jovic, G.; Kuhne, T.; Kager, L.; Kalle, T. von; Kabickova, E.; Lang, S.; Lau, C.C.; Leavey, P.J.; Lessnick, S.L.; Mascarenhas, L.; Mayer-Steinacker, R.; Meyers, P.A.; Nagarajan, R.; Randall, R.L.; Reichardt, P.; Renard, M.; Rechnitzer, C.; Schwartz, C.L.; Strauss, S.; Teot, L.; Timmeimann, B.; Sydes, M.R. & Marina, N. (2019), Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort, European Journal of Cancer 109: 36-50.
- Smeland, S.; Bielack, S.S.; Whelan, J.; Bernstein, M.; Hogendoorn, P.; Krailo, M.D.; Gorlick, R.; Janeway, K.A.; Ingleby, F.C.; Anninga, J.; Antal, I.; Arndt, C.; Brown, K.L.B.; Butterfass-Bahloul, T.; Calaminus, G.; Capra, M.; Dhooge, C.; Eriksson, M.; Flanagan, A.M.; Friedel, G.; Gebhardt, M.C.; Gelderblom, H.; Goldsby, R.; Grier, H.E.; Grimer, R.; Hawkins, D.S.; Hecker-Nolting, S.; Hall, K.S.; Isakoff, M.S.; Jovic, G.; Kuhne, T.; Kager, L.; Kalle, T. von; Kabickova, E.; Lang, S.; Lau, C.C.; Leavey, P.J.; Lessnick, S.L.; Mascarenhas, L.; Mayer-Steinacker, R.; Meyers, P.A.; Nagarajan, R.; Randall, R.L.; Reichardt, P.; Renard, M.; Rechnitzer, C.; Schwartz, C.L.; Strauss, S.; Teot, L.; Timmeimann, B.; Sydes, M.R. & Marina, N. (2019), Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort, European Journal of Cancer 109: 36-50.
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2019), Non-ossifying fibroma: A RAS-MAPK driven benign bone neoplasm, Journal of Pathology 248(2): 127-130.
- Edmunds, L.D.; Gluderer, S.; Ovseiko, P.V.; Kamerling, R.; Ton, J.; Vis, L.; Jenni, M.; Tutton, G.; Lawton-Smith, H.; Nadaban, M.V.; Rab, M.; Rees, J.; Anson, J.; Rushforth, A.D.; Allen, M.; Buchan, A.M.; Vendrell, M.; Casta, A.; Mehes, G.; Hogendoorn, P.C.W.; Hafen, E. & Hassan, A.B. (2019), New indicators and indexes for benchmarking university-industry-government innovation in medical and life science clusters: results from the European FP7 Regions of Knowledge HealthTIES project, Health Research Policy and Systems 17.
- Venneker, S.; Szuhai, K.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2019), Mutation-driven epigenetic alterations as a defining hallmark of central cartilaginous tumours, giant cell tumour of bone and chondroblastoma, Virchows Archiv.
- Lancia, C.; Anninga, J.; Spitoni, C.; Sydes, M.R.; Whelan, J.; Hogendoorn, P.C.W.; Gelderblom, H. & Fiocco, M. (2019), Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma, BMJ Open 9(5).
- Lipplaa, A.; Kroep, J.R.; Heijden, L. van der; Jutte, P.C.; Hogendoorn, P.C.W.; Dijkstra, S. & Gelderblom, H. (2019), Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial., The Oncologist 24(7).
- Vries, W.M. de; Briaire-de Bruijn, I.H.; Benthem, P.P.G. van; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2019), M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma, Virchows Archiv 474(3): 375-381.
- Khalil, R.; Koop, K.; Kreutz, R.; Spaink, H.P.; Hogendoorn, P.C.W.; Bruijn, J.A. & Baelde, H.J. (2019), Increased dynamin expression precedes proteinuria in glomerular disease, Journal of Pathology 247(2): 177-185.
- Khalil, R.; Lalai, R.A.; Wiweger, M.I.; Avramut, C.M.; Koster, A.J.; Spaink, H.P.; Bruijn, J.A.; Hogendoorn, P.C.W. & Baelde, H.J. (2019), Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos, American Journal of Physiology - Renal Physiology 317(5): F1211-F1216.
- Groot, V. de; Verhelst, E.; Hogendoorn, P.C.W. & Keizer, R.J.W. de (2019), Conjunctival Leiomyosarcoma, a Rare Neoplasm Always Originating at the Limbus? Report of a New Case and Review of 11 Published Cases, Ocular Oncology and Pathology 5(5): 333-339.
- Lancia, C.; Anninga, J.K.; Sydes, M.R.; Spitoni, C.; Whelan, J.; Hogendoorn, P.C.W.; Gelderblom, H. & Fiocco, M. (2019), A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup, Cancer Chemotherapy and Pharmacology 83(5): 951-962.
- Hendriks, I.; Zhuravloyv, D.; Bovill, J.; Boer, F. & Hogendoorn, P. (2019), Women in healthcare in Imperial Russia, Journal of Medical Biography 29(1).
- Orekhov, A.V. (2019), The role of Dutch representatives in the development of medicine in Russia from the 9th to the 13th century, Vestnik Saint Petersburg University. Medicine. 14(1).
- D.A. Zhuravlev, Military Medical Museum, Lazeretniy 2, St.Petersburg, 191180, Russian Federation I.V. Gaivoronskii, Military Medical Academy S.M. Kirov, Ul. Akademika Lebedeva 6, St.Petersburg, 194044 & Russian Federation (2019), The development of Russian Medicine in the Petrine era and the role of Dutch doctors in this process., Vestnik Saint Petersburg University. Medicine. 14(2).
- Hendriks, I.F.; Zhuravlev, D.A.; Bovill, J.G.; Boer, F.; Gaivoronskii, I.V.; Hogendoorn, P.C.W. & DeRuiter, M.C. (2019), Nikolay Ivanovich Pirogov (1810–1881):Anatomical Research to Develop Surgery, Clinical Anatomy 00(0).
- Orekhov, A.V. (2019), The role of Dutch representatives in the development of medicine in Russia from the 9th to the 13th century, Vestnik Saint Petersburg University. Medicine. 14(1).
- Khalil, R.; Lalai, R.A.; Wiweger, M.I.; Avramut, C.M.; Koster, A.J.; Spaink, H.P.; Bruijn, J.A.; Hogendoorn, P.C.W. & Baelde, H.J. (2019), Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos, American Journal of Physiology - Renal Physiology 317(5).
- Lipplaa, A.; Kroep, J.R.; Heijden, L. van der; Jutte, P.C.; Hogendoorn, P.C.W.; Dijkstra, S. & Gelderblom, H. (2019), Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial., The Oncologist 24(7).
- Calaminus, G.; Jenney, M.; Hjorth, L.; Baust, K.; Bernstein, M.; Bielack, S.; Vos, P. de; Hogendoorn, P.C.W.; Jovic, G.; Krailo, M.; Kreitz, K.; Marina, N.; Popoola, B.O.; Sauerland, C.; Smeland, S.; Teske, C.; Schweinitz, C.V.; Whelan, J.; Wiener, A.; Sydes, M.R. & Nagarajan, R. (2019), Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy, JMIR Research Protocols 8(9).
- Calaminus, G.; Jenney, M.; Hjorth, L.; Baust, K.; Bernstein, M.; Bielack, S.; Vos, P. de; Hogendoorn, P.C.W.; Jovic, G.; Krailo, M.; Kreitz, K.; Marina, N.; Popoola, B.O.; Sauerland, C.; Smeland, S.; Teske, C.; Schweinitz, C.V.; Whelan, J.; Wiener, A.; Sydes, M.R. & Nagarajan, R. (2019), Quality of Life of Patients With Osteosarcoma in the European American Osteosarcoma Study-1 (EURAMOS-1): Development and Implementation of a Questionnaire Substudy, JMIR Research Protocols 8(9).
- Lipplaa, A.; Kroep, J.R.; Heijden, L. van der; Jutte, P.C.; Hogendoorn, P.C.W.; Dijkstra, S. & Gelderblom, H. (2019), Adjuvant Zoledronic Acid in High-Risk Giant Cell Tumor of Bone: A Multicenter Randomized Phase II Trial, Oncologist 24(7): 889-+.
- Lancia, C.; Anninga, J.K.; Sydes, M.R.; Spitoni, C.; Whelan, J.; Hogendoorn, P.C.W.; Gelderblom, H. & Fiocco, M. (2019), A novel method to address the association between received dose intensity and survival outcome: benefits of approaching treatment intensification at a more individualised level in a trial of the European Osteosarcoma Intergroup, Cancer Chemotherapy and Pharmacology 83(5): 951-962.
- Groot, V. de; Verhelst, E.; Hogendoorn, P.C.W. & Keizer, R.J.W. de (2019), Conjunctival Leiomyosarcoma, a Rare Neoplasm Always Originating at the Limbus? Report of a New Case and Review of 11 Published Cases, Ocular Oncology and Pathology 5(5): 333-339.
- Khalil, R.; Lalai, R.A.; Wiweger, M.I.; Avramut, C.M.; Koster, A.J.; Spaink, H.P.; Bruijn, J.A.; Hogendoorn, P.C.W. & Baelde, H.J. (2019), Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos, American Journal of Physiology - Renal Physiology 317(5).
- Khalil, R.; Lalai, R.A.; Wiweger, M.I.; Avramut, C.M.; Koster, A.J.; Spaink, H.P.; Bruijn, J.A.; Hogendoorn, P.C.W. & Baelde, H.J. (2019), Glomerular permeability is not affected by heparan sulfate glycosaminoglycan deficiency in zebrafish embryos, American Journal of Physiology - Renal Physiology 317(5): F1211-F1216.
- Khalil, R.; Koop, K.; Kreutz, R.; Spaink, H.P.; Hogendoorn, P.C.W.; Bruijn, J.A. & Baelde, H.J. (2019), Increased dynamin expression precedes proteinuria in glomerular disease, Journal of Pathology 247(2): 177-185.
- Vries, W.M. de; Briaire-de Bruijn, I.H.; Benthem, P.P.G. van; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2019), M-CSF and IL-34 expression as indicators for growth in sporadic vestibular schwannoma, Virchows Archiv 474(3): 375-381.
- Lancia, C.; Anninga, J.; Spitoni, C.; Sydes, M.R.; Whelan, J.; Hogendoorn, P.C.W.; Gelderblom, H. & Fiocco, M. (2019), Method to measure the mismatch between target and achieved received dose intensity of chemotherapy in cancer trials: a retrospective analysis of the MRC BO06 trial in osteosarcoma, BMJ Open 9(5).
- Bosma, S.E.; Driel, P.B.A.A. van; Hogendoorn, P.C.W.; Dijkstra, P.D.S. & Sier, C.F.M. (2018), Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma, Journal of Surgical Oncology 118(6): 906-914.
- Hendriks, I.F.; Bovill, J.G.; Luijt, P.A. van & Hogendoorn, P.C.W. (2018), Nikolay Ivanovich Pirogov (1810-1881): A pioneering Russian surgeon and medical scientist, Journal of Medical Biography 26(1): 10-22.
- Verschoor, A.J.; Bovee, J.V.M.G.; Overbeek, L.I.H.; Hogendoorn, P.C.W.; Gelderblom, H. & PALGA Grp (2018), The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study, Virchows Archiv 472(2): 221-229.
- Verschoor, A.J.; Bovee, J.V.M.G.; Overbeek, L.I.H.; Hogendoorn, P.C.W.; Gelderblom, H. & PALGA Grp (2018), The incidence, mutational status, risk classification and referral pattern of gastro-intestinal stromal tumours in the Netherlands: a nationwide pathology registry (PALGA) study, Virchows Archiv 472(2): 221-229.
- Hendriks, I.F.; Bovill, J.G.; Luijt, P.A. van & Hogendoorn, P.C.W. (2018), Nikolay Ivanovich Pirogov (1810-1881): A pioneering Russian surgeon and medical scientist, Journal of Medical Biography 26(1): 10-22.
- Wal, S. van der; Korne, C.M. de; Sand, L.G.L.; Willigen, D.M. van; Hogendoorn, P.C.W.; Szuhai, K.; Leeuwen, F.W.B. van & Buckle, T. (2018), Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches, ChemBioChem 19(16): 1758-1765.
- Bosma, S.E.; Driel, P.B.A.A. van; Hogendoorn, P.C.W.; Dijkstra, P.D.S. & Sier, C.F.M. (2018), Introducing fluorescence guided surgery into orthopedic oncology: A systematic review of candidate protein targets for Ewing sarcoma, Journal of Surgical Oncology 118(6): 906-914.
- Wal, S. van der; Korne, C.M. de; Sand, L.G.L.; Willigen, D.M. van; Hogendoorn, P.C.W.; Szuhai, K.; Leeuwen, F.W.B. van & Buckle, T. (2018), Bioorthogonally Applicable Fluorescence Deactivation Strategy for Receptor Kinetics Study and Theranostic Pretargeting Approaches, ChemBioChem 19(16): 1758-1765.
- Vries, M. de; Tellingen, O. van; Mey, A.G.L. van der; Bunt, A.M.G.; Briaire-de Bruijn, I. & Hogendoorn, P.C.W. (2017), BCRP expression in schwannoma, plexiform neurofibroma and MPNST, Oncotarget 8(51): 88751-88759.
- Casali, P.G.; Zalcberg, J.; Cesne, A. le; Reichardt, P.; Blay, J.Y.; Lindner, L.H.; Judson, I.R.; Schoffski, P.; Leyvraz, S.; Italiano, A.; Grunwald, V.; Pousa, A.L.; Kotasek, D.; Sleijfer, S.; Kerst, J.M.; Rutkowski, P.; Fumagalli, E.; Hogendoorn, P.; Litiere, S.; Marreaud, S.; Graaf, W. van der; Gronchi, A.; Verweij, J.; European Org Res Treatment Canc So; Italian Sarcoma Grp & Australasian Gastrointestinal Tria (2017), Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels, Journal of Clinical Oncology 35(15): 1713-+.
- Young, R.J.; Litiere, S.; Lia, M.; Hogendoorn, P.C.W.; Fisher, C.; Mechtersheimer, G.; Daugaard, S.; Sciot, R.; Collin, F.; Messiou, C.; Grunwald, V.; Gronchi, A.; Graaf, W. van der; Wardelmann, E. & Judson, I. (2017), Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study, Acta Oncologica 56(7): 1013-1020.
- Wal, S. van der; Korne, C.M. de; Sand, L.G.L.; Hogendoorn, P.C.W.; Szuhai, K.; Leeuwen, F.W.B. van & Buckle, T. (2017), Multicolor fluorescence click-chemistry as a means to select membrane targets for pre-targeting by function of their internalization, European Journal of Nuclear Medicine and Molecular Imaging 44: S206-S206.
- Wal, S. van der; Korne, C.M. de; Sand, L.G.L.; Hogendoorn, P.C.W.; Szuhai, K.; Leeuwen, F.W.B. van & Buckle, T. (2017), Multicolor fluorescence click-chemistry as a means to select membrane targets for pre-targeting by function of their internalization, European Journal of Nuclear Medicine and Molecular Imaging 44: S206-S206.
- Andritsch, E.; Beishon, M.; Bielack, S.; Bonvalot, S.; Casali, P.; Crul, M.; Delgado-Bolton, R.; Donatih, D.M.; Douis, H.; Haas, R.; Hogendoorn, P.; Kozhaeva, O.; Lavender, V.; Lovey, J.; Negrouk, A.; Pereira, P.; Roca, P.; Lempdes, G.R. de; Saarto, T.; Berck, B. van; Vassal, G.; Wartenberg, M.; Yared, W.; Costa, A. & Naredi, P. (2017), ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review, Critical Reviews in Oncology/Hematology 110: 94-105.
- Valkema, P.A.; Luymes, C.H.; Witteveen, J.E.; Cessie, S. le; Appelman-Dijkstra, N.M.; Hogendoorn, P.C.W. & Hamdy, N.A.T. (2017), High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis: survey of a Dutch cohort, Orphanet Journal of Rare Diseases 12.
- Sand, L.G.L.; Buckle, T.; Leeuwen, F.W.B. van; Corver, W.E.; Kruisselbrink, A.B.; Jochemsen, A.G.; Hogendoorn, P.C.W. & Szuhai, K. (2017), Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma, BMC Cancer 17.
- Sand, L.G.L.; Buckle, T.; Leeuwen, F.W.B. van; Corver, W.E.; Kruisselbrink, A.B.; Jochemsen, A.G.; Hogendoorn, P.C.W. & Szuhai, K. (2017), Fluorescent CXCR4 targeting peptide as alternative for antibody staining in Ewing sarcoma, BMC Cancer 17.
- Valkema, P.A.; Luymes, C.H.; Witteveen, J.E.; Cessie, S. le; Appelman-Dijkstra, N.M.; Hogendoorn, P.C.W. & Hamdy, N.A.T. (2017), High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis: survey of a Dutch cohort, Orphanet Journal of Rare Diseases 12.
- Casali, P.G.; Zalcberg, J.; Cesne, A. le; Reichardt, P.; Blay, J.Y.; Lindner, L.H.; Judson, I.R.; Schoffski, P.; Leyvraz, S.; Italiano, A.; Grunwald, V.; Pousa, A.L.; Kotasek, D.; Sleijfer, S.; Kerst, J.M.; Rutkowski, P.; Fumagalli, E.; Hogendoorn, P.; Litiere, S.; Marreaud, S.; Graaf, W. van der; Gronchi, A.; Verweij, J.; European Org Res Treatment Canc So; Italian Sarcoma Grp & Australasian Gastrointestinal Tria (2017), Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels, Journal of Clinical Oncology 35(15): 1713-+.
- Young, R.J.; Litiere, S.; Lia, M.; Hogendoorn, P.C.W.; Fisher, C.; Mechtersheimer, G.; Daugaard, S.; Sciot, R.; Collin, F.; Messiou, C.; Grunwald, V.; Gronchi, A.; Graaf, W. van der; Wardelmann, E. & Judson, I. (2017), Predictive and prognostic factors associated with soft tissue sarcoma response to chemotherapy: a subgroup analysis of the European Organisation for Research and Treatment of Cancer 62012 study, Acta Oncologica 56(7): 1013-1020.
- Vries, M. de; Tellingen, O. van; Mey, A.G.L. van der; Bunt, A.M.G.; Briaire-de Bruijn, I. & Hogendoorn, P.C.W. (2017), BCRP expression in schwannoma, plexiform neurofibroma and MPNST, Oncotarget 8(51): 88751-88759.
- Andritsch, E.; Beishon, M.; Bielack, S.; Bonvalot, S.; Casali, P.; Crul, M.; Delgado-Bolton, R.; Donatih, D.M.; Douis, H.; Haas, R.; Hogendoorn, P.; Kozhaeva, O.; Lavender, V.; Lovey, J.; Negrouk, A.; Pereira, P.; Roca, P.; Lempdes, G.R. de; Saarto, T.; Berck, B. van; Vassal, G.; Wartenberg, M.; Yared, W.; Costa, A. & Naredi, P. (2017), ECCO Essential Requirements for Quality Cancer Care: Soft Tissue Sarcoma in Adults and Bone Sarcoma. A critical review, Critical Reviews in Oncology/Hematology 110: 94-105.
- Beletkaia E., Fenz S.A., Pomp W., Snaar-Jagalska B.E., Hogendoorn P.W.C. & Schmidt T. (2016), CXCR4 signaling is controlled by immobilization at the plasma membrane, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863(4): 607–616.
- Verdegaal, S.H.M.; Rijswijk, C.S. van; Brouwers, H.F.C.; Dijkstra, P.D.S.; Sand, M.A.J. van de; Hogendoorn, P.C.W. & Taminiau, A.H.M. (2016), MRI appearances of atypical cartilaginous tumour/grade I chondrosarcoma after treatment by curettage, phenolisation and allografting, Bone and Joint Journal 98B(12): 1674-1681.
- Roos, E.; Coevorden, F. van; Verhoef, C.; Wouters, M.W.; Kroon, H.M.; Hogendoorn, P.C.W. & Houdt, W.J. van (2016), Prognosis of Primary and Recurrent Chondrosarcoma of the Rib, Annals of Surgical Oncology 23(3): 811-817.
- Roos, E.; Coevorden, F. van; Verhoef, C.; Wouters, M.W.; Kroon, H.M.; Hogendoorn, P.C.W. & Houdt, W.J. van (2016), Prognosis of Primary and Recurrent Chondrosarcoma of the Rib, Annals of Surgical Oncology 23(3): 811-817.
- Verdegaal, S.H.M.; Rijswijk, C.S. van; Brouwers, H.F.C.; Dijkstra, P.D.S.; Sand, M.A.J. van de; Hogendoorn, P.C.W. & Taminiau, A.H.M. (2016), MRI appearances of atypical cartilaginous tumour/grade I chondrosarcoma after treatment by curettage, phenolisation and allografting, Bone and Joint Journal 98B(12): 1674-1681.
- Cleven, A.H.G.; Sannaa, G.A. al; Briaire-de Bruijn, I.; Ingram, D.R.; Rijn, M. van de; Rubin, B.P.; Vries, M.W. de; Watson, K.L.; Torres, K.E.; Wang, W.L.; Duinen, S.G. van; Hogendoorn, P.C.W.; Lazar, A.J. & Bovee, J.V.M.G. (2016), Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival, Modern Pathology 29(6): 582-590.
- Valkema, P.; Luymes, C.; Witteveen, J.; Cessie, S. le; Appelman-Dijkstra, N.; Hogendoorn, P. & Hamdy, N. (2016), High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis, Virchows Archiv 469: S217-S217.
- Sand, L.G.L.; Berghuis, D.; Szuhai, K. & Hogendoorn, P.C.W. (2016), Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy, Cancer Immunology, Immunotherapy 65(8): 995-1002.
- Maldegem, A.M. van; Bovee, J.V.M.G.; Peterse, E.F.P.; Hogendoorn, P.C.W. & Gelderblom, H. (2016), Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway, European Journal of Cancer 53: 171-180.
- Beletkaia, E.; Fenz, S.F.; Pomp, W.; Snaar-Jagalska, B.E.; Hogendoorn, P.W.C. & Schmidt, T. (2016), CXCR4 signaling is controlled by immobilization at the plasma membrane, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863(4): 607-616.
- Marina, N.M.; Smeland, S.; Bielack, S.S.; Bernstein, M.; Jovic, G.; Krailo, M.D.; Hook, J.M.; Arndt, C.; Berg, H. van den; Brennan, B.; Brichard, B.; Brown, K.L.B.; Butterfass-Bahloul, T.; Calaminus, G.; Daldrup-Link, H.E.; Eriksson, M.; Gebhardt, M.C.; Gelderblom, H.; Gerss, J.; Goldsby, R.; Goorin, A.; Gorlick, R.; Grier, H.E.; Hale, J.P.; Hall, K.S.; Hardes, J.; Hawkins, D.S.; Helmke, K.; Hogendoorn, P.C.W.; Isakoff, M.S.; Janeway, K.A.; Jurgens, H.; Kager, L.; Kuhne, T.; Lau, C.C.; Leavey, P.J.; Lessnick, S.L.; Mascarenhas, L.; Meyers, P.A.; Mottl, H.; Nathrath, M.; Papai, Z.; Randall, R.L.; Reichardt, P.; Renard, M.; Safwat, A.A.; Schwartz, C.L.; Stevens, M.C.G.; Strauss, S.J.; Teot, L.; Werner, M.; Sydes, M.R. & Whelan, J.S. (2016), Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial, The Lancet Oncology 17(10): 1396-1408.
- Ent, W. van der; Veneman, W.J.; Groenewoud, A.; Chen, L.P.; Tulotta, C.; Hogendoorn, P.C.W.; Spaink, H.P.; Snaar-Jagalska, B.E. & Langenau, D.M. (2016), Automation of Technology for Cancer Research, Advances in Experimental Medicine and Biology 916: 315-332.
- Ent, W. van der; Veneman, W.J.; Groenewoud, A.; Chen, L.P.; Tulotta, C.; Hogendoorn, P.C.W.; Spaink, H.P.; Snaar-Jagalska, B.E. & Langenau, D.M. (2016), Automation of Technology for Cancer Research, Advances in Experimental Medicine and Biology 916: 315-332.
- Marina, N.M.; Smeland, S.; Bielack, S.S.; Bernstein, M.; Jovic, G.; Krailo, M.D.; Hook, J.M.; Arndt, C.; Berg, H. van den; Brennan, B.; Brichard, B.; Brown, K.L.B.; Butterfass-Bahloul, T.; Calaminus, G.; Daldrup-Link, H.E.; Eriksson, M.; Gebhardt, M.C.; Gelderblom, H.; Gerss, J.; Goldsby, R.; Goorin, A.; Gorlick, R.; Grier, H.E.; Hale, J.P.; Hall, K.S.; Hardes, J.; Hawkins, D.S.; Helmke, K.; Hogendoorn, P.C.W.; Isakoff, M.S.; Janeway, K.A.; Jurgens, H.; Kager, L.; Kuhne, T.; Lau, C.C.; Leavey, P.J.; Lessnick, S.L.; Mascarenhas, L.; Meyers, P.A.; Mottl, H.; Nathrath, M.; Papai, Z.; Randall, R.L.; Reichardt, P.; Renard, M.; Safwat, A.A.; Schwartz, C.L.; Stevens, M.C.G.; Strauss, S.J.; Teot, L.; Werner, M.; Sydes, M.R. & Whelan, J.S. (2016), Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial, The Lancet Oncology 17(10): 1396-1408.
- Beletkaia, E.; Fenz, S.F.; Pomp, W.; Snaar-Jagalska, B.E.; Hogendoorn, P.W.C. & Schmidt, T. (2016), CXCR4 signaling is controlled by immobilization at the plasma membrane, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863(4): 607-616.
- Maldegem, A.M. van; Bovee, J.V.M.G.; Peterse, E.F.P.; Hogendoorn, P.C.W. & Gelderblom, H. (2016), Ewing sarcoma: The clinical relevance of the insulin-like growth factor 1 and the poly-ADP-ribose-polymerase pathway, European Journal of Cancer 53: 171-180.
- Sand, L.G.L.; Berghuis, D.; Szuhai, K. & Hogendoorn, P.C.W. (2016), Expression of CCL21 in Ewing sarcoma shows an inverse correlation with metastases and is a candidate target for immunotherapy, Cancer Immunology, Immunotherapy 65(8): 995-1002.
- Valkema, P.; Luymes, C.; Witteveen, J.; Cessie, S. le; Appelman-Dijkstra, N.; Hogendoorn, P. & Hamdy, N. (2016), High prevalence of autoimmune disease in the rare inflammatory bone disorder sternocostoclavicular hyperostosis, Virchows Archiv 469: S217-S217.
- Cleven, A.H.G.; Sannaa, G.A. al; Briaire-de Bruijn, I.; Ingram, D.R.; Rijn, M. van de; Rubin, B.P.; Vries, M.W. de; Watson, K.L.; Torres, K.E.; Wang, W.L.; Duinen, S.G. van; Hogendoorn, P.C.W.; Lazar, A.J. & Bovee, J.V.M.G. (2016), Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival, Modern Pathology 29(6): 582-590.
- Baranski, Z.; Booij, T.H.; Cleton-Jansen, A.M.; Price, L.S.; Water, B. van de; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Danen, E.H.J. (2015), Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma, Journal of Pathology 236(3): 348-359.
- Sand, L.G.L.; Szuhai, K. & Hogendoorn, P.C.W. (2015), Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes, International Journal of Molecular Sciences 16(7): 16176.
- Graaff, M.A. de; Jong, D. de; Briaire-De Bruijn, I.H.; Hogendoorn, P.C.W.; Bovee, J.V.M.G. & Szuhai, K. (2015), A translocation t(6;14) in two cases of leiomyosarcoma: Molecular cytogenetic and array-based comparative genomic hybridization characterization, Cancer Genetics 208(11): 537-544.
- Heijden, L. van der; Sande, M.A.J. van de; Hogendoorn, P.C.W.; Gelderblom, H. & Dijkstra, P.D.S. (2015), Neoadjuvant denosumab for extensive giant cell tumor in os ischium - a case report, Acta Orthopaedica 86(3): 393-395.
- Baranski, Z.; Jong, Y. de; Ilkova, T.; Peterse, E.F.P.; Cleton-Jansen, A.M.; Water, B. van de; Hogendoorn, P.C.W.; Bovee, J.V.M.G. & Danen, E.H.J. (2015), Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin, Oncotarget 6(34): 36113-36125.
- Cleven, A.H.G.; Zwartkruis, E.; Hogendoorn, P.C.W.; Kroon, H.M.; Briaire-de Bruijn, I. & Bovee, J.V.M.G. (2015), Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype, Histopathology 67(4): 483-490.
- Hendriks, I.F.; Bovill, J.G.; Boer, F.; Houwaart, E.S. & Hogendoorn, P.C.W. (2015), Nikolay Ivanovich Pirogov: a surgeon's contribution to military and civilian anaesthesia, Anaesthesia 70(2): 219-227.
- Sand, L.G.L.; Jochemsen, A.G.; Beletkaia, E.; Schmidt, T.; Hogendoorn, P.C.W. & Szuhai, K. (2015), Novel splice variants of CXCR4 identified by transcriptome sequencing, Biochemical and Biophysical Research Communications 466(1): 89-94.
- Balluff, B.; Frese, C.K.; Maier, S.K.; Schone, C.; Kuster, B.; Schmitt, M.; Aubele, M.; Hofler, H.; Deelder, A.M.; Heck, A.J.R.; Hogendoorn, P.C.W.; Morreau, J.; Altelaar, A.F.M.; Walch, A. & McDonnell, L.A. (2015), De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry, Journal of Pathology 235(1): 3-13.
- Whelan, J.S.; Bielack, S.S.; Marina, N.; Smeland, S.; Jovic, G.; Hook, J.M.; Krailo, M.; Anninga, J.; Butterfass-Bahloul, T.; Bohling, T.; Calaminus, G.; Capra, M.; Deffenbaugh, C.; Dhooge, C.; Eriksson, M.; Flanagan, A.M.; Gelderblom, H.; Goorin, A.; Gorlick, R.; Gosheger, G.; Grimer, R.J.; Hall, K.S.; Helmke, K.; Hogendoorn, P.C.W.; Jundt, G.; Kager, L.; Kuehne, T.; Lau, C.C.; Letson, G.D.; Meyer, J.; Meyers, P.A.; Morris, C.; Mottl, H.; Nadel, H.; Nagarajan, R.; Randall, R.L.; Schomberg, P.; Schwarz, R.; Teot, L.A.; Sydes, M.R.; Bernstein, M. & EURAMOS Collaborators (2015), EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment, Annals of Oncology 26(2): 407-414.
- Hoekstra, A.S.; Graaff, M.A. de; Briaire-de Bruijn, I.H.; Ras, C.; Seifar, R.M.; Minderhout, I. van; Cornelisse, C.J.; Hogendoorn, P.C.W.; Breuning, M.H.; Suijker, J.; Korpershoek, E.; Kunst, H.P.M.; Frizzell, N.; Devilee, P.; Bayley, J.P. & Bovee, J.V.M.G. (2015), Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors, Oncotarget 6(36): 38777-38788.
- Bielack, S.S.; Smeland, S.; Whelan, J.S.; Marina, N.; Jovic, G.; Hook, J.M.; Krailo, M.D.; Gebhardt, M.; Papai, Z.; Meyer, J.; Nadel, H.; Randall, R.L.; Deffenbaugh, C.; Nagarajan, R.; Brennan, B.; Letson, G.D.; Teot, L.A.; Goorin, A.; Baumhoer, D.; Kager, L.; Werner, M.; Lau, C.C.; Hall, K.S.; Gelderblom, H.; Meyers, P.; Gorlick, R.; Windhager, R.; Helmke, K.; Eriksson, M.; Hoogerbrugge, P.M.; Schomberg, P.; Tunn, P.U.; Kuhne, T.; Jurgens, H.; Berg, H. van den; Bohling, T.; Picton, S.; Renard, M.; Reichardt, P.; Gerss, J.; Butterfass-Bahloul, T.; Morris, C.; Hogendoorn, P.C.W.; Seddon, B.; Calaminus, G.; Michelagnoli, M.; Dhooge, C.; Sydes, M.R.; Bernstein, M. & EURAMOS-1 Investigators (2015), Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial, Journal of Clinical Oncology 33(20): 2279-U92.
- Sand, L.G.L.; Scotlandi, K.; Berghuis, D.; Snaar-Jagalska, B.E.; Picci, P.; Schmidt, T.; Szuhai, K. & Hogendoorn, P.C.W. (2015), CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients, European Journal of Cancer 51(17): 2624-2633.
- Vries, M. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2015), Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics, Otology and Neurotology 36(7): 1128-1136.
- Buddingh, E.P.; Ruslan, S.E.N.; Reijnders, C.M.A.; Szuhai, K.; Kuijjer, M.L.; Roelofs, H.; Hogendoorn, P.C.W.; Egeler, R.M.; Cleton-Jansen, A.M. & Lankester, A.C. (2015), Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture, Clinical Sarcoma Research 5.
- Vries, M. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2015), Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics, Otology and Neurotology.
- Houwaart, ES, Professor of Medical History, Department of Health, Ethics and Society, University of Maastricht, Maastricht & The Netherlands. (2015), Nikolay Ivanovich Pirogov: a surgeon’s contribution to military and civilian anaesthesia., Anaesthesia 70(2).
- Houwaart, ES, Professor of Medical History, Department of Health, Ethics and Society, University of Maastricht, Maastricht & The Netherlands. (2015), Nikolay Ivanovich Pirogov: a surgeon’s contribution to military and civilian anaesthesia., Anaesthesia 70(2).
- Vries, M. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2015), Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics, Otology and Neurotology.
- Sand, L.G.L.; Szuhai, K. & Hogendoorn, P.C.W. (2015), Sequencing Overview of Ewing Sarcoma: A Journey across Genomic, Epigenomic and Transcriptomic Landscapes, International Journal of Molecular Sciences 16(7): 16176.
- Sand, L.G.L.; Scotlandi, K.; Berghuis, D.; Snaar-Jagalska, B.E.; Picci, P.; Schmidt, T.; Szuhai, K. & Hogendoorn, P.C.W. (2015), CXCL14, CXCR7 expression and CXCR4 splice variant ratio associate with survival and metastases in Ewing sarcoma patients, European Journal of Cancer 51(17): 2624-2633.
- Graaff, M.A. de; Jong, D. de; Briaire-De Bruijn, I.H.; Hogendoorn, P.C.W.; Bovee, J.V.M.G. & Szuhai, K. (2015), A translocation t(6;14) in two cases of leiomyosarcoma: Molecular cytogenetic and array-based comparative genomic hybridization characterization, Cancer Genetics 208(11): 537-544.
- Sand, L.G.L.; Jochemsen, A.G.; Beletkaia, E.; Schmidt, T.; Hogendoorn, P.C.W. & Szuhai, K. (2015), Novel splice variants of CXCR4 identified by transcriptome sequencing, Biochemical and Biophysical Research Communications 466(1): 89-94.
- Hendriks, I.F.; Bovill, J.G.; Boer, F.; Houwaart, E.S. & Hogendoorn, P.C.W. (2015), Nikolay Ivanovich Pirogov: a surgeon's contribution to military and civilian anaesthesia, Anaesthesia 70(2): 219-227.
- Baranski, Z.; Jong, Y. de; Ilkova, T.; Peterse, E.F.P.; Cleton-Jansen, A.M.; Water, B. van de; Hogendoorn, P.C.W.; Bovee, J.V.M.G. & Danen, E.H.J. (2015), Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin, Oncotarget 6(34): 36113-36125.
- Baranski, Z.; Booij, T.H.; Cleton-Jansen, A.M.; Price, L.S.; Water, B. van de; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Danen, E.H.J. (2015), Aven-mediated checkpoint kinase control regulates proliferation and resistance to chemotherapy in conventional osteosarcoma, Journal of Pathology 236(3): 348-359.
- Hoekstra, A.S.; Graaff, M.A. de; Briaire-de Bruijn, I.H.; Ras, C.; Seifar, R.M.; Minderhout, I. van; Cornelisse, C.J.; Hogendoorn, P.C.W.; Breuning, M.H.; Suijker, J.; Korpershoek, E.; Kunst, H.P.M.; Frizzell, N.; Devilee, P.; Bayley, J.P. & Bovee, J.V.M.G. (2015), Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors, Oncotarget 6(36): 38777-38788.
- Vries, M. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2015), Tumor Biology of Vestibular Schwannoma: A Review of Experimental Data on the Determinants of Tumor Genesis and Growth Characteristics, Otology and Neurotology 36(7): 1128-1136.
- Whelan, J.S.; Bielack, S.S.; Marina, N.; Smeland, S.; Jovic, G.; Hook, J.M.; Krailo, M.; Anninga, J.; Butterfass-Bahloul, T.; Bohling, T.; Calaminus, G.; Capra, M.; Deffenbaugh, C.; Dhooge, C.; Eriksson, M.; Flanagan, A.M.; Gelderblom, H.; Goorin, A.; Gorlick, R.; Gosheger, G.; Grimer, R.J.; Hall, K.S.; Helmke, K.; Hogendoorn, P.C.W.; Jundt, G.; Kager, L.; Kuehne, T.; Lau, C.C.; Letson, G.D.; Meyer, J.; Meyers, P.A.; Morris, C.; Mottl, H.; Nadel, H.; Nagarajan, R.; Randall, R.L.; Schomberg, P.; Schwarz, R.; Teot, L.A.; Sydes, M.R.; Bernstein, M. & EURAMOS Collaborators (2015), EURAMOS-1, an international randomised study for osteosarcoma: results from pre-randomisation treatment, Annals of Oncology 26(2): 407-414.
- Cleven, A.H.G.; Zwartkruis, E.; Hogendoorn, P.C.W.; Kroon, H.M.; Briaire-de Bruijn, I. & Bovee, J.V.M.G. (2015), Periosteal chondrosarcoma: a histopathological and molecular analysis of a rare chondrosarcoma subtype, Histopathology 67(4): 483-490.
- Balluff, B.; Frese, C.K.; Maier, S.K.; Schone, C.; Kuster, B.; Schmitt, M.; Aubele, M.; Hofler, H.; Deelder, A.M.; Heck, A.J.R.; Hogendoorn, P.C.W.; Morreau, J.; Altelaar, A.F.M.; Walch, A. & McDonnell, L.A. (2015), De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry, Journal of Pathology 235(1): 3-13.
- Heijden, L. van der; Sande, M.A.J. van de; Hogendoorn, P.C.W.; Gelderblom, H. & Dijkstra, P.D.S. (2015), Neoadjuvant denosumab for extensive giant cell tumor in os ischium - a case report, Acta Orthopaedica 86(3): 393-395.
- Bielack, S.S.; Smeland, S.; Whelan, J.S.; Marina, N.; Jovic, G.; Hook, J.M.; Krailo, M.D.; Gebhardt, M.; Papai, Z.; Meyer, J.; Nadel, H.; Randall, R.L.; Deffenbaugh, C.; Nagarajan, R.; Brennan, B.; Letson, G.D.; Teot, L.A.; Goorin, A.; Baumhoer, D.; Kager, L.; Werner, M.; Lau, C.C.; Hall, K.S.; Gelderblom, H.; Meyers, P.; Gorlick, R.; Windhager, R.; Helmke, K.; Eriksson, M.; Hoogerbrugge, P.M.; Schomberg, P.; Tunn, P.U.; Kuhne, T.; Jurgens, H.; Berg, H. van den; Bohling, T.; Picton, S.; Renard, M.; Reichardt, P.; Gerss, J.; Butterfass-Bahloul, T.; Morris, C.; Hogendoorn, P.C.W.; Seddon, B.; Calaminus, G.; Michelagnoli, M.; Dhooge, C.; Sydes, M.R.; Bernstein, M. & EURAMOS-1 Investigators (2015), Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial, Journal of Clinical Oncology 33(20): 2279-U92.
- Buddingh, E.P.; Ruslan, S.E.N.; Reijnders, C.M.A.; Szuhai, K.; Kuijjer, M.L.; Roelofs, H.; Hogendoorn, P.C.W.; Egeler, R.M.; Cleton-Jansen, A.M. & Lankester, A.C. (2015), Mesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture, Clinical Sarcoma Research 5.
- (2015), De Jhr prof. dr Jaap de Graeff-penning door Frank Letterie, De Beeldenaar 39(2).
- Ent W. van der, Jochemsen A.G., Teunisse A.F., Krens S.G., Szuhai K., Spaink H.P., Hogendoorn P.C. & Snaar-Jagalska B.E. (2014), Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53, Journal of Pathology 223(4): 415-424.
- Wiweger, M.I.; Andrea, C.E. de; Scheepstra, K.W.F.; Zhao, Z. & Hogendoorn, P.C.W. (2014), Possible effects of EXT2 on mesenchymal differentiation - lessons from the zebrafish, Orphanet Journal of Rare Diseases 9.
- Duijsens, H.M.; Vanhoenacker, F.M.; Braak, B.P. ter; Hogendoorn, P.C. & Kroon, H.M. (2014), PRIMARY INTRAOSSEOUS MANIFESTATION OF ROSAI-DORFMAN DISEASE: 2 CASES AND REVIEW OF LITERATURE, Jbr-btr 97(2): 84-89.
- Buhnemann, C.; Li, S.; Yu, H.Y.; White, H.B.; Schafer, K.L.; Llombart-Bosch, A.; Machado, I.; Picci, P.; Hogendoorn, P.C.W.; Athanasou, N.A.; Noble, J.A. & Hassan, A.B. (2014), Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis, PLoS ONE 9(9).
- Heijden, L. van der; Dijkstra, P.D.S.; Sande, M.A.J. van de; Kroep, J.R.; Nout, R.A.; Rijswijk, C.S.P. van; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Gelderblom, H. (2014), The Clinical Approach Toward Giant Cell Tumor of Bone, The Oncologist 19(5): 550-561.
- Rajnai, H.; Heyning, F.H.; Koens, L.; Sebestyen, A.; Andrikovics, H.; Hogendoorn, P.C.W.; Matolcsy, A. & Szepesi, A. (2014), The density of CD8+T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone, Virchows Archiv 464(2): 229-239.
- Beletkaia, E.; Fenz, S.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2014), The Molecular Mechanisms of Gradient Sensing by CXCR4, Biophysical Journal 106(2): 519A-519A.
- Szuhai, K.; Jong, D. de; Leung, W.Y.; Fletcher, C.D.M. & Hogendoorn, P.C.W. (2014), Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma, Journal of Pathology 232(3): 300-307.
- Mohseny, A.B.; Hogendoorn, P.C.W. & Kleinerman, E.S. (2014), Zebrafish as a Model for Human Osteosarcoma, Advances in Experimental Medicine and Biology 804: 221-236.
- Mohseny, A.B.; Hogendoorn, P.C.W. & Kleinerman, E.S. (2014), Zebrafish as a Model for Human Osteosarcoma, Advances in Experimental Medicine and Biology 804: 221-236.
- Szuhai, K.; Jong, D. de; Leung, W.Y.; Fletcher, C.D.M. & Hogendoorn, P.C.W. (2014), Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma, Journal of Pathology 232(3): 300-307.
- Beletkaia, E.; Fenz, S.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2014), The Molecular Mechanisms of Gradient Sensing by CXCR4, Biophysical Journal 106(2): 519A-519A.
- Rajnai, H.; Heyning, F.H.; Koens, L.; Sebestyen, A.; Andrikovics, H.; Hogendoorn, P.C.W.; Matolcsy, A. & Szepesi, A. (2014), The density of CD8+T-cell infiltration and expression of BCL2 predicts outcome of primary diffuse large B-cell lymphoma of bone, Virchows Archiv 464(2): 229-239.
- Heijden, L. van der; Dijkstra, P.D.S.; Sande, M.A.J. van de; Kroep, J.R.; Nout, R.A.; Rijswijk, C.S.P. van; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Gelderblom, H. (2014), The Clinical Approach Toward Giant Cell Tumor of Bone, The Oncologist 19(5): 550-561.
- Buhnemann, C.; Li, S.; Yu, H.Y.; White, H.B.; Schafer, K.L.; Llombart-Bosch, A.; Machado, I.; Picci, P.; Hogendoorn, P.C.W.; Athanasou, N.A.; Noble, J.A. & Hassan, A.B. (2014), Quantification of the Heterogeneity of Prognostic Cellular Biomarkers in Ewing Sarcoma Using Automated Image and Random Survival Forest Analysis, PLoS ONE 9(9).
- Duijsens, H.M.; Vanhoenacker, F.M.; Braak, B.P. ter; Hogendoorn, P.C. & Kroon, H.M. (2014), PRIMARY INTRAOSSEOUS MANIFESTATION OF ROSAI-DORFMAN DISEASE: 2 CASES AND REVIEW OF LITERATURE, Jbr-btr 97(2): 84-89.
- Wiweger, M.I.; Andrea, C.E. de; Scheepstra, K.W.F.; Zhao, Z. & Hogendoorn, P.C.W. (2014), Possible effects of EXT2 on mesenchymal differentiation - lessons from the zebrafish, Orphanet Journal of Rare Diseases 9.
- Kuijjer, M.L.; Akker, B.E.W.M. van den; Hilhorst, R.; Mommersteeg, M.; Buddingh, E.P.; Serra, M.; Burger, H.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2014), Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy, BMC Medical Genomics 7.
- Nord, K.H.; Lilljebjorn, H.; Vezzi, F.; Nilsson, J.; Magnusson, L.; Tayebwa, J.; Jong, D. de; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Szuhai, K. (2014), GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma, Nature Genetics 46(5): 474-477.
- Heijden, L. van der; Dijkstra, P.D.S.; Sande, M.A.J. van de; Kroep, J.R.; Nout, R.A.; Rijswijk, C.S.P. van; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Gelderblom, H. (2014), Giant Cell Tumor of Bone Reply, The Oncologist 19(11): 1208-1208.
- Lieveld, M.; Bodson, E.; Boeck, G. de; Nouman, B.; Cleton-Jansen, A.M.; Korsching, E.; Benassi, M.S.; Picci, P.; Sys, G.; Poffyn, B.; Athanasou, N.A.; Hogendoorn, P.C.W. & Forsyth, R.G. (2014), Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis, Virchows Archiv 465(6): 703-713.
- Ent, W. van der; Jochemsen, A.G.; Teunisse, A.F.A.S.; Krens, S.F.G.; Szuhai, K.; Spaink, H.P.; Hogendoorn, P.C.W. & Snaar-Jagalska, B.E. (2014), Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53, Journal of Pathology 233(4): 415-424.
- Cesne, A. le; Ouali, M.; Leahy, M.G.; Santoro, A.; Hoekstra, H.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Hoesel, R. van; Verweij, J.; Bonvalot, S.; Steward, W.P.; Gronchi, A.; Hogendoorn, P.C.W.; Litiere, S.; Marreaud, S.; Blay, J.Y. & Graaf, W.T.A. van der (2014), Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials, Annals of Oncology 25(12): 2425-2432.
- Judson, I.; Verweij, J.; Gelderblom, H.; Hartmann, J.T.; Schoffski, P.; Blay, J.Y.; Kerst, J.M.; Sufliarsky, J.; Whelan, J.; Hohenberger, P.; Krarup-Hansen, A.; Alcindor, T.; Marreaud, S.; Litiere, S.; Hermans, C.; Fisher, C.; Hogendoorn, P.C.W.; Tos, A.P. dei; Graaf, W.T.A. van der; European Org & Treatment Canc Soft Tissue Bone Sa (2014), Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial, The Lancet Oncology 15(4): 415-423.
- Sand, L.; Szuhai, K.; Berghuis, D. & Hogendoorn, P.C.W. (2014), CXCR4 splice variant ratio, CXCL14 and CXCR7 predict survival in Ewing sarcoma by inhibiting CXCR4 activation, Virchows Archiv 465: S17-S17.
- Kajtar, B.; Tornoczky, T.; Kalman, E.; Kuzsner, J.; Hogendoorn, P.C.W. & Szuhai, K. (2014), CD99-positive undifferentiated round cell sarcoma diagnosed on fine needle aspiration cytology, later found to harbour a CIC-DUX4 translocation: a recently described entity, Cytopathology 25(2): 129-132.
- Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, S.; Kerst, J.M.; Rutkowski, P.; Bauer, S.; Ouali, M.; Marreaud, S.; Straaten, R.J.H.M. van der; Guchelaar, H.J.; Weitman, S.D.; Hogendoorn, P.C.W. & Hohenberger, P. (2014), Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study, European Journal of Cancer 50(2): 388-396.
- Pappo, A.S.; Vassal, G.; Crowley, J.J.; Bolejack, V.; Hogendoorn, P.C.W.; Chugh, R.; Ladanyi, M.; Grippo, J.F.; Dall, G.; Staddon, A.P.; Chawla, S.P.; Maki, R.G.; Araujo, D.M.; Geoerger, B.; Ganjoo, K.; Marina, N.; Blay, J.Y.; Schuetze, S.M.; Chow, W.A. & Helman, L.J. (2014), A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study, Cancer 120(16): 2448-2456.
- Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; Jesus, J.M. de; Miller, N.H.; Hubbard, V.S.; Lee, I.M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E.; Nonas, C.A.; Sacks, F.M.; Smith, S.C.; Svetkey, L.P.; Wadden, T.A. & Yanovski, S.Z. (2014), 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Journal of the American College of Cardiology 63(25): 2960-2984.
- Eckel, R.H.; Jakicic, J.M.; Ard, J.D.; Jesus, J.M. de; Miller, N.H.; Hubbard, V.S.; Lee, I.M.; Lichtenstein, A.H.; Loria, C.M.; Millen, B.E.; Nonas, C.A.; Sacks, F.M.; Smith, S.C.; Svetkey, L.P.; Wadden, T.A. & Yanovski, S.Z. (2014), 2013 AHA/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, Journal of the American College of Cardiology 63(25): 2960-2984.
- Pappo, A.S.; Vassal, G.; Crowley, J.J.; Bolejack, V.; Hogendoorn, P.C.W.; Chugh, R.; Ladanyi, M.; Grippo, J.F.; Dall, G.; Staddon, A.P.; Chawla, S.P.; Maki, R.G.; Araujo, D.M.; Geoerger, B.; Ganjoo, K.; Marina, N.; Blay, J.Y.; Schuetze, S.M.; Chow, W.A. & Helman, L.J. (2014), A Phase 2 Trial of R1507, a Monoclonal Antibody to the Insulin-Like Growth Factor-1 Receptor (IGF-1R), in Patients With Recurrent or Refractory Rhabdomyosarcoma, Osteosarcoma, Synovial Sarcoma, and Other Soft Tissue Sarcomas Results of a Sarcoma Alliance for Research Through Collaboration Study, Cancer 120(16): 2448-2456.
- Gelderblom, H.; Blay, J.Y.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.; Sleijfer, S.; Kerst, J.M.; Rutkowski, P.; Bauer, S.; Ouali, M.; Marreaud, S.; Straaten, R.J.H.M. van der; Guchelaar, H.J.; Weitman, S.D.; Hogendoorn, P.C.W. & Hohenberger, P. (2014), Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study, European Journal of Cancer 50(2): 388-396.
- Kajtar, B.; Tornoczky, T.; Kalman, E.; Kuzsner, J.; Hogendoorn, P.C.W. & Szuhai, K. (2014), CD99-positive undifferentiated round cell sarcoma diagnosed on fine needle aspiration cytology, later found to harbour a CIC-DUX4 translocation: a recently described entity, Cytopathology 25(2): 129-132.
- Sand, L.; Szuhai, K.; Berghuis, D. & Hogendoorn, P.C.W. (2014), CXCR4 splice variant ratio, CXCL14 and CXCR7 predict survival in Ewing sarcoma by inhibiting CXCR4 activation, Virchows Archiv 465: S17-S17.
- Judson, I.; Verweij, J.; Gelderblom, H.; Hartmann, J.T.; Schoffski, P.; Blay, J.Y.; Kerst, J.M.; Sufliarsky, J.; Whelan, J.; Hohenberger, P.; Krarup-Hansen, A.; Alcindor, T.; Marreaud, S.; Litiere, S.; Hermans, C.; Fisher, C.; Hogendoorn, P.C.W.; Tos, A.P. dei; Graaf, W.T.A. van der; European Org & Treatment Canc Soft Tissue Bone Sa (2014), Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial, The Lancet Oncology 15(4): 415-423.
- Cesne, A. le; Ouali, M.; Leahy, M.G.; Santoro, A.; Hoekstra, H.J.; Hohenberger, P.; Coevorden, F. van; Rutkowski, P.; Hoesel, R. van; Verweij, J.; Bonvalot, S.; Steward, W.P.; Gronchi, A.; Hogendoorn, P.C.W.; Litiere, S.; Marreaud, S.; Blay, J.Y. & Graaf, W.T.A. van der (2014), Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC phase III clinical trials, Annals of Oncology 25(12): 2425-2432.
- Ent, W. van der; Jochemsen, A.G.; Teunisse, A.F.A.S.; Krens, S.F.G.; Szuhai, K.; Spaink, H.P.; Hogendoorn, P.C.W. & Snaar-Jagalska, B.E. (2014), Ewing sarcoma inhibition by disruption of EWSR1-FLI1 transcriptional activity and reactivation of p53, Journal of Pathology 233(4): 415-424.
- Lieveld, M.; Bodson, E.; Boeck, G. de; Nouman, B.; Cleton-Jansen, A.M.; Korsching, E.; Benassi, M.S.; Picci, P.; Sys, G.; Poffyn, B.; Athanasou, N.A.; Hogendoorn, P.C.W. & Forsyth, R.G. (2014), Gene expression profiling of giant cell tumor of bone reveals downregulation of extracellular matrix components decorin and lumican associated with lung metastasis, Virchows Archiv 465(6): 703-713.
- Heijden, L. van der; Dijkstra, P.D.S.; Sande, M.A.J. van de; Kroep, J.R.; Nout, R.A.; Rijswijk, C.S.P. van; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Gelderblom, H. (2014), Giant Cell Tumor of Bone Reply, The Oncologist 19(11): 1208-1208.
- Nord, K.H.; Lilljebjorn, H.; Vezzi, F.; Nilsson, J.; Magnusson, L.; Tayebwa, J.; Jong, D. de; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & Szuhai, K. (2014), GRM1 is upregulated through gene fusion and promoter swapping in chondromyxoid fibroma, Nature Genetics 46(5): 474-477.
- Kuijjer, M.L.; Akker, B.E.W.M. van den; Hilhorst, R.; Mommersteeg, M.; Buddingh, E.P.; Serra, M.; Burger, H.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2014), Kinome and mRNA expression profiling of high-grade osteosarcoma cell lines implies Akt signaling as possible target for therapy, BMC Medical Genomics 7.
- Anninga J.K., Picci P., Fiocco M., Kroon H.M.J.A., Vanel D., Alberghini M., Gelderblom H. & Hogendoorn P.C.W. (2013), Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup, Virchows Archiv 462(1): 109-120.
- Kacker, C.; Marx, A.; Mossinger, K.; Svehla, F.; Schneider, U.; Hogendoorn, P.C.W.; Nielsen, O.S.; Kuffer, S.; Sauer, C.; Fisher, C.; Hallermann, C.; Hartmann, J.T.; Blay, J.Y.; Mechtersheimer, G.; Hohenberger, P. & Strobel, P. (2013), High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas, Genes, Chromosomes & Cancer 52(1): 93-98.
- Solomon, D.A.; Bondaruk, J.; Shariat, S.F.; Wang, Z.F.; Elkahloun, A.G.; Zhang, S.; Navai, N.; Gerard, J.; Robinson, B.D.; Zhoung, D.; Rink, M.; Volkmer, B.; Hautmann, R.; Kufer, R.; Hogendoorn, P.C.W.; Netto, G.; Theodorescu, D.; Kim, J.S.; Czerniak, B.; Miettinen, M. & Waldman, T. (2013), Truncating Mutations of STAG2 Define a Molecular Subgroup of Aneuploid Bladder Cancers with Poor Prognosis.
- Vries, M. de; Briaire-de Bruijn, I.; Cleton-Jansen, A.M.; Malessy, M.J.A.; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2013), Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas, Virchows Archiv 462(2): 211-217.
- Anninga, J.K.; Picci, P.; Fiocco, M.; Kroon, H.M.J.A.; Vanel, D.; Alberghini, M.; Gelderblom, H. & Hogendoorn, P.C.W. (2013), Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup., Virchows Archiv 462(1): 109-20.
- Heijden, L. van der; Gibbons, C.L.M.H.; Hassan, A.B.; Kroep, J.R.; Gelderblom, H.; Rijswijk, C.S.P. van; Nout, R.A.; Bradley, K.M.; Athanasou, N.A.; Dijkstra, P.D.S.; Hogendoorn, P.C.W. & Sande, M.A.J. van de (2013), A multidisciplinary approach to giant cell tumors of tendon sheath and synoviumA critical appraisal of literature and treatment proposal, Journal of Surgical Oncology 107(4): 433-445.
- Keus, R.B.; Nout, R.A.; Blay, J.Y.; Jong, J.M. de; Hennig, I.; Saran, F.; Hartmann, J.T.; Sunyach, M.P.; Gwyther, S.J.; Ouali, M.; Kirkpatrick, A.; Poortmans, P.M.; Hogendoorn, P.C.W. & Graaf, W.T.A. van der (2013), Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998), Annals of Oncology 24(10): 2672-2676.
- Vries, M. de; Briaire-de Bruijn, I.; Malessy, M.J.A.; Bruine, S.F.T. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2013), Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas, Otology and Neurotology.
- Kacker, C.; Marx, A.; Mossinger, K.; Svehla, F.; Schneider, U.; Hogendoorn, P.C.W.; Nielsen, O.S.; Kuffer, S.; Sauer, C.; Fisher, C.; Hallermann, C.; Hartmann, J.T.; Blay, J.Y.; Mechtersheimer, G.; Hohenberger, P. & Strobel, P. (2013), High frequency of MYC gene amplification is a common feature of radiation-induced sarcomas, Genes, Chromosomes & Cancer 52(1): 93-98.
- Solomon, D.A.; Bondaruk, J.; Shariat, S.F.; Wang, Z.F.; Elkahloun, A.G.; Zhang, S.; Navai, N.; Gerard, J.; Robinson, B.D.; Zhoung, D.; Rink, M.; Volkmer, B.; Hautmann, R.; Kufer, R.; Hogendoorn, P.C.W.; Netto, G.; Theodorescu, D.; Kim, J.S.; Czerniak, B.; Miettinen, M. & Waldman, T. (2013), Truncating Mutations of STAG2 Define a Molecular Subgroup of Aneuploid Bladder Cancers with Poor Prognosis.
- Vries, M. de; Briaire-de Bruijn, I.; Cleton-Jansen, A.M.; Malessy, M.J.A.; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2013), Mutations affecting BRAF, EGFR, PIK3CA, and KRAS are not associated with sporadic vestibular schwannomas, Virchows Archiv 462(2): 211-217.
- Koens, L.; Heyning, F.H.; Szepesi, A.; Matolcsy, A.; Hogendoorn, P.C.W. & Jansen, P.M. (2013), Nuclear factor-kappa B activation in primary lymphoma of bone, Virchows Archiv 462(3): 349-354.
- Nord, K.H.; Nilsson, J.; Arbajian, E.; Steyern, F.V. von; Brosjo, O.; Cleton-Jansen, A.M.; Szuhai, K. & Hogendoorn, P.C.W. (2013), Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway, PLoS ONE 8(11).
- Oosterwijk, J.G. van; Meijer, D.; Ruler, M.A.J.H. van; Akker, B.E.W.M. van den; Oosting, J.; Krenacs, T.; Picci, P.; Flanagan, A.M.; Liegl-Atzwanger, B.; Leithner, A.; Athanasou, N.; Daugaard, S.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2013), Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGF beta as Potential Targets, American Journal of Pathology 182(4): 1347-1356.
- Beletkaia, E.; Fenz, S.F.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2013), Understanding the Molecular Mechanism of Gradient Sensing, Biophysical Journal 104(2): 320A-320A.
- Beletkaia, E.; Fenz, S.F.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2013), Understanding the Molecular Mechanism of Gradient Sensing, Biophysical Journal 104(2): 320A-320A.
- Oosterwijk, J.G. van; Meijer, D.; Ruler, M.A.J.H. van; Akker, B.E.W.M. van den; Oosting, J.; Krenacs, T.; Picci, P.; Flanagan, A.M.; Liegl-Atzwanger, B.; Leithner, A.; Athanasou, N.; Daugaard, S.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2013), Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGF beta as Potential Targets, American Journal of Pathology 182(4): 1347-1356.
- Nord, K.H.; Nilsson, J.; Arbajian, E.; Steyern, F.V. von; Brosjo, O.; Cleton-Jansen, A.M.; Szuhai, K. & Hogendoorn, P.C.W. (2013), Recurrent Chromosome 22 Deletions in Osteoblastoma Affect Inhibitors of the Wnt/Beta-Catenin Signaling Pathway, PLoS ONE 8(11).
- Koens, L.; Heyning, F.H.; Szepesi, A.; Matolcsy, A.; Hogendoorn, P.C.W. & Jansen, P.M. (2013), Nuclear factor-kappa B activation in primary lymphoma of bone, Virchows Archiv 462(3): 349-354.
- Sarver, A.L.; Thayanithy, V.; Scott, M.C.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W.; Modiano, J.F. & Subramanian, S. (2013), MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma, Orphanet Journal of Rare Diseases 8: -.
- Bielack, S.S.; Smeland, S.; Whelan, J.; Marina, N.; Hook, J.; Jovic, G.; Krailo, M.D.; Butterfass-Bahloul, T.; Kuhne, T.; Eriksson, M.; Teot, L.A.; Gelderblom, H.; Kager, L.; Hall, K.S.; Gorlick, R.G.; Randall, R.L.; Hogendoorn, P.C.W.; Calaminus, G.; Sydes, M.R. & Bernstein, M.L. (2013), MAP plus maintenance pegylated interferon alpha-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization., Journal of Clinical Oncology 31(18).
- Bielack, S.S.; Smeland, S.; Whelan, J.; Marina, N.; Hook, J.; Jovic, G.; Krailo, M.D.; Butterfass-Bahloul, T.; Kuhne, T.; Eriksson, M.; Teot, L.A.; Gelderblom, H.; Kager, L.; Hall, K.S.; Gorlick, R.G.; Randall, R.L.; Hogendoorn, P.C.W.; Calaminus, G.; Sydes, M.R. & Bernstein, M.L. (2013), MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization., Journal of Clinical Oncology 31(15).
- Kuijjer, M.L.; Peterse, E.F.P.; Akker, B.E.W.M. van den; Briaire-de Bruijn, I.H.; Serra, M.; Meza-Zepeda, L.A.; Myklebost, O.; Hassan, A.B.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2013), IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma, BMC Cancer 13.
- Pelczar, P.; Zibat, A.; Dop, W.A. van; Heijmans, J.; Bleckmann, A.; Gruber, W.; Nitzki, F.; Uhmann, A.; Guijarro, M.V.; Hernando, E.; Dittmann, K.; Wienands, J.; Dressel, R.; Wojnowski, L.; Binder, C.; Taguchi, T.; Beissbarth, T.; Hogendoorn, P.C.W.; Antonescu, C.R.; Rubin, B.P.; Schulz-Schaeffer, W.; Aberger, F.; Brink, G.R. van den & Hahn, H. (2013), Inactivation of Patched1 in Mice Leads to Development of Gastrointestinal Stromal-Like Tumors That Express Pdgfr alpha but Not Kit, Gastroenterology 144(1): 134-U256.
- Jones, E.A.; Schmitz, N.; Waaijer, C.J.F.; Frese, C.K.; Remoortere, A. van; Zeijl, R.J.M. van; Heck, A.J.R.; Hogendoorn, P.C.W.; Deelder, A.M.; Altelaar, A.F.M.; Bovee, J.V.M.G. & McDonnell, L.A. (2013), Imaging Mass Spectrometry-based Molecular Histology Differentiates Microscopically Identical and Heterogeneous Tumors, Journal of Proteome Research 12(4): 1847-1855.
- Kuijjer, M.L.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2013), Genome-wide analyses on high-grade osteosarcoma: Making sense of a genomically most unstable tumor, International Journal of Cancer 133(11): 2512-2521.
- Solomon, D.A.; Kim, J.S.; Bondaruk, J.; Shariat, S.F.; Wang, Z.F.; Elkahloun, A.G.; Ozawa, T.; Gerard, J.; Zhuang, D.Z.; Zhang, S.Z.; Navai, N.; Siefker-Radtke, A.; Phillips, J.J.; Robinson, B.D.; Rubin, M.A.; Volkmer, B.; Hautmann, R.; Kufer, R.; Hogendoorn, P.C.W.; Netto, G.; Theodorescu, D.; James, C.D.; Czerniak, B.; Miettinen, M. & Waldman, T. (2013), Frequent truncating mutations of STAG2 in bladder cancer, Nature Genetics 45(12): 1428-U171.
- Gautier, T.; Haan, W. de; Grober, J.; Ye, D.; Bahr, M.J.; Claudel, T.; Nijstad, N.; Berkel, T.J.C. van; Havekes, L.M.; Manns, M.P.; Willems, S.M.; Hogendoorn, P.C.W.; Lagrost, L.; Kuipers, F.; Eck, M. van; Rensen, P.C.N. & Tietge, U.J.F. (2013), Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice, Journal of Lipid Research 54(8): 2195-2205.
- Vries, M. de; Briaire-de Bruijn, I.; Malessy, M.J.A.; Bruine, S.F.T. de; Mey, A.G.L. van der & Hogendoorn, P.C.W. (2013), Tumor-associated macrophages are related to volumetric growth of vestibular schwannomas, Otology and Neurotology.
- Keus, R.B.; Nout, R.A.; Blay, J.Y.; Jong, J.M. de; Hennig, I.; Saran, F.; Hartmann, J.T.; Sunyach, M.P.; Gwyther, S.J.; Ouali, M.; Kirkpatrick, A.; Poortmans, P.M.; Hogendoorn, P.C.W. & Graaf, W.T.A. van der (2013), Results of a phase II pilot study of moderate dose radiotherapy for inoperable desmoid-type fibromatosis-an EORTC STBSG and ROG study (EORTC 62991-22998), Annals of Oncology 24(10): 2672-2676.
- Anninga, J.K.; Picci, P.; Fiocco, M.; Kroon, H.M.J.A.; Vanel, D.; Alberghini, M.; Gelderblom, H. & Hogendoorn, P.C.W. (2013), Osteosarcoma of the hands and feet: a distinct clinico-pathological subgroup., Virchows Archiv 462(1): 109-20.
- Heijden, L. van der; Gibbons, C.L.M.H.; Hassan, A.B.; Kroep, J.R.; Gelderblom, H.; Rijswijk, C.S.P. van; Nout, R.A.; Bradley, K.M.; Athanasou, N.A.; Dijkstra, P.D.S.; Hogendoorn, P.C.W. & Sande, M.A.J. van de (2013), A multidisciplinary approach to giant cell tumors of tendon sheath and synoviumA critical appraisal of literature and treatment proposal, Journal of Surgical Oncology 107(4): 433-445.
- Gautier, T.; Haan, W. de; Grober, J.; Ye, D.; Bahr, M.J.; Claudel, T.; Nijstad, N.; Berkel, T.J.C. van; Havekes, L.M.; Manns, M.P.; Willems, S.M.; Hogendoorn, P.C.W.; Lagrost, L.; Kuipers, F.; Eck, M. van; Rensen, P.C.N. & Tietge, U.J.F. (2013), Farnesoid X receptor activation increases cholesteryl ester transfer protein expression in humans and transgenic mice, Journal of Lipid Research 54(8): 2195-2205.
- Solomon, D.A.; Kim, J.S.; Bondaruk, J.; Shariat, S.F.; Wang, Z.F.; Elkahloun, A.G.; Ozawa, T.; Gerard, J.; Zhuang, D.Z.; Zhang, S.Z.; Navai, N.; Siefker-Radtke, A.; Phillips, J.J.; Robinson, B.D.; Rubin, M.A.; Volkmer, B.; Hautmann, R.; Kufer, R.; Hogendoorn, P.C.W.; Netto, G.; Theodorescu, D.; James, C.D.; Czerniak, B.; Miettinen, M. & Waldman, T. (2013), Frequent truncating mutations of STAG2 in bladder cancer, Nature Genetics 45(12): 1428-U171.
- Kuijjer, M.L.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2013), Genome-wide analyses on high-grade osteosarcoma: Making sense of a genomically most unstable tumor, International Journal of Cancer 133(11): 2512-2521.
- Jones, E.A.; Schmitz, N.; Waaijer, C.J.F.; Frese, C.K.; Remoortere, A. van; Zeijl, R.J.M. van; Heck, A.J.R.; Hogendoorn, P.C.W.; Deelder, A.M.; Altelaar, A.F.M.; Bovee, J.V.M.G. & McDonnell, L.A. (2013), Imaging Mass Spectrometry-based Molecular Histology Differentiates Microscopically Identical and Heterogeneous Tumors, Journal of Proteome Research 12(4): 1847-1855.
- Pelczar, P.; Zibat, A.; Dop, W.A. van; Heijmans, J.; Bleckmann, A.; Gruber, W.; Nitzki, F.; Uhmann, A.; Guijarro, M.V.; Hernando, E.; Dittmann, K.; Wienands, J.; Dressel, R.; Wojnowski, L.; Binder, C.; Taguchi, T.; Beissbarth, T.; Hogendoorn, P.C.W.; Antonescu, C.R.; Rubin, B.P.; Schulz-Schaeffer, W.; Aberger, F.; Brink, G.R. van den & Hahn, H. (2013), Inactivation of Patched1 in Mice Leads to Development of Gastrointestinal Stromal-Like Tumors That Express Pdgfr alpha but Not Kit, Gastroenterology 144(1): 134-U256.
- Kuijjer, M.L.; Peterse, E.F.P.; Akker, B.E.W.M. van den; Briaire-de Bruijn, I.H.; Serra, M.; Meza-Zepeda, L.A.; Myklebost, O.; Hassan, A.B.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2013), IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma, BMC Cancer 13.
- Bielack, S.S.; Smeland, S.; Whelan, J.; Marina, N.; Hook, J.; Jovic, G.; Krailo, M.D.; Butterfass-Bahloul, T.; Kuhne, T.; Eriksson, M.; Teot, L.A.; Gelderblom, H.; Kager, L.; Hall, K.S.; Gorlick, R.G.; Randall, R.L.; Hogendoorn, P.C.W.; Calaminus, G.; Sydes, M.R. & Bernstein, M.L. (2013), MAP plus maintenance pegylated interferon alpha-2b (MAP-IFN) versus MAP alone in patients (pts) with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 good response randomization., Journal of Clinical Oncology 31(15).
- Bielack, S.S.; Smeland, S.; Whelan, J.; Marina, N.; Hook, J.; Jovic, G.; Krailo, M.D.; Butterfass-Bahloul, T.; Kuhne, T.; Eriksson, M.; Teot, L.A.; Gelderblom, H.; Kager, L.; Hall, K.S.; Gorlick, R.G.; Randall, R.L.; Hogendoorn, P.C.W.; Calaminus, G.; Sydes, M.R. & Bernstein, M.L. (2013), MAP plus maintenance pegylated interferon alpha-2b (MAPIfn) versus MAP alone in patients with resectable high-grade osteosarcoma and good histologic response to preoperative MAP: First results of the EURAMOS-1 "good response" randomization., Journal of Clinical Oncology 31(18).
- Sarver, A.L.; Thayanithy, V.; Scott, M.C.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W.; Modiano, J.F. & Subramanian, S. (2013), MicroRNAs at the human 14q32 locus have prognostic significance in osteosarcoma, Orphanet Journal of Rare Diseases 8: -.
- Truong H.H., Sonneville J. de, Ghotra V.P., Xiong J., Price L., Hogendoorn P.C., Spaink H.P., Water B. van de & Danen E.H. (2012), Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens, Biomaterials 33(1): 181-188.
- Andrea, C.E. de; Kroon, H.M.; Wolterbeck, R.; Romeo, S.; Rosenberg, A.E.; DeYoung, B.R.; Liegl-Alzwanger, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.F.; Idoate, M.; Athanasou, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver Reliability in the Histopathological Diagnosis of Peripheral Cartilaginous Tumors in Patients with Multiple Osteochondromas: How Can We Improve Diagnostic Quality?
- Whelan, J.S.; Jinks, R.C.; McTiernan, A.; Sydes, M.R.; Hook, J.M.; Trani, L.; Uscinska, B.; Bramwell, V.; Lewis, I.J.; Nooij, M.A.; Glabbeke, M. van; Grimer, R.J.; Hogendoorn, P.C.W.; Taminiau, A.H.M. & Gelderblom, H. (2012), Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials, Annals of Oncology 23(6): 1607-1616.
- McTiernan, A.; Jinks, R.C.; Sydes, M.R.; Uscinska, B.; Hook, J.M.; Glabbeke, M. van; Bramwell, V.; Lewis, I.J.; Taminiau, A.H.M.; Nooij, M.A.; Hogendoorn, P.C.W.; Gelderblom, H. & Whelan, J.S. (2012), Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup, European Journal of Cancer 48(5): 703-712.
- Verdegaal, S.H.M.; Brouwers, H.F.G.; Zwet, E.W. van; Hogendoorn, P.C.W. & Taminiau, A.H.M. (2012), Low-Grade Chondrosarcoma of Long Bones Treated with Intralesional Curettage Followed by Application of Phenol, Ethanol, and Bone-Grafting, Journal of Bone and Joint Surgery, American Volume 94A(13): 1201-1207.
- Heijden, L. van der; Gibbons, C.L.M.H.; Dijkstra, P.D.S.; Kroep, J.R.; Rijswijk, C.S.P. van; Nout, R.A.; Bradley, K.M.; Athanasou, N.A.; Hogendoorn, P.C.W. & Sande, M.A.J. van de (2012), The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).
- Oosterwijk, J.G. van; Jong, D. de; Ruler, M.A.J.H. van; Hogendoorn, P.C.W.; Dijkstra, P.D.S.; Rijswijk, C.S.P. van; Machado, I.; Llombart-Bosch, A.; Szuhai, K. & Bovee, J.V.M.G. (2012), Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone, BMC Cancer 12: -.
- Mohseny, A.B.; Xiao, W.; Carvalho, R.; Spaink, H.P.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2012), An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration, The Journal of Pathology 227(2): 245-253.
- Kresse, S.H.; Rydbeck, H.; Skarn, M.; Namlos, H.M.; Barragan-Polania, A.H.; Cleton-Jansen, A.M.; Serra, M.; Liestol, K.; Hogendoorn, P.C.W.; Hovig, E.; Myklebost, O. & Meza-Zepeda, L.A. (2012), Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma, PLoS ONE 7(11): -.
- Andrea, C.E. de; Wiweger, M.I.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2012), Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation, Virchows Archiv 460(1): 95-102.
- Taylor, R.M.; Kashima, T.G.; Ferguson, D.J.; Szuhai, K.; Hogendoorn, P.C. & Athanasou, N.A. (2012), Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones, Modern Pathology 25(1): 56-64.
- Woll, P.J.; Reichardt, P.; Cesne, A. le; Bonvalot, S.; Azzarelli, A.; Hoekstra, H.J.; Leahy, M.; Coevorden, F. van; Verweij, J.; Hogendoorn, P.C.W.; Ouali, M.; Marreaud, S.; Bramwell, V.H.C.; Hohenberger, P.; EORTC Soft Tissue Bone Sarcoma Grp & NCIC Clinical Trials Grp Sarcoma D (2012), Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Hogendoorn, P.C.W.; Lopez-Terrada, D.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma, Modern Pathology 25(10): 1378-1383.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Lopez-Terrada, D.; Hogendoorn, P.C.W.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets Family Transcription Factor, Specifically Identifies ERG-Rearranged Ewing Sarcoma.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Lopez-Terrada, D.; Hogendoorn, P.C.W.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets Family Transcription Factor, Specifically Identifies ERG-Rearranged Ewing Sarcoma.
- Pahl, J.H.W.; Ruslan, S.E.N.; Buddingh, E.P.; Santos, S.J.; Szuhai, K.; Serra, M.; Gelderblom, H.; Hogendoorn, P.C.W.; Egeler, R.M.; Schilham, M.W. & Lankester, A.C. (2012), Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma, Clinical Cancer Research 18(2): 432-441.
- Wiweger, M.I.; Zhao, Z.; Merkesteyn, R.J.P. van; Roehl, H.H. & Hogendoorn, P.C.W. (2012), HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas, PLoS ONE 7(1): -.
- Berghuis, D.; Schilham, M.W.; Santos, S.J.; Savola, S.; Knowles, H.J.; Dirksen, U.; Schaefer, K.L.; Vakkila, J.; Hogendoorn, P.C.W. & Lankester, A.C. (2012), The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease., Clinical Sarcoma Research 2(1): 24.
- Hemingway, F.; Kashima, T.G.; Mahendra, G.; Dhongre, A.; Hogendoorn, P.C.W.; Mertens, F. & Athanasou, N.A. (2012), Smooth muscle actin expression in primary bone tumours, Virchows Archiv 460(5): 525-534.
- Kuijjer, M.L.; Rydbeck, H.; Kresse, S.H.; Buddingh, E.P.; Lid, A.B.; Roelofs, H.; Burger, H.; Myklebost, O.; Hogendoorn, P.C.W.; Meza-Zepeda, L.A. & Cleton-Jansen, A.M. (2012), Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data, Genes, Chromosomes and Cancer 51(7): 696-706.
- Andrea, C.E. de; Kroon, H.M.; Wolterbeek, R.; Romeo, S.; Rosenberg, A.E.; Young, B.R. de; Liegl, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.F.; Idoate, M.; Athanasou, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver reliability in the histopathological diagnosis of cartilaginous tumors in patients with multiple osteochondromas, Modern Pathology 25(9): 1275-1283.
- Romeo, S.; Bovee, J.V.M.G.; Kroon, H.M.; Tirabosco, R.; Natali, C.; Zanatta, L.; Sciot, R.; Mertens, F.; Athanasou, N.; Alberghini, M.; Szuhai, K.; Hogendoorn, P.C.W. & Tos, A.P.D. (2012), Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches, Virchows Archiv 461(5): 561-570.
- Mohseny, A.B.; Cai, Y.P.; Kuijjer, M.; Xiao, W.; Akker, B. van den; Andrea, C.E. de; Jacobs, R.; Dijke, P. ten; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2012), The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma, European Journal of Cancer 48(18): 3429-3438.
- Szuhai, K. & Hogendoorn, P.C.W. (2012), 'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma, Journal of Pathology 228(3): 261-265.
- Mackintosh, C.; Ordonez, J.L.; Garcia-Dominguez, D.J.; Sevillano, V.; Llombart-Bosch, A.; Szuhai, K.; Scotlandi, K.; Alberghini, M.; Sciot, R.; Sinnaeve, F.; Hogendoorn, P.C.W.; Picci, P.; Knuutila, S.; Dirksen, U.; Debiec-Rychter, M.; Schaefer, K.L. & Alava, E. de (2012), 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma, Oncogene 31(10): 1287-1298.
- Szuhai, K.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Molecular pathology and its diagnostic use in bone tumors, Cancer Genetics 205(5): 193-204.
- Buddingh, E.P.; Ruslan, S.E.N.; Berghuis, D.; Gelderblom, H.; Anninga, J.K.; Hogendoorn, P.C.W.; Egeler, R.M.; Schilham, M.W. & Lankester, A.C. (2012), Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients, Cancer Immunology, Immunotherapy 61(6): 941-947.
- Lenos, K.; Grawenda, A.M.; Lodder, K.; Kuijjer, M.L.; Teunisse, A.F.A.S.; Repapi, E.; Grochola, L.F.; Bartel, F.; Hogendoorn, P.C.W.; Wuerl, P.; Taubert, H.; Cleton-Jansen, A.M.; Bond, G.L. & Jochemsen, A.G. (2012), Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer, Cancer Research 72(16): 4074-4084.
- Vries, M. de; Hogendoorn, P.C.W.; Briaire-de Bruyn, I.; Malessy, M.J.A. & Mey, A.G.L. van der (2012), Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas, Virchows Archiv 460(6): 629-636.
- Andrea, C.E. de; Reijnders, C.M.A.; Kroon, H.M.; Jong, D. de; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2012), Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT, Oncogene 31(9): 1095-1104.
- Anninga, J.K.; Picci, P.; Kroon, H.M.; Vanel, D. & Hogendoorn, P.C.W. (2012), Osteosarcoma of the Hands and Feet: A Clinico-Pathologic Distinct Subgroup of OS?
- Anninga, J.K.; Picci, P.; Kroon, H.M.; Vanel, D. & Hogendoorn, P.C.W. (2012), Osteosarcoma of the Hands and Feet: A Clinico-Pathologic Distinct Subgroup of OS?
- Andrea, C.E. de; Kroon, H.M.; Wolterbeek, R.; Romeo, S.; Rosenbeig, A.E.; DeYoung, B.R.; Liegl-Atzwanger, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.; Idoate, M.; Athanason, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver Reliability in the Histopathological Diagnosis of Peripheral Cartilaginous Tumors in Patients with Multiple Osteochondromas: How Can We Improve Diagnostic Quality?
- Truong, H.H.; Sonneville, J. de; Ghotra, V.P.S.; Xiong, J.L.; Price, L.; Hogendoorn, P.C.W.; Spaink, H.H.; Water, B. van de & Danen, E.H.J. (2012), Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens, Biomaterials 33(1): 181-188.
- Andrea, C.E. de & Hogendoorn, P.C.W. (2012), Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter, The Journal of Pathology 226(2): 219-228.
- Wang, L.; Motoi, T.; Khanin, R.; Olshen, A.; Mertens, F.; Bridge, J.; Cin, P. dal; Antonescu, C.R.; Singer, S.; Hameed, M.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Socci, N. & Ladanyi, M. (2012), Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data, Genes, Chromosomes and Cancer 51(2): 127-139.
- Jones, E.A.; Deininger, S.O.; Hogendoorn, P.C.W.; Deelder, A.M. & McDonnell, L.A. (2012), Imaging mass spectrometry statistical analysis, Journal of Proteomics 75(16): 4962-4989.
- Vries, M. de; Hogendoorn, P.C.W.; Briaire-de Bruyn, I.; Malessy, M.J.A. & Mey, A.G.L. van der (2012), Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas, Virchows Archiv 460.
- Andrea, C.E. de; Reijnders, C.M.A.; Kroon, H.M.; Jong, D. de; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2012), Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT, Oncogene 31(9): 1095-1104.
- Romeo, S.; Bovee, J.V.M.G.; Kroon, H.M.; Tirabosco, R.; Natali, C.; Zanatta, L.; Sciot, R.; Mertens, F.; Athanasou, N.; Alberghini, M.; Szuhai, K.; Hogendoorn, P.C.W. & Tos, A.P.D. (2012), Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches, Virchows Archiv 461(5): 561-570.
- Anninga, J.K.; Picci, P.; Kroon, H.M.; Vanel, D. & Hogendoorn, P.C.W. (2012), Osteosarcoma of the Hands and Feet: A Clinico-Pathologic Distinct Subgroup of OS?
- Wang, L.; Motoi, T.; Khanin, R.; Olshen, A.; Mertens, F.; Bridge, J.; Cin, P. dal; Antonescu, C.R.; Singer, S.; Hameed, M.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Socci, N. & Ladanyi, M. (2012), Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data, Genes, Chromosomes and Cancer 51(2): 127-139.
- Andrea, C.E. de & Hogendoorn, P.C.W. (2012), Epiphyseal growth plate and secondary peripheral chondrosarcoma: the neighbours matter, The Journal of Pathology 226(2): 219-228.
- Truong, H.H.; Sonneville, J. de; Ghotra, V.P.S.; Xiong, J.L.; Price, L.; Hogendoorn, P.C.W.; Spaink, H.H.; Water, B. van de & Danen, E.H.J. (2012), Automated microinjection of cell-polymer suspensions in 3D ECM scaffolds for high-throughput quantitative cancer invasion screens, Biomaterials 33(1): 181-188.
- Pahl, J.H.W.; Ruslan, S.E.N.; Buddingh, E.P.; Santos, S.J.; Szuhai, K.; Serra, M.; Gelderblom, H.; Hogendoorn, P.C.W.; Egeler, R.M.; Schilham, M.W. & Lankester, A.C. (2012), Anti-EGFR Antibody Cetuximab Enhances the Cytolytic Activity of Natural Killer Cells toward Osteosarcoma, Clinical Cancer Research 18(2): 432-441.
- Taylor, R.M.; Kashima, T.G.; Ferguson, D.J.; Szuhai, K.; Hogendoorn, P.C. & Athanasou, N.A. (2012), Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones, Modern Pathology 25(1): 56-64.
- Wiweger, M.I.; Zhao, Z.; Merkesteyn, R.J.P. van; Roehl, H.H. & Hogendoorn, P.C.W. (2012), HSPG-Deficient Zebrafish Uncovers Dental Aspect of Multiple Osteochondromas, PLoS ONE 7(1): -.
- Woll, P.J.; Reichardt, P.; Cesne, A. le; Bonvalot, S.; Azzarelli, A.; Hoekstra, H.J.; Leahy, M.; Coevorden, F. van; Verweij, J.; Hogendoorn, P.C.W.; Ouali, M.; Marreaud, S.; Bramwell, V.H.C.; Hohenberger, P.; EORTC Soft Tissue Bone Sarcoma Grp & NCIC Clinical Trials Grp Sarcoma D (2012), Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Hogendoorn, P.C.W.; Lopez-Terrada, D.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma, Modern Pathology 25(10): 1378-1383.
- Mackintosh, C.; Ordonez, J.L.; Garcia-Dominguez, D.J.; Sevillano, V.; Llombart-Bosch, A.; Szuhai, K.; Scotlandi, K.; Alberghini, M.; Sciot, R.; Sinnaeve, F.; Hogendoorn, P.C.W.; Picci, P.; Knuutila, S.; Dirksen, U.; Debiec-Rychter, M.; Schaefer, K.L. & Alava, E. de (2012), 1q gain and CDT2 overexpression underlie an aggressive and highly proliferative form of Ewing sarcoma, Oncogene 31(10): 1287-1298.
- Wang, W.L.; Patel, N.R.; Caragea, M.; Lopez-Terrada, D.; Hogendoorn, P.C.W.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets Family Transcription Factor, Specifically Identifies ERG-Rearranged Ewing Sarcoma.
- Heijden, L. van der; Gibbons, C.L.M.H.; Dijkstra, P.D.S.; Kroep, J.R.; Rijswijk, C.S.P. van; Nout, R.A.; Bradley, K.M.; Athanasou, N.A.; Hogendoorn, P.C.W. & Sande, M.A.J. van de (2012), The management of diffuse-type giant cell tumour (pigmented villonodular synovitis) and giant cell tumour of tendon sheath (nodular tenosynovitis).
- Wang, W.L.; Patel, N.R.; Caragea, M.; Lopez-Terrada, D.; Hogendoorn, P.C.W.; Hornick, J.L. & Lazar, A.J. (2012), Expression of ERG, an Ets Family Transcription Factor, Specifically Identifies ERG-Rearranged Ewing Sarcoma.
- Verdegaal, S.H.M.; Brouwers, H.F.G.; Zwet, E.W. van; Hogendoorn, P.C.W. & Taminiau, A.H.M. (2012), Low-Grade Chondrosarcoma of Long Bones Treated with Intralesional Curettage Followed by Application of Phenol, Ethanol, and Bone-Grafting, Journal of Bone and Joint Surgery, American Volume 94A(13): 1201-1207.
- Mohseny, A.B.; Xiao, W.; Carvalho, R.; Spaink, H.P.; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2012), An osteosarcoma zebrafish model implicates Mmp-19 and Ets-1 as well as reduced host immune response in angiogenesis and migration, The Journal of Pathology 227(2): 245-253.
- Jones, E.A.; Deininger, S.O.; Hogendoorn, P.C.W.; Deelder, A.M. & McDonnell, L.A. (2012), Imaging mass spectrometry statistical analysis, Journal of Proteomics 75(16): 4962-4989.
- Andrea, C.E. de; Wiweger, M.I.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2012), Peripheral chondrosarcoma progression is associated with increased type X collagen and vascularisation, Virchows Archiv 460(1): 95-102.
- Lenos, K.; Grawenda, A.M.; Lodder, K.; Kuijjer, M.L.; Teunisse, A.F.A.S.; Repapi, E.; Grochola, L.F.; Bartel, F.; Hogendoorn, P.C.W.; Wuerl, P.; Taubert, H.; Cleton-Jansen, A.M.; Bond, G.L. & Jochemsen, A.G. (2012), Alternate Splicing of the p53 Inhibitor HDMX Offers a Superior Prognostic Biomarker than p53 Mutation in Human Cancer, Cancer Research 72(16): 4074-4084.
- Mohseny, A.B.; Cai, Y.P.; Kuijjer, M.; Xiao, W.; Akker, B. van den; Andrea, C.E. de; Jacobs, R.; Dijke, P. ten; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2012), The activities of Smad and Gli mediated signalling pathways in high-grade conventional osteosarcoma, European Journal of Cancer 48(18): 3429-3438.
- Kresse, S.H.; Rydbeck, H.; Skarn, M.; Namlos, H.M.; Barragan-Polania, A.H.; Cleton-Jansen, A.M.; Serra, M.; Liestol, K.; Hogendoorn, P.C.W.; Hovig, E.; Myklebost, O. & Meza-Zepeda, L.A. (2012), Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma, PLoS ONE 7(11): -.
- Oosterwijk, J.G. van; Jong, D. de; Ruler, M.A.J.H. van; Hogendoorn, P.C.W.; Dijkstra, P.D.S.; Rijswijk, C.S.P. van; Machado, I.; Llombart-Bosch, A.; Szuhai, K. & Bovee, J.V.M.G. (2012), Three new chondrosarcoma cell lines: one grade III conventional central chondrosarcoma and two dedifferentiated chondrosarcomas of bone, BMC Cancer 12: -.
- Whelan, J.S.; Jinks, R.C.; McTiernan, A.; Sydes, M.R.; Hook, J.M.; Trani, L.; Uscinska, B.; Bramwell, V.; Lewis, I.J.; Nooij, M.A.; Glabbeke, M. van; Grimer, R.J.; Hogendoorn, P.C.W.; Taminiau, A.H.M. & Gelderblom, H. (2012), Survival from high-grade localised extremity osteosarcoma: combined results and prognostic factors from three European Osteosarcoma Intergroup randomised controlled trials, Annals of Oncology 23(6): 1607-1616.
- Hemingway, F.; Kashima, T.G.; Mahendra, G.; Dhongre, A.; Hogendoorn, P.C.W.; Mertens, F. & Athanasou, N.A. (2012), Smooth muscle actin expression in primary bone tumours, Virchows Archiv 460(5): 525-534.
- McTiernan, A.; Jinks, R.C.; Sydes, M.R.; Uscinska, B.; Hook, J.M.; Glabbeke, M. van; Bramwell, V.; Lewis, I.J.; Taminiau, A.H.M.; Nooij, M.A.; Hogendoorn, P.C.W.; Gelderblom, H. & Whelan, J.S. (2012), Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: A report from the European Osteosarcoma Intergroup, European Journal of Cancer 48(5): 703-712.
- Szuhai, K. & Hogendoorn, P.C.W. (2012), 'The chicken or the egg?' dilemma strikes back for the controlling mechanism in chordoma, Journal of Pathology 228(3): 261-265.
- Kuijjer, M.L.; Rydbeck, H.; Kresse, S.H.; Buddingh, E.P.; Lid, A.B.; Roelofs, H.; Burger, H.; Myklebost, O.; Hogendoorn, P.C.W.; Meza-Zepeda, L.A. & Cleton-Jansen, A.M. (2012), Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data, Genes, Chromosomes and Cancer 51(7): 696-706.
- Szuhai, K.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Molecular pathology and its diagnostic use in bone tumors, Cancer Genetics 205(5): 193-204.
- Blay, J.Y.; Blomqvist, C.; Bonvalot, S.; Boukovinas, I.; Casali, P.G.; Alava, E. de; Tos, A.P. dei; Dirksen, U.; Duffaud, F.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Garcia del Muro, X.; Gelderblom, H.; Grimer, R.; Gronchi, A.; Hall, K.S.; Hassan, B.; Hogendoorn, P.; Hohenberger, P.; Issels, R.; Joensuu, H.; Jost, L.; Jurgens, H.; Kager, L.; Cesne, A. le; Leyvraz, S.; Martin, J.; Merimsky, O.; Nishida, O.; Picci, P.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Sleijfer, S.; Stacchiotti, S.; Taminiau, A.; Wardelmann, E. & ESMO European Sarcoma Network Work (2012), Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 23: 49-55.
- Whelan, J.; Hook, J.; Bielack, S.S.; Marina, N.; Smeland, S.; Jovic, G.; Krailo, M.D.; Kuhne, T.; Eriksson, M.; Butterfass-Bahloul, T.; Teot, L.A.; Kager, L.; Gelderblom, H.; Hall, K.S.; Hogendoorn, P.C.W.; Sydes, M.R.; Bernstein, M.L. & EURAMOS (2012), EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma, Journal of Clinical Oncology 30(15).
- Maldegem, A.M. van; Bhosale, A.; Gelderblom, H.J.; Hogendoorn, P.C.W. & Hassan, A.B. (2012), Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment., Clinical Sarcoma Research.
- Vries, M. de; Hogendoorn, P.C.W.; Briaire-de Bruyn, I.; Malessy, M.J.A. & Mey, A.G.L. van der (2012), Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas, Virchows Archiv 460.
- Maldegem, A.M. van; Bhosale, A.; Gelderblom, H.J.; Hogendoorn, P.C.W. & Hassan, A.B. (2012), Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment., Clinical Sarcoma Research.
- Berghuis, D.; Schilham, M.W.; Santos, S.J.; Savola, S.; Knowles, H.J.; Dirksen, U.; Schaefer, K.L.; Vakkila, J.; Hogendoorn, P.C.W. & Lankester, A.C. (2012), The CXCR4-CXCL12 axis in Ewing sarcoma: promotion of tumor growth rather than metastatic disease., Clinical Sarcoma Research 2(1): 24.
- Andrea, C.E. de; Kroon, H.M.; Wolterbeek, R.; Romeo, S.; Rosenberg, A.E.; Young, B.R. de; Liegl, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.F.; Idoate, M.; Athanasou, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver reliability in the histopathological diagnosis of cartilaginous tumors in patients with multiple osteochondromas, Modern Pathology 25(9): 1275-1283.
- Anninga, J.K.; Picci, P.; Kroon, H.M.; Vanel, D. & Hogendoorn, P.C.W. (2012), Osteosarcoma of the Hands and Feet: A Clinico-Pathologic Distinct Subgroup of OS?
- Whelan, J.; Hook, J.; Bielack, S.S.; Marina, N.; Smeland, S.; Jovic, G.; Krailo, M.D.; Kuhne, T.; Eriksson, M.; Butterfass-Bahloul, T.; Teot, L.A.; Kager, L.; Gelderblom, H.; Hall, K.S.; Hogendoorn, P.C.W.; Sydes, M.R.; Bernstein, M.L. & EURAMOS (2012), EURAMOS-1 study: Recruitment, characteristics, and initial treatment of more than 2,000 patients (pts) with high-grade osteosarcoma, Journal of Clinical Oncology 30(15).
- Andrea, C.E. de; Kroon, H.M.; Wolterbeek, R.; Romeo, S.; Rosenbeig, A.E.; DeYoung, B.R.; Liegl-Atzwanger, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.; Idoate, M.; Athanason, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver Reliability in the Histopathological Diagnosis of Peripheral Cartilaginous Tumors in Patients with Multiple Osteochondromas: How Can We Improve Diagnostic Quality?
- Kovar, H.; Alonso, J.; Aman, P.; Aryee, D.N.T.; Ban, J.; Burchill, S.A.; Burdach, S.; Alava, E. de; Delattre, O.; Dirksen, U.; Fourtouna, A.; Fulda, S.; Helman, L.J.; Herrero-Martin, D.; Hogendoorn, P.C.W.; Kontny, U.; Lawlor, E.R.; Lessnick, S.L.; Llombart-Bosch, A.; Metzler, M.; Moriggl, R.; Niedan, S.; Potratz, J.; Redini, F.; Richter, G.H.S.; Riedmann, L.T.; Rossig, C.; Schafer, B.W.; Schwentner, R.; Scotlandi, K.; Sorensen, P.H.; Staege, M.S.; Tirode, F.; Toretsky, J.; Ventura, S.; Eggert, A. & Ladenstein, R. (2012), The first European interdisciplinary Ewing sarcoma research summit, Frontiers in Oncology 2: 1-10.
- Kovar, H.; Alonso, J.; Aman, P.; Aryee, D.N.T.; Ban, J.; Burchill, S.A.; Burdach, S.; Alava, E. de; Delattre, O.; Dirksen, U.; Fourtouna, A.; Fulda, S.; Helman, L.J.; Herrero-Martin, D.; Hogendoorn, P.C.W.; Kontny, U.; Lawlor, E.R.; Lessnick, S.L.; Llombart-Bosch, A.; Metzler, M.; Moriggl, R.; Niedan, S.; Potratz, J.; Redini, F.; Richter, G.H.S.; Riedmann, L.T.; Rossig, C.; Schafer, B.W.; Schwentner, R.; Scotlandi, K.; Sorensen, P.H.; Staege, M.S.; Tirode, F.; Toretsky, J.; Ventura, S.; Eggert, A. & Ladenstein, R. (2012), The first European interdisciplinary Ewing sarcoma research summit, Frontiers in Oncology 2: 1-10.
- Vries, M. de; Hogendoorn, P.C.W.; Briaire-de Bruyn, I.; Malessy, M.J.A. & Mey, A.G.L. van der (2012), Intratumoral hemorrhage, vessel density, and the inflammatory reaction contribute to volume increase of sporadic vestibular schwannomas, Virchows Archiv 460(6): 629-636.
- Blay, J.Y.; Blomqvist, C.; Bonvalot, S.; Boukovinas, I.; Casali, P.G.; Alava, E. de; Tos, A.P. dei; Dirksen, U.; Duffaud, F.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Garcia del Muro, X.; Gelderblom, H.; Grimer, R.; Gronchi, A.; Hall, K.S.; Hassan, B.; Hogendoorn, P.; Hohenberger, P.; Issels, R.; Joensuu, H.; Jost, L.; Jurgens, H.; Kager, L.; Cesne, A. le; Leyvraz, S.; Martin, J.; Merimsky, O.; Nishida, O.; Picci, P.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Sleijfer, S.; Stacchiotti, S.; Taminiau, A.; Wardelmann, E. & ESMO European Sarcoma Network Work (2012), Gastrointestinal stromal tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 23: 49-55.
- Buddingh, E.P.; Ruslan, S.E.N.; Berghuis, D.; Gelderblom, H.; Anninga, J.K.; Hogendoorn, P.C.W.; Egeler, R.M.; Schilham, M.W. & Lankester, A.C. (2012), Intact interferon signaling in peripheral blood leukocytes of high-grade osteosarcoma patients, Cancer Immunology, Immunotherapy 61(6): 941-947.
- Andrea, C.E. de; Kroon, H.M.; Wolterbeck, R.; Romeo, S.; Rosenberg, A.E.; DeYoung, B.R.; Liegl-Alzwanger, B.; Inwards, C.Y.; Hauben, E.; McCarthy, E.F.; Idoate, M.; Athanasou, N.A.; Jones, K.B.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2012), Interobserver Reliability in the Histopathological Diagnosis of Peripheral Cartilaginous Tumors in Patients with Multiple Osteochondromas: How Can We Improve Diagnostic Quality?
- Cliteur, V.P.; Szuhai, K.; Baelde, H.J.; Dam, J. van; Gelderblom, H. & Hogendoorn, P.C. (2012), Paratesticular desmoplastic small round cell tumour: an unusual tumour with an unusual fusion; cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH., Clinical Sarcoma Research 2(1): 3.
- Gelderblom, A.J. (2012), Comprehensive analysis of published phase I/II clinical trials between 1990-2010 in osteosarcoma and Ewing sarcoma confirms limited outcomes and need for translational investment, Clinical Sarcoma Research.
- Blay, J.Y.; Blomqvist, C.; Bonvalot, S.; Boukovinas, I.; Casali, P.G.; Alava, E. de; Tos, A.P. dei; Dirksen, U.; Duffaud, F.; Eriksson, M.; Fedenko, A.; Ferrari, A.; Ferrari, S.; Garcia del Muro, X.; Gelderblom, H.; Grimer, R.; Gronchi, A.; Hall, K.S.; Hassan, B.; Hogendoorn, P.; Hohenberger, P.; Issels, R.; Joensuu, H.; Jost, L.; Jurgens, H.; Kager, L.; Cesne, A. le; Leyvraz, S.; Martin, J.; Merimsky, O.; Nishida, T.; Picci, P.; Reichardt, P.; Rutkowski, P.; Schlemmer, M.; Sleijfer, S.; Stacchiotti, S.; Taminiau, A.; Wardelmann, E. & ESMO European Sarcoma Network Working Grp (2012), Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 23: 92-99.
- Beletkaia, E.; Fenz, S.F.; Snaar-Jagalska, E.; Hogendoorn, P. & Schmidt, T. (2012), Molecular Mechanisms of Gradient Sensing in Ewing's Sarcoma Cells, Biophysical Journal 102(3): 513A-513A.
- Kashima, T.G.; Dongre, A.; Flanagan, A.M.; Hogendoorn, P.C.W.; Taylor, R. & Athanasou, N.A. (2011), Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia, Virchows Archiv 459(1): 41-46.
- Maggiani, F.; Forsyth, R.; Hogendoorn, P.C.W.; Krenacs, T. & Athanasou, N.A. (2011), The immunophenotype of osteoclasts and macrophage polykaryons, Journal of Clinical Pathology 64(8): 701-705.
- Mohseny, A.B. & Hogendoorn, P.C.W. (2011), Concise Review: Mesenchymal Tumors: When Stem Cells Go Mad, Stem Cells 29(3): 397-403.
- Verdegaal, S.H.M.; Bovee, J.V.M.G.; Pansuriya, T.C.; Grimer, R.J.; Ozger, H.; Jutte, P.C.; San Julian, M.; Biau, D.J.; Geest, I.C.M. van der; Leithner, A.; Streitburger, A.; Klenke, F.M.; Gouin, F.G.; Campanacci, D.A.; Marec-Berard, P.; Hogendoorn, P.C.W.; Brand, R. & Taminiau, A.H.M. (2011), Incidence, predictive factors, and prognosis of chondrosarcoma in patients with ollier disease and maffucci syndrome: an international multicenter study of 161 patients., The Oncologist 16(12): 1771-9.
- Presneau, N.; Shalaby, A.; Ye, H.T.; Pillay, N.; Halai, D.; Idowu, B.; Tirabosco, R.; Whitwell, D.; Jacques, T.S.; Kindblom, L.G.; Bruderlein, S.; Moller, P.; Leithner, A.; Liegl, B.; Amary, F.M.; Athanasou, N.N.; Hogendoorn, P.C.W.; Mertens, F.; Szuhai, K. & Flanagan, A.M. (2011), Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study, Journal of Pathology 223(3): 327-335.
- Verbeke, S.L.J.; Bertoni, F.; Bacchini, P.; Sciot, R.; Fletcher, C.D.M.; Kroon, H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2011), Distinct histological features characterize primary angiosarcoma of bone, Histopathology 58(2): 254-264.
- Berghuis, D.; Santos, S.J.; Baelde, H.J.; Taminiau, A.H.M.; Egeler, R.M.; Schilham, M.W.; Hogendoorn, P.C.W. & Lankester, A.C. (2011), Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression, Journal of Pathology 223(3): 347-357.
- Anninga, J.K.; Gelderblom, H.; Fiocco, M.; Kroep, J.R.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Egeler, R.M. (2011), Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?, European Journal of Cancer 47(16): 2431-2445.
- Pansuriya, T.C.; Oosting, J.; Krenacs, T.; Taminiau, A.H.M.; Verdegaal, S.H.M.; Sangiorgi, L.; Sciot, R.; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2011), Genome-wide analysis of Ollier disease: Is it all in the genes?, Orphanet Journal of Rare Diseases 6.
- Shalaby, A.; Presneau, N.; Ye, H.T.; Halai, D.; Berisha, F.; Idowu, B.; Leithner, A.; Liegl, B.; Briggs, T.R.W.; Bacsi, K.; Kindblom, L.G.; Athanasou, N.; Amary, M.F.; Hogendoorn, P.C.W.; Tirabosco, R. & Flanagan, A.M. (2011), The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target, Journal of Pathology 223(3): 336-346.
- Picci, P.; Sieberova, G.; Alberghini, M.; Balladelli, A.; Vanel, D.; Hogendoorn, P.C.W. & Mercuri, M. (2011), Late sarcoma development after curettage and bone grafting of benign bone tumors, European Journal of Radiology 77(1): 19-25.
- Ladanyi, M. & Hogendoorn, P.C.W. (2011), Cancer biology and genomics: translating discoveries, transforming pathology, Journal of Pathology 223(2): 99-101.
- Gelderblom, H.; Jinks, R.C.; Sydes, M.; Bramwell, V.H.C.; Glabbeke, M. van; Grimer, R.J.; Hogendoorn, P.C.W.; McTiernan, A.; Lewis, I.J.; Nooij, M.A.; Taminiau, A.H.M.; Whelan, J. & European Osteosarcoma Intergrp (2011), Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials, European Journal of Cancer 47(6): 895-902.
- Pardali, E.; Schaft, D.W.J. van der; Wiercinska, E.; Gorter, A.; Hogendoorn, P.C.W.; Griffioen, A.W. & Dijke, P. ten (2011), Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma, Oncogene 30(3): 334-345.
- Balke, M.; Neumann, A.; Szuhai, K.; Agelopoulos, K.; August, C.; Gosheger, G.; Hogendoorn, P.C.W.; Athanasou, N.; Buerger, H. & Hagedorn, M. (2011), A short-term in vivo model for giant cell tumor of bone, BMC Cancer 11.
- Jennes, I.; Jong, D. de; Mees, K.; Hogendoorn, P.C.W.; Szuhai, K. & Wuyts, W. (2011), Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families, BMC Medical Genetics 12.
- Pansuriya, T.C.; Oosting, J.; Verdegaal, S.H.M.; Flanagan, A.M.; Sciot, R.; Kindblom, L.G.; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2011), Maffucci Syndrome: A Genome-Wide Analysis Using High Resolution Single Nucleotide Polymorphism and Expression Arrays on Four Cases, Genes, Chromosomes and Cancer 50(9): 673-679.
- He, S.N.; Krens, S.F.G.; Zhan, H.Q.; Gong, Z.Y.; Hogendoorn, P.C.W.; Spaink, H.P. & Snaar-Jagalska, B.E. (2011), A Delta Raf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures, Journal of Pathology 225(1): 19-28.
- Mohseny, A.B.; Machado, I.; Cai, Y.P.; Schaefer, K.L.; Serra, M.; Hogendoorn, P.C.W.; Llombart-Bosch, A. & Cleton-Jansen, A.M. (2011), Functional characterization of osteosarcoma cell lines provides representative models to study the human disease, Laboratory Investigation 91(8): 1195-1205.
- Andrea, C.E. de; Prins, F.A.; Wiweger, M.I. & Hogendoorn, P.C.W. (2011), Growth plate regulation and osteochondroma formation: insights from tracing proteoglycans in zebrafish models and human cartilage, Journal of Pathology 224(2): 160-168.
- Amary, M.F.; Bacsi, K.; Maggiani, F.; Damato, S.; Halai, D.; Berisha, F.; Pollock, R.; O'Donnell, P.; Grigoriadis, A.; Diss, T.; Eskandarpour, M.; Presneau, N.; Hogendoorn, P.C.W.; Futreal, A.; Tirabosco, R. & Flanagan, A.M. (2011), IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours, The Journal of Pathology 224(3): 334-343.
- Martins, A.S.; Ordonez, J.L.; Amaral, A.T.; Prins, F.; Floris, G.; Debiec-Rychter, M.; Hogendoorn, P.C.W. & Alava, E. de (2011), IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis, PLoS ONE 6(5): -.
- Nieuwenhuis, M.H.; Casparie, M.; Mathus-Vliegen, L.M.H.; Dekkers, O.M.; Hogendoorn, P.C.W. & Vasen, H.F.A. (2011), A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses, International Journal of Cancer 129(1): 256-261.
- Kuijjer, M.L.; Namlos, H.M.; Hauben, E.I.; Machado, I.; Kresse, S.H.; Serra, M.; Llombart-Bosch, A.; Hogendoorn, P.C.W.; Meza-Zepeda, L.A.; Myklebost, O. & Cleton-Jansen, A.M. (2011), mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts, BMC Medical Genomics 4: -.
- Jones, E.A.; Remoortere, A. van; Zeijl, R.J.M. van; Hogendoorn, P.C.W.; Bovee, J.V.M.G.; Deelder, A.M. & McDonnell, L.A. (2011), Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma, PLoS ONE 6(9): -.
- Buddingh, E.P.; Schilham, M.W.; Eriaty, S.; Ruslan, N.; Berghuis, D.; Szuhai, K.; Suurmond, J.; Taminiau, A.H.M.; Gelderblom, H.; Egeler, R.M.; Serra, M.; Hogendoorn, P.C.W. & Lankester, A.C. (2011), Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells, Cancer Immunology, Immunotherapy 60(4): 575-586.
- Wiweger, M.I.; Avramut, C.M.; Andrea, C.E. de; Prins, F.A.; Koster, A.J.; Ravelli, R.B.G. & Hogendoom, P.C.W. (2011), Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders, Journal of Pathology 223(4): 531-542.
- Szuhai, K.; Jennes, I.; Jong, D. de; Bovee, J.V.M.G.; Wiweger, M.; Wuyts, W. & Hogendoorn, P.C.W. (2011), Tiling Resolution Array-CGH Shows That Somatic Mosaic Deletion of the EXT Gene is Causative in EXT Gene Mutation Negative Multiple Osteochondromas Patients, Human Mutation 32(2): E2036-E2049.
- de Jong D, Verbeke SLj, Meijer D, Hogendoorn PC, Bovee JV & Szuhai K (2011), Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples., BMC Research Notes 4: 1.
- Kroep, J.R.; Ouali, M.; Gelderblom, H.; Cesne, A. le; Dekker, T.J.A.; Glabbeke, M. van; Hogendoorn, P.C.W. & Hohenberger, P. (2011), First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study, Annals of Oncology 22(1): 207-214.
- Romeo, S.; Bovee, J.V.M.G.; Carraretto, I.; Tirabosco, R.; Natali, C.; Kroon, H.M.; Zanatta, L.; Sciot, R.; Mertens, F.; Athanasou, N.; Alberghini, M.; Hogendoorn, P.C.W. & Tos, A.P. dei (2011), Malignant Fibrous Histiocytoma and Fibrosarcoma of Bone in 2011: What's New?, Modern Pathology 24: 20A21A.
- Meijer, D.; Gelderblom, H.; Karperien, M.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2011), Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo, Clinical Sarcoma Research 1.
- Mertens, F.; Romeo, S.; Bovee, J.V.M.G.; Tirabosco, R.; Athanasou, N.; Alberghini, M.; Hogendoorn, P.C.W.; Tos, A.P.D.; Sciot, R.; Domanski, H.A.; Astrom, K.; Mandahl, N. & Debiec-Rychter, M. (2011), Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features, Clinical Sarcoma Research 1.
- Meijer, D.; Gelderblom, H.; Karperien, M.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2011), Expression of aromatase and estrogen receptor alpha in chondrosarcoma, but no beneficial effect of inhibiting estrogen signaling both in vitro and in vivo, Clinical Sarcoma Research 1.
- de Jong D, Verbeke SLj, Meijer D, Hogendoorn PC, Bovee JV & Szuhai K (2011), Opening the archives for state of the art tumour genetic research: sample processing for array-CGH using decalcified, formalin-fixed, paraffin-embedded tissue-derived DNA samples., BMC Research Notes 4: 1.
- Verdegaal, S.H.M.; Bovee, J.V.M.G.; Pansuriya, T.C.; Grimer, R.J.; Ozger, H.; Jutte, P.C.; San Julian, M.; Biau, D.J.; Geest, I.C.M. van der; Leithner, A.; Streitburger, A.; Klenke, F.M.; Gouin, F.G.; Campanacci, D.A.; Marec-Berard, P.; Hogendoorn, P.C.W.; Brand, R. & Taminiau, A.H.M. (2011), Incidence, predictive factors, and prognosis of chondrosarcoma in patients with ollier disease and maffucci syndrome: an international multicenter study of 161 patients., The Oncologist 16(12): 1771-9.
- Picci, P.; Sieberova, G.; Alberghini, M.; Balladelli, A.; Vanel, D.; Hogendoorn, P.C.W. & Mercuri, M. (2011), Late sarcoma development after curettage and bone grafting of benign bone tumors, European Journal of Radiology 77(1): 19-25.
- Pansuriya, T.C.; Oosting, J.; Verdegaal, S.H.M.; Flanagan, A.M.; Sciot, R.; Kindblom, L.G.; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2011), Maffucci Syndrome: A Genome-Wide Analysis Using High Resolution Single Nucleotide Polymorphism and Expression Arrays on Four Cases, Genes, Chromosomes and Cancer 50(9): 673-679.
- Kroep, J.R.; Ouali, M.; Gelderblom, H.; Cesne, A. le; Dekker, T.J.A.; Glabbeke, M. van; Hogendoorn, P.C.W. & Hohenberger, P. (2011), First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study, Annals of Oncology 22(1): 207-214.
- Balke, M.; Neumann, A.; Szuhai, K.; Agelopoulos, K.; August, C.; Gosheger, G.; Hogendoorn, P.C.W.; Athanasou, N.; Buerger, H. & Hagedorn, M. (2011), A short-term in vivo model for giant cell tumor of bone, BMC Cancer 11.
- Jennes, I.; Jong, D. de; Mees, K.; Hogendoorn, P.C.W.; Szuhai, K. & Wuyts, W. (2011), Breakpoint characterization of large deletions in EXT1 or EXT2 in 10 Multiple Osteochondromas families, BMC Medical Genetics 12.
- Pansuriya, T.C.; Oosting, J.; Krenacs, T.; Taminiau, A.H.M.; Verdegaal, S.H.M.; Sangiorgi, L.; Sciot, R.; Hogendoorn, P.C.W.; Szuhai, K. & Bovee, J.V.M.G. (2011), Genome-wide analysis of Ollier disease: Is it all in the genes?, Orphanet Journal of Rare Diseases 6.
- Nieuwenhuis, M.H.; Casparie, M.; Mathus-Vliegen, L.M.H.; Dekkers, O.M.; Hogendoorn, P.C.W. & Vasen, H.F.A. (2011), A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses, International Journal of Cancer 129(1): 256-261.
- Buddingh, E.P.; Schilham, M.W.; Eriaty, S.; Ruslan, N.; Berghuis, D.; Szuhai, K.; Suurmond, J.; Taminiau, A.H.M.; Gelderblom, H.; Egeler, R.M.; Serra, M.; Hogendoorn, P.C.W. & Lankester, A.C. (2011), Chemotherapy-resistant osteosarcoma is highly susceptible to IL-15-activated allogeneic and autologous NK cells, Cancer Immunology, Immunotherapy 60(4): 575-586.
- Ladanyi, M. & Hogendoorn, P.C.W. (2011), Cancer biology and genomics: translating discoveries, transforming pathology, Journal of Pathology 223(2): 99-101.
- Pardali, E.; Schaft, D.W.J. van der; Wiercinska, E.; Gorter, A.; Hogendoorn, P.C.W.; Griffioen, A.W. & Dijke, P. ten (2011), Critical role of endoglin in tumor cell plasticity of Ewing sarcoma and melanoma, Oncogene 30(3): 334-345.
- Shalaby, A.; Presneau, N.; Ye, H.T.; Halai, D.; Berisha, F.; Idowu, B.; Leithner, A.; Liegl, B.; Briggs, T.R.W.; Bacsi, K.; Kindblom, L.G.; Athanasou, N.; Amary, M.F.; Hogendoorn, P.C.W.; Tirabosco, R. & Flanagan, A.M. (2011), The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target, Journal of Pathology 223(3): 336-346.
- Berghuis, D.; Santos, S.J.; Baelde, H.J.; Taminiau, A.H.M.; Egeler, R.M.; Schilham, M.W.; Hogendoorn, P.C.W. & Lankester, A.C. (2011), Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression, Journal of Pathology 223(3): 347-357.
- Presneau, N.; Shalaby, A.; Ye, H.T.; Pillay, N.; Halai, D.; Idowu, B.; Tirabosco, R.; Whitwell, D.; Jacques, T.S.; Kindblom, L.G.; Bruderlein, S.; Moller, P.; Leithner, A.; Liegl, B.; Amary, F.M.; Athanasou, N.N.; Hogendoorn, P.C.W.; Mertens, F.; Szuhai, K. & Flanagan, A.M. (2011), Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study, Journal of Pathology 223(3): 327-335.
- Verbeke, S.L.J.; Bertoni, F.; Bacchini, P.; Sciot, R.; Fletcher, C.D.M.; Kroon, H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2011), Distinct histological features characterize primary angiosarcoma of bone, Histopathology 58(2): 254-264.
- Martins, A.S.; Ordonez, J.L.; Amaral, A.T.; Prins, F.; Floris, G.; Debiec-Rychter, M.; Hogendoorn, P.C.W. & Alava, E. de (2011), IGF1R Signaling in Ewing Sarcoma Is Shaped by Clathrin-/Caveolin-Dependent Endocytosis, PLoS ONE 6(5): -.
- Maggiani, F.; Forsyth, R.; Hogendoorn, P.C.W.; Krenacs, T. & Athanasou, N.A. (2011), The immunophenotype of osteoclasts and macrophage polykaryons, Journal of Clinical Pathology 64(8): 701-705.
- Mohseny, A.B. & Hogendoorn, P.C.W. (2011), Concise Review: Mesenchymal Tumors: When Stem Cells Go Mad, Stem Cells 29(3): 397-403.
- He, S.N.; Krens, S.F.G.; Zhan, H.Q.; Gong, Z.Y.; Hogendoorn, P.C.W.; Spaink, H.P. & Snaar-Jagalska, B.E. (2011), A Delta Raf1-ER-inducible oncogenic zebrafish liver cell model identifies hepatocellular carcinoma signatures, Journal of Pathology 225(1): 19-28.
- Buddingh, E.P.; Kuijjer, M.L.; Duim, R.A.J.; Burger, H.; Agelopoulos, K.; Myklebost, O.; Serra, M.; Mertens, F.; Hogendoom, P.C.W.; Lankester, A.C. & Cleton-Jansen, A.M. (2011), Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents, Clinical Cancer Research 17(8): 2110-2119.
- Buddingh, E.P.; Kuijjer, M.L.; Duim, R.A.J.; Burger, H.; Agelopoulos, K.; Myklebost, O.; Serra, M.; Mertens, F.; Hogendoom, P.C.W.; Lankester, A.C. & Cleton-Jansen, A.M. (2011), Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents, Clinical Cancer Research 17(8): 2110-2119.
- Kuijjer, M.L.; Namlos, H.M.; Hauben, E.I.; Machado, I.; Kresse, S.H.; Serra, M.; Llombart-Bosch, A.; Hogendoorn, P.C.W.; Meza-Zepeda, L.A.; Myklebost, O. & Cleton-Jansen, A.M. (2011), mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts, BMC Medical Genomics 4: -.
- Kashima, T.G.; Dongre, A.; Flanagan, A.M.; Hogendoorn, P.C.W.; Taylor, R. & Athanasou, N.A. (2011), Podoplanin expression in adamantinoma of long bones and osteofibrous dysplasia, Virchows Archiv 459(1): 41-46.
- Andrea, C.E. de; Prins, F.A.; Wiweger, M.I. & Hogendoorn, P.C.W. (2011), Growth plate regulation and osteochondroma formation: insights from tracing proteoglycans in zebrafish models and human cartilage, Journal of Pathology 224(2): 160-168.
- Szuhai, K.; Jennes, I.; Jong, D. de; Bovee, J.V.M.G.; Wiweger, M.; Wuyts, W. & Hogendoorn, P.C.W. (2011), Tiling Resolution Array-CGH Shows That Somatic Mosaic Deletion of the EXT Gene is Causative in EXT Gene Mutation Negative Multiple Osteochondromas Patients, Human Mutation 32(2): E2036-E2049.
- Mohseny, A.B.; Machado, I.; Cai, Y.P.; Schaefer, K.L.; Serra, M.; Hogendoorn, P.C.W.; Llombart-Bosch, A. & Cleton-Jansen, A.M. (2011), Functional characterization of osteosarcoma cell lines provides representative models to study the human disease, Laboratory Investigation 91(8): 1195-1205.
- Gelderblom, H.; Jinks, R.C.; Sydes, M.; Bramwell, V.H.C.; Glabbeke, M. van; Grimer, R.J.; Hogendoorn, P.C.W.; McTiernan, A.; Lewis, I.J.; Nooij, M.A.; Taminiau, A.H.M.; Whelan, J. & European Osteosarcoma Intergrp (2011), Survival after recurrent osteosarcoma: Data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials, European Journal of Cancer 47(6): 895-902.
- Anninga, J.K.; Gelderblom, H.; Fiocco, M.; Kroep, J.R.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Egeler, R.M. (2011), Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?, European Journal of Cancer 47(16): 2431-2445.
- Wiweger, M.I.; Avramut, C.M.; Andrea, C.E. de; Prins, F.A.; Koster, A.J.; Ravelli, R.B.G. & Hogendoom, P.C.W. (2011), Cartilage ultrastructure in proteoglycan-deficient zebrafish mutants brings to light new candidate genes for human skeletal disorders, Journal of Pathology 223(4): 531-542.
- Jones, E.A.; Remoortere, A. van; Zeijl, R.J.M. van; Hogendoorn, P.C.W.; Bovee, J.V.M.G.; Deelder, A.M. & McDonnell, L.A. (2011), Multiple Statistical Analysis Techniques Corroborate Intratumor Heterogeneity in Imaging Mass Spectrometry Datasets of Myxofibrosarcoma, PLoS ONE 6(9): -.
- Amary, M.F.; Bacsi, K.; Maggiani, F.; Damato, S.; Halai, D.; Berisha, F.; Pollock, R.; O'Donnell, P.; Grigoriadis, A.; Diss, T.; Eskandarpour, M.; Presneau, N.; Hogendoorn, P.C.W.; Futreal, A.; Tirabosco, R. & Flanagan, A.M. (2011), IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours, The Journal of Pathology 224(3): 334-343.
- Romeo, S.; Bovee, J.V.M.G.; Carraretto, I.; Tirabosco, R.; Natali, C.; Kroon, H.M.; Zanatta, L.; Sciot, R.; Mertens, F.; Athanasou, N.; Alberghini, M.; Hogendoorn, P.C.W. & Tos, A.P. dei (2011), Malignant Fibrous Histiocytoma and Fibrosarcoma of Bone in 2011: What's New?, Modern Pathology 24: 20A21A.
- Buddingh, E.P.; Kuijjer, M.L.; Duim, R.; Burger, H.; Agelopoulos, K.; Myklebost, O.; Serra, M.; Mertens, F.; Hogendoorn, P.C.W.; Lankester, A.C. & Cleton-Jansen, A.M. (2011), Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage-Activating Agents, Modern Pathology 24: 10A10A.
- Romeo, S.; Bovee, J.V.M.G.; Carrareno, I.; Tirabosco, R.; Natali, C.; Kroon, H.M.; Zanatta, L.; Sciot, R.; Mertens, F.; Athanasou, N.; Alberghini, M.; Hogendoorn, P.C.W. & Tos, A.P. dei (2011), Malignant Fibrous Histiocytoma and Fibrosarcoma of Bone in 2011: What's New?, Laboratory Investigation 91: 20A21A.
- Berghuis, D.; Santos, S.J.; Baelde, J.J.; Taminiau, A.H.M.; Egeler, R.M.; Schilham, M.W.; Hogendoorn, P.C.W. & Lankester, A.C. (2010), A Pro-Inflammatory Tumor Microenvironment with High Chemokine Expression and High Tumor-Infiltrating CD3+CD8+Numbers Associates with Improved Survival in Ewing Sarcoma (EWS), Laboratory Investigation 90: 15A15A.
- Guillou, L.; Hogendoorn, P.C.W. & Bosman, F.T. (2010), Soft tissue sarcomas: introduction to the Virchows Archiv review issue, Virchows Archiv 456(2): 107-109.
- Willems, S.M.; Wiweger, M.; Roggen, J.F.G. van & Hogendoorn, P.C.W. (2010), Running GAGs: myxoid matrix in tumor pathology revisited, Virchows Archiv 456(2): 181-192.
- Buddingh, E.P.; Anninga, J.K.; Versteegh, M.I.M.; Taminiau, A.H.M.; Egeler, R.M.; Rijswijk, C.S.P. van; Hogendoorn, P.C.W.; Lankester, A.C. & Gelderblom, H. (2010), Prognostic Factors in Pulmonary Metastasized High-Grade Osteosarcoma, Pediatric Blood and Cancer 54(2): 216-221.
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2010), Molecular pathology of sarcomas: concepts and clinical implications, Virchows Archiv 456(2): 193-199.
- Egeler, R.M.; Halteren, A.G.S. van; Hogendoorn, P.C.W.; Laman, J.D. & Leenen, P.J.M. (2010), Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage, Immunological Reviews 234: 213-232.
- Ottaviano, L.; Schaefer, K.L.; Gajewski, M.; Huckenbeck, W.; Baldus, S.; Rogel, U.; Mackintosh, C.; Alava, E. de; Myklebost, O.; Kresse, S.H.; Meza-Zepeda, L.A.; Serra, M.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W.; Buerger, H.; Aigner, T.; Gabbert, H.E. & Poremba, C. (2010), Molecular characterization of commonly used cell lines for bone tumor research , Genes, Chromosomes & Cancer 49(1): 40-51.
- Sleijfer, S.; Ouali, M.; Glabbeke, M. van; Krarup-Hansen, A.; Rodenhuis, S.; Cesne, A. le; Hogendoorn, P.C.W.; Verweij, J. & Blay, J.Y. (2010), Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG), European Journal of Cancer 46(1): 72-83.
- Egeler, R.M.; Halteren, A.G.S. van; Hogendoorn, P.C.W.; Laman, J.D. & Leenen, P.J.M. (2010), Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.
- Mohseny, A.B.; Tieken, C.; Velden, P.A. van der; Szuhai, K.; Andrea, C. de; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2010), Small Deletions but not Methylation Underlie CDKN2A/p16 Loss of Expression in Conventional Osteosarcoma, Genes, Chromosomes and Cancer 49(12): 1095-1103.
- Willems, S.M.; Schrage, Y.M.; Briaire-de Bruijn, I.H.; Szuhai, K.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2010), Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option, Molecular Cancer 9.
- Diaz-Romero, J.; Romeo, S.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Heini, P.F. & Mainil-Varlet, P. (2010), Hierarchical Clustering of Flow Cytometry Data for the Study of Conventional Central Chondrosarcoma, Journal of Cellular Physiology 225(2): 601-611.
- Novelli, M.; Rossi, S.; Rodriguez-Justo, M.; Taniere, P.; Seddon, B.; Toffolatti, L.; Sartor, C.; Hogendoorn, P.C.W.; Sciot, R.; Glabbeke, M. van; Verweij, J.; Blay, J.Y.; Hohenberger, P.; Flanagan, A. & Tos, A.P. dei (2010), DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours, Histopathology 57(2): 259-270.
- Dewaele, B.; Floris, G.; Finalet-Ferreiro, J.; Fletcher, C.D.; Coindre, J.M.; Guillou, L.; Hogendoorn, P.C.W.; Wozniak, A.; Vanspauwen, V.; Schoffski, P.; Marynen, P.; Vandenberghe, P.; Sciot, R. & Debiec-Rychter, M. (2010), Coactivated Platelet-Derived Growth Factor Receptor alpha and Epidermal Growth Factor Receptor Are Potential Therapeutic Targets in Intimal Sarcoma, Cancer Research 70(18): 7304-7314.
- Romeo, S.; Duim, R.A.J.; Bridge, J.A.; Mertens, F.; Jong, D. de; Cin, P. dal; Wijers-Koster, P.M.; Debiec-Rychter, M.; Sciot, R.; Rosenberg, A.E.; Szuhai, K. & Hogendoorn, P.C.W. (2010), Heterogeneous and Complex Rearrangements of Chromosome Arm 6q in Chondromyxoid Fibroma Delineation of Breakpoints and Analysis of Candidate Target Genes, American Journal of Pathology 177(3): 1365-1376.
- Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Wunder, J.S. & Alman, B.A. (2010), Cartilage tumours and bone development: molecular pathology and possible therapeutic targets, Nature Reviews Cancer 10(7): 481-488.
- Balke, M.; Campanacci, L.; Gebert, C.; Picci, P.; Gibbons, M.; Taylor, R.; Hogendoorn, P.; Kroep, J.; Wass, J. & Athanasou, N. (2010), Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone, BMC Cancer 10.
- Reijnders, C.M.A.; Waaijer, C.J.F.; Hamilton, A.; Buddingh, E.P.; Dijkstra, S.P.D.; Ham, J.; Bakker, E.; Szuhai, K.; Karperien, M.; Hogendoorn, P.C.W.; Stringer, S.E. & Bovee, J.V.M.G. (2010), No Haploinsufficiency but Loss of Heterozygosity for EXT in Multiple Osteochondromas, American Journal of Pathology 177(4): 1946-1957.
- Romeo, S.; Duim, R.A.J.; Bridge, J.A.; Mertens, F.; Jong, D. de; Cin, P. dal; Wijers-Koster, P.M.; Debiec-Rychter, M.; Sciot, R.; Rosenberg, A.; Szuhai, K. & Hogendoorn, P.C.W. (2010), Heterogeneous and Complex Rearragements of the Long Arm of Chromosome 6 in Chondromyxoid Fibroma, Modern Pathology 23: 27A27A.
- Romeo, S.; Duim, R.A.J.; Bridge, J.A.; Mertens, F.; Jong, D. de; Cin, P. dal; Wijers-Koster, P.M.; Debiec-Rychter, M.; Sciot, R.; Rosenberg, A.; Szuhai, K. & Hogendoorn, P.C.W. (2010), Heterogeneous and Complex Rearragements of the Long Arm of Chromosome 6 in Chondromyxoid Fibroma, Laboratory Investigation 90: 27A27A.
- Heyning, F.H.; Jansen, P.M.; Hogendoorn, P.C.W. & Szuhai, K. (2010), Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone, Journal of Clinical Pathology 63(12): 1095-1100.
- Reijnders, C.M.A.; Waaijer, C.J.F.; Hamilton, A.; Buddingh, E.; Dijkstra, P.D.S.; Ham, S.J.; Bakker, E.; Szuhai, K.; Karperien, M.; Hogendoorn, P.C.W.; Stringer, S.E. & Bovee, J.V.M.G. (2010), Osteochondroma Formation: Haploinsufficiency or Two Hits?, Modern Pathology 23: 26A26A.
- Reijnders, C.M.A.; Waaijer, C.J.F.; Hamilton, A.; Buddingh, E.; Dijkstra, P.D.S.; Ham, S.J.; Bakker, E.; Szuhai, K.; Karperien, M.; Hogendoorn, P.C.W.; Stringer, S.E. & Bovee, J.V.M.G. (2010), Osteochondroma Formation: Haploinsufficiency or Two Hits?, Laboratory Investigation 90: 26A26A.
- Boeuf, S.; Bovee, J.V.M.G.; Lehner, B.; Hogendoorn, P.C.W. & Richter, W. (2010), Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours, Histopathology 56(5): 641-651.
- Deley, M.C. le; Delattre, O.; Schaefer, K.L.; Burchill, S.A.; Koehler, G.; Hogendoorn, P.C.W.; Lion, T.; Poremba, C.; Marandet, J.; Ballet, S.; Pierron, G.; Brownhill, S.C.; Nesslbock, M.; Ranft, A.; Dirksen, U.; Oberlin, O.; Lewis, I.J.; Craft, A.W.; Jurgens, H. & Kovar, H. (2010), Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-EWING 99 Trial, Journal of Clinical Oncology 28(12): 1982-1988.
- Verbeke, S.L.J.; Fletcher, C.D.M.; Alberghini, M.; Daugaard, S.; Flanagan, A.M.; Parratt, T.; Kroon, H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2010), A Reappraisal of Hemangiopericytoma of Bone; Analysis of Cases Reclassified as Synovial Sarcoma and Solitary Fibrous Tumor of Bone, American Journal of Surgical Pathology 34(6): 777-783.
- Buddingh, E.P.; Anninga, J.K.; Versteegh, M.I.M.; Taminiau, A.H.M.; Egeler, R.M.; Rijswijk, C.S.P. van; Hogendoorn, P.C.W.; Lankester, A.C. & Gelderblom, H. (2010), Prognostic factors in pulmonary metastasized high-grade osteosarcoma., Pediatric Blood and Cancer 54(2): 216-21.
- Subramanian, S.; Thayanithy, V.; West, R.B.; Lee, C.H.; Beck, A.H.; Zhu, S.; Downs-Kelly, E.; Montgomery, K.; Goldblum, J.R.; Hogendoom, P.C.W.; Corless, C.L.; Oliveira, A.M.; Dry, S.M.; Nielsen, T.O.; Rubin, B.P.; Fletcher, J.A.; Fletcher, C.D.M. & Rijn, M. van de (2010), Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours, The Journal of Pathology 220(1): 58-70.
- Nieuwenhuis, M.H.; Casparie, M.; Mathus-Vliegen, L.M.H.; Dekkers, O.M.; Hogendoorn, P.C.W. & Vasen, H.F.A. (2010), A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses., International Journal of Cancer.
- de Andrea CE, Wiweger M, Bovee JVMG, Romeo S & Hogendoorn PCW (2010), Primary Cilia Organization Orchestrating Cell Polarity in the Growth Plate and Its Loss in Osteochondroma, Laboratory Investigation 90: 18A18A.
- Andrea, C.E. de; Wiweger, M.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2010), Primary Cilia Organization Orchestrating Cell Polarity in the Growth Plate and Its Loss in Osteochondroma, Modern Pathology 23: 18A18A.
- Andrea, C.E. de; Wiweger, M.; Prins, F.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2010), Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma, Laboratory Investigation 90(7): 1091-1101.
- Mohseny, A.B.; Machado, I.; Cai, Y.; Schaefer, K.L.; Hogendoorn, P.C.; Llombart-Bosch, A. & Cleton-Jansen, A.M. (2010), Functional and Phenotypical Analysis of 19 EuroBoNet Osteosarcoma Cell Lines, Laboratory Investigation 90: 25A25A.
- Mohseny, A.B.; Machado, I.; Cai, Y.; Schaefer, K.L.; Hogendoorn, P.C.; Llombart-Bosch, A. & Cleton-Jansen, A.M. (2010), Functional and Phenotypical Analysis of 19 EuroBoNet Osteosarcoma Cell Lines, Modern Pathology 23: 25A25A.
- Hogendoorn, P.C.W.; Athanasou, N.; Bielack, S.; Alava, E. de; Tos, A.P.D.; Ferrari, S.; Gelderblom, H.; Grimer, R.; Hall, K.S.; Hassan, B.; Hogendoorn, P.C.W.; Jurgens, H.; Paulussen, M.; Rozeman, L.; Taminiau, A.H.M.; Whelan, J.; Vanel, D. & ESMO EUROBONET Working Grp (2010), Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- Willems, S.M.; Remoortere, A. van; Zeijl, R. van; Deelder, A.M.; McDonnell, L.A. & Hogendoorn, P.C.W. (2010), Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity, Journal of Pathology 222(4): 400-409.
- Hogendoorn, P.C.W.; Athanasou, N.; Bielack, S.; Alava, E. de; Tos, A.P.D.; Ferrari, S.; Gelderblom, H.; Grimer, R.; Hall, K.S.; Hassan, B.; Hogendoorn, P.C.W.; Jurgens, H.; Paulussen, M.; Rozeman, L.; Taminiau, A.H.M.; Whelan, J.; Vanel, D. & ESMO EUROBONET Working Grp (2010), Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 21: v204v213.
- Dongen, M. van; Savage, N.D.L.; Jordanova, E.S.; Briaire-de Bruijn, I.H.; Walburg, K.V.; Ottenhoff, T.H.M.; Hogendoorn, P.C.W.; Burg, S.H. van der; Gelderblom, H. & Hall, T. van (2010), Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors, International Journal of Cancer 127(4): 899-909.
- Nieuwenhuis, M.H.; Casparie, M.; Mathus-Vliegen, L.M.H.; Dekkers, O.M.; Hogendoorn, P.C.W. & Vasen, H.F.A. (2010), A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses., International Journal of Cancer.
- Hogendoorn, P.C.W.; Athanasou, N.; Bielack, S.; Alava, E. de; Tos, A.P.D.; Ferrari, S.; Gelderblom, H.; Grimer, R.; Hall, K.S.; Hassan, B.; Hogendoorn, P.C.W.; Jurgens, H.; Paulussen, M.; Rozeman, L.; Taminiau, A.H.M.; Whelan, J.; Vanel, D. & ESMO EUROBONET Working Grp (2010), Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
- de Andrea CE, Wiweger M, Bovee JVMG, Romeo S & Hogendoorn PCW (2010), Primary Cilia Organization Orchestrating Cell Polarity in the Growth Plate and Its Loss in Osteochondroma, Laboratory Investigation 90: 18A18A.
- Gelderblom, H.; Blay, J.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.L.; Brauwer, A. de; Veyt, E.; Weitman, S.D.; Hogendoorn, P.C. & Hohenberger, P. (2010), Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study., Journal of Clinical Oncology 28(15).
- Gelderblom, H.; Blay, J.; Seddon, B.M.; Leahy, M.; Ray-Coquard, I.L.; Brauwer, A. de; Veyt, E.; Weitman, S.D.; Hogendoorn, P.C. & Hohenberger, P. (2010), Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An EORTC Soft Tissue and Bone Sarcoma Group randomized phase II study., Journal of Clinical Oncology 28(15).
- Egeler, R.M.; Halteren, A.G.S. van; Hogendoorn, P.C.W.; Laman, J.D. & Leenen, P.J.M. (2010), Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage.
- Buddingh, E.P.; Anninga, J.K.; Versteegh, M.I.M.; Taminiau, A.H.M.; Egeler, R.M.; Rijswijk, C.S.P. van; Hogendoorn, P.C.W.; Lankester, A.C. & Gelderblom, H. (2010), Prognostic factors in pulmonary metastasized high-grade osteosarcoma., Pediatric Blood and Cancer 54(2): 216-21.
- Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Wunder, J.S. & Alman, B.A. (2010), Cartilage tumours and bone development: molecular pathology and possible therapeutic targets, Nature Reviews Cancer 10(7): 481-488.
- Willems, S.M.; Wiweger, M.; Roggen, J.F.G. van & Hogendoorn, P.C.W. (2010), Running GAGs: myxoid matrix in tumor pathology revisited, Virchows Archiv 456(2): 181-192.
- Hogendoorn, P.C.W.; Athanasou, N.; Bielack, S.; Alava, E. de; Tos, A.P.D.; Ferrari, S.; Gelderblom, H.; Grimer, R.; Hall, K.S.; Hassan, B.; Hogendoorn, P.C.W.; Jurgens, H.; Paulussen, M.; Rozeman, L.; Taminiau, A.H.M.; Whelan, J.; Vanel, D. & ESMO EUROBONET Working Grp (2010), Bone sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology 21: v204v213.
- Diaz-Romero, J.; Romeo, S.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Heini, P.F. & Mainil-Varlet, P. (2010), Hierarchical Clustering of Flow Cytometry Data for the Study of Conventional Central Chondrosarcoma, Journal of Cellular Physiology 225(2): 601-611.
- Dewaele, B.; Floris, G.; Finalet-Ferreiro, J.; Fletcher, C.D.; Coindre, J.M.; Guillou, L.; Hogendoorn, P.C.W.; Wozniak, A.; Vanspauwen, V.; Schoffski, P.; Marynen, P.; Vandenberghe, P.; Sciot, R. & Debiec-Rychter, M. (2010), Coactivated Platelet-Derived Growth Factor Receptor alpha and Epidermal Growth Factor Receptor Are Potential Therapeutic Targets in Intimal Sarcoma, Cancer Research 70(18): 7304-7314.
- Boeuf, S.; Bovee, J.V.M.G.; Lehner, B.; Hogendoorn, P.C.W. & Richter, W. (2010), Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours, Histopathology 56(5): 641-651.
- Willems, S.M.; Schrage, Y.M.; Briaire-de Bruijn, I.H.; Szuhai, K.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2010), Kinome profiling of myxoid liposarcoma reveals NF-kappaB-pathway kinase activity and Casein Kinase II inhibition as a potential treatment option, Molecular Cancer 9.
- Heyning, F.H.; Jansen, P.M.; Hogendoorn, P.C.W. & Szuhai, K. (2010), Array-based comparative genomic hybridisation analysis reveals recurrent chromosomal alterations in primary diffuse large B cell lymphoma of bone, Journal of Clinical Pathology 63(12): 1095-1100.
- Romeo, S.; Duim, R.A.J.; Bridge, J.A.; Mertens, F.; Jong, D. de; Cin, P. dal; Wijers-Koster, P.M.; Debiec-Rychter, M.; Sciot, R.; Rosenberg, A.E.; Szuhai, K. & Hogendoorn, P.C.W. (2010), Heterogeneous and Complex Rearrangements of Chromosome Arm 6q in Chondromyxoid Fibroma Delineation of Breakpoints and Analysis of Candidate Target Genes, American Journal of Pathology 177(3): 1365-1376.
- Reijnders, C.M.A.; Waaijer, C.J.F.; Hamilton, A.; Buddingh, E.P.; Dijkstra, S.P.D.; Ham, J.; Bakker, E.; Szuhai, K.; Karperien, M.; Hogendoorn, P.C.W.; Stringer, S.E. & Bovee, J.V.M.G. (2010), No Haploinsufficiency but Loss of Heterozygosity for EXT in Multiple Osteochondromas, American Journal of Pathology 177(4): 1946-1957.
- Dongen, M. van; Savage, N.D.L.; Jordanova, E.S.; Briaire-de Bruijn, I.H.; Walburg, K.V.; Ottenhoff, T.H.M.; Hogendoorn, P.C.W.; Burg, S.H. van der; Gelderblom, H. & Hall, T. van (2010), Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors, International Journal of Cancer 127(4): 899-909.
- Ottaviano, L.; Schaefer, K.L.; Gajewski, M.; Huckenbeck, W.; Baldus, S.; Rogel, U.; Mackintosh, C.; Alava, E. de; Myklebost, O.; Kresse, S.H.; Meza-Zepeda, L.A.; Serra, M.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W.; Buerger, H.; Aigner, T.; Gabbert, H.E. & Poremba, C. (2010), Molecular characterization of commonly used cell lines for bone tumor research , Genes, Chromosomes & Cancer 49(1): 40-51.
- Balke, M.; Campanacci, L.; Gebert, C.; Picci, P.; Gibbons, M.; Taylor, R.; Hogendoorn, P.; Kroep, J.; Wass, J. & Athanasou, N. (2010), Bisphosphonate treatment of aggressive primary, recurrent and metastatic Giant Cell Tumour of Bone, BMC Cancer 10.
- Egeler, R.M.; Halteren, A.G.S. van; Hogendoorn, P.C.W.; Laman, J.D. & Leenen, P.J.M. (2010), Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage, Immunological Reviews 234: 213-232.
- Andrea, C.E. de; Wiweger, M.; Prins, F.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2010), Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma, Laboratory Investigation 90(7): 1091-1101.
- Deley, M.C. le; Delattre, O.; Schaefer, K.L.; Burchill, S.A.; Koehler, G.; Hogendoorn, P.C.W.; Lion, T.; Poremba, C.; Marandet, J.; Ballet, S.; Pierron, G.; Brownhill, S.C.; Nesslbock, M.; Ranft, A.; Dirksen, U.; Oberlin, O.; Lewis, I.J.; Craft, A.W.; Jurgens, H. & Kovar, H. (2010), Impact of EWS-ETS Fusion Type on Disease Progression in Ewing's Sarcoma/Peripheral Primitive Neuroectodermal Tumor: Prospective Results From the Cooperative Euro-EWING 99 Trial, Journal of Clinical Oncology 28(12): 1982-1988.
- Willems, S.M.; Remoortere, A. van; Zeijl, R. van; Deelder, A.M.; McDonnell, L.A. & Hogendoorn, P.C.W. (2010), Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity, Journal of Pathology 222(4): 400-409.
- Novelli, M.; Rossi, S.; Rodriguez-Justo, M.; Taniere, P.; Seddon, B.; Toffolatti, L.; Sartor, C.; Hogendoorn, P.C.W.; Sciot, R.; Glabbeke, M. van; Verweij, J.; Blay, J.Y.; Hohenberger, P.; Flanagan, A. & Tos, A.P. dei (2010), DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours, Histopathology 57(2): 259-270.
- Sleijfer, S.; Ouali, M.; Glabbeke, M. van; Krarup-Hansen, A.; Rodenhuis, S.; Cesne, A. le; Hogendoorn, P.C.W.; Verweij, J. & Blay, J.Y. (2010), Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas An exploratory, retrospective analysis on large series from the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG), European Journal of Cancer 46(1): 72-83.
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2010), Molecular pathology of sarcomas: concepts and clinical implications, Virchows Archiv 456(2): 193-199.
- Mohseny, A.B.; Tieken, C.; Velden, P.A. van der; Szuhai, K.; Andrea, C. de; Hogendoorn, P.C.W. & Cleton-Jansen, A.M. (2010), Small Deletions but not Methylation Underlie CDKN2A/p16 Loss of Expression in Conventional Osteosarcoma, Genes, Chromosomes and Cancer 49(12): 1095-1103.
- Buddingh, E.P.; Anninga, J.K.; Versteegh, M.I.M.; Taminiau, A.H.M.; Egeler, R.M.; Rijswijk, C.S.P. van; Hogendoorn, P.C.W.; Lankester, A.C. & Gelderblom, H. (2010), Prognostic Factors in Pulmonary Metastasized High-Grade Osteosarcoma, Pediatric Blood and Cancer 54(2): 216-221.
- Verbeke, S.L.J.; Fletcher, C.D.M.; Alberghini, M.; Daugaard, S.; Flanagan, A.M.; Parratt, T.; Kroon, H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2010), A Reappraisal of Hemangiopericytoma of Bone; Analysis of Cases Reclassified as Synovial Sarcoma and Solitary Fibrous Tumor of Bone, American Journal of Surgical Pathology 34(6): 777-783.
- Subramanian, S.; Thayanithy, V.; West, R.B.; Lee, C.H.; Beck, A.H.; Zhu, S.; Downs-Kelly, E.; Montgomery, K.; Goldblum, J.R.; Hogendoom, P.C.W.; Corless, C.L.; Oliveira, A.M.; Dry, S.M.; Nielsen, T.O.; Rubin, B.P.; Fletcher, J.A.; Fletcher, C.D.M. & Rijn, M. van de (2010), Genome-wide transcriptome analyses reveal p53 inactivation mediated loss of miR-34a expression in malignant peripheral nerve sheath tumours, The Journal of Pathology 220(1): 58-70.
- Romeo, S.; Duim, R.A.J.; Bridge, J.A.; Mertens, F.; Jong, D. de; Cin, P. dal; Wijers-Koster, P.M.; Debiec-Rychter, M.; Sciot, R.; Rosenberg, A.; Szuhai, K. & Hogendoorn, P.C.W. (2010), Heterogeneous and Complex Rearragements of the Long Arm of Chromosome 6 in Chondromyxoid Fibroma, Laboratory Investigation 90: 27A27A.
- Guillou, L.; Hogendoorn, P.C.W. & Bosman, F.T. (2010), Soft tissue sarcomas: introduction to the Virchows Archiv review issue, Virchows Archiv 456(2): 107-109.
- Reijnders, C.M.A.; Waaijer, C.J.F.; Hamilton, A.; Buddingh, E.; Dijkstra, P.D.S.; Ham, S.J.; Bakker, E.; Szuhai, K.; Karperien, M.; Hogendoorn, P.C.W.; Stringer, S.E. & Bovee, J.V.M.G. (2010), Osteochondroma Formation: Haploinsufficiency or Two Hits?, Laboratory Investigation 90: 26A26A.
- Romeo, S.; Duim, R.A.J.; Bridge, J.A.; Mertens, F.; Jong, D. de; Cin, P. dal; Wijers-Koster, P.M.; Debiec-Rychter, M.; Sciot, R.; Rosenberg, A.; Szuhai, K. & Hogendoorn, P.C.W. (2010), Heterogeneous and Complex Rearragements of the Long Arm of Chromosome 6 in Chondromyxoid Fibroma, Modern Pathology 23: 27A27A.
- Berghuis, D.; Santos, S.J.; Baelde, J.J.; Taminiau, A.H.M.; Egeler, R.M.; Schilham, M.W.; Hogendoorn, P.C.W. & Lankester, A.C. (2010), A Pro-Inflammatory Tumor Microenvironment with High Chemokine Expression and High Tumor-Infiltrating CD3+CD8+Numbers Associates with Improved Survival in Ewing Sarcoma (EWS), Laboratory Investigation 90: 15A15A.
- Andrea, C.E. de; Wiweger, M.; Bovee, J.V.M.G.; Romeo, S. & Hogendoorn, P.C.W. (2010), Primary Cilia Organization Orchestrating Cell Polarity in the Growth Plate and Its Loss in Osteochondroma, Modern Pathology 23: 18A18A.
- Reijnders, C.M.A.; Waaijer, C.J.F.; Hamilton, A.; Buddingh, E.; Dijkstra, P.D.S.; Ham, S.J.; Bakker, E.; Szuhai, K.; Karperien, M.; Hogendoorn, P.C.W.; Stringer, S.E. & Bovee, J.V.M.G. (2010), Osteochondroma Formation: Haploinsufficiency or Two Hits?, Modern Pathology 23: 26A26A.
- Mohseny, A.B.; Machado, I.; Cai, Y.; Schaefer, K.L.; Hogendoorn, P.C.; Llombart-Bosch, A. & Cleton-Jansen, A.M. (2010), Functional and Phenotypical Analysis of 19 EuroBoNet Osteosarcoma Cell Lines, Laboratory Investigation 90: 25A25A.
- Mohseny, A.B.; Machado, I.; Cai, Y.; Schaefer, K.L.; Hogendoorn, P.C.; Llombart-Bosch, A. & Cleton-Jansen, A.M. (2010), Functional and Phenotypical Analysis of 19 EuroBoNet Osteosarcoma Cell Lines, Modern Pathology 23: 25A25A.
- Dirk Engberts & Pancras Hogendoorn (2010), Historisch-anatomische collecties : een onrustig bezit, Museumtijdschrift.
- Cai, Y.P.; Mohseny, A.B.; Karperien, M.; Hogendoom, P.C.W.; Zhou, G.Y. & Cleton-Jansen, A.M. (2010), Inactive Wnt/beta-catenin pathway in conventional high-grade osteosarcoma, The Journal of Pathology 220(1): 24-33.
- Ye, H.; Shalaby, A.; Presneau, N.; Pillay, N.; Idowu, B.; Halai, D.; Tirabosco, R.; Jacques, T.; Mertens, F.; Szuhai, K.; Kindblom, L.; Hogendoom, P. & Flanagan, A.M. (2010), Genetic Abnormalities of the Transcription Factor T (Brachyury) in Sporadic Chordomas, The Journal of Molecular Diagnostics 12(6): 906-906.
- Berghuis, D.; Santos, S.J.; Baelde, J.J.; Taminiau, A.H.M.; Egeler, R.M.; Schilham, M.W.; Hogendoorn, P.C.W. & Lankester, A.C. (2010), A Pro-Inflammatory Tumor Microenvironment with High Chemokine Expression and High Tumor-Infiltrating CD3+CD8+Numbers Associates with Improved Survival in Ewing Sarcoma (EWS), Modern Pathology 23: 15A15A.
- Shalaby, A.; Presneau, N.; Pillay, N.; Ye, H.; Idowu, B.; Halai, D.; Tirabosco, R.; Jacques, T.; Mertens, F.; Szuhai, K.; Kindblom, L.; Hogendoorn, P. & Flanagan, A. (2010), In Vivo and In Vitro Implications of the Transcription Factor T (Brachyury) in Pathogenesis of Sporadic Chordomas, The Journal of Pathology 222: S6S6.
- Berghuis, D.; Santos, S.J.; Baelde, J.J.; Taminiau, A.H.M.; Egeler, R.M.; Schilham, M.W.; Hogendoorn, P.C.W. & Lankester, A.C. (2010), A Pro-Inflammatory Tumor Microenvironment with High Chemokine Expression and High Tumor-Infiltrating CD3+CD8+Numbers Associates with Improved Survival in Ewing Sarcoma (EWS).
- Szuhai, K.; Ijszenga, M.; Jong, D. de; Karseladze, A.; Tanke, H.J. & Hogendoorn, P.C.W. (2009), The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology, Clinical Cancer Research 15(7): 2259-2268.
- Szuhai K, de Jong J, Bovee JVMG, Jennes I, Wuyts W, Wiweger M, Tanke HJ & Hogendoorn PCW (2009), Somatic Mosaicism Is Causative in EXT1/2 Negative Multiple Osteochondroma Detected by Tiling Resolution Array-CGH, Modern Pathology 22: 23A23A.
- Szuhai K, de Jong J, Bovee JVMG, Jennes I, Wuyts W, Wiweger M, Tanke HJ & Hogendoorn PCW (2009), Somatic Mosaicism Is Causative in EXT1/2 Negative Multiple Osteochondroma Detected by Tiling Resolution Array-CGH, Laboratory Investigation 89: 23A23A.
- Szuhai K, IJszenga M, de Jong D, Karseladze A, Tanke HJ & Hogendoorn PCW (2009), Novel, Cloned Translocation Partner in Ewing Sarcoma Couples Its Function to Oncology, Modern Pathology 22: 23A23A.
- Heyning FH, Hogendoorn PCW, Kramer MHH, Holland CTQ, Dreef E & Jansen PM (2009), Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype, Journal of Clinical Pathology 62(9): 820-824.
- Hensen, E.F.; Goeman, J.J.; Oosting, J.; Mey, A.G.L. van der; Hogendoorn, P.C.W.; Cremers, C.W.R.J.; Devilee, P. & Cornelisse, C.J. (2009), Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis, BMC Medical Genomics 2.
- Szuhai K, IJszenga M, de Jong D, Karseladze A, Tanke HJ & Hogendoorn PCW (2009), Novel, Cloned Translocation Partner in Ewing Sarcoma Couples Its Function to Oncology, Laboratory Investigation 89: 23A23A.
- Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, de Jong D, van Pel M, Cleton-Jansen AM & Hogendoorn PCW (2009), Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2, Journal of Pathology 219(3): 294-305.
- Willems, S.M.; Mohseny, A.B.; Balog, C.; Sewrajsing, R.; Briaire-de Bruijn, I.H.; Knijnenburg, J.; Cleton-Jansen, A.M.; Sciot, R.; Fletcher, C.D.M.; Deelder, A.M.; Szuhai, K.; Hensbergen, P.J. & Hogendoorn, P.C.W. (2009), Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix, Journal of Cellular and Molecular Medicine 13(7): 1291-1301.
- Romeo, S.; Szuhai, K.; Nishimori, I.; Ijszenga, M.; Wijers-Koster, P.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes, BMC Cancer 9.
- Schrage, Y.M.; Hameetman, L.; Szuhai, K.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Aberrant Heparan Sulfate Proteoglycan Localization, Despite Normal Exostosin, in Central Chondrosarcoma, American Journal of Pathology 174(3): 979-988.
- Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Bruijn IBD, de Jong D, van Pel M, Hogendoorn PCW & Cleton-Jansen AM (2009), Homozygous Deletion of CDKN2 in Tumorigenic Mesenchymal Stem Cells: A Key Event for Osteosarcoma Genesis, Laboratory Investigation 89: 19A19A.
- Cesne, A. le; Glabbeke, M. van; Verweij, J.; Casali, P.G.; Findlay, M.; Reichardt, P.; Issels, R.; Judson, I.; Schoffski, P.; Leyvraz, S.; Bui, B.; Hogendoorn, P.C.W.; Sciot, R. & Blay, J.Y. (2009), Absence of Progression As Assessed by Response Evaluation Criteria in Solid Tumors Predicts Survival in Advanced GI Stromal Tumors Treated With Imatinib Mesylate: The Intergroup EORTC-ISG-AGITG Phase III Trial, Journal of Clinical Oncology 27(24): 3969-3974.
- Cai YP, Mohseny AB, Karperien M, Zhou GY, Hogendoorn PCW & Cleton-Jansen AM (2009), Activation of Canonical Wnt Signalling Inhibits Proliferation or Promotes Differentiaiton in High-Grade Osteosarcoma, Modern Pathology 22: 345A345A.
- Cai YP, Mohseny AB, Karperien M, Zhou GY, Hogendoorn PCW & Cleton-Jansen AM (2009), Activation of Canonical Wnt Signalling Inhibits Proliferation or Promotes Differentiaiton in High-Grade Osteosarcoma, Laboratory Investigation 89: 345A345A.
- Eefting D, Schrage YM, Geirnaerdt MJA, Le Cessie S, Taminiau AHM, Bovee JVMG & Hogendoorn PCW (2009), Assessment of Interobserver Variability and Histologic Parameters to Improve Reliability in Classification and Grading of Central Cartilaginous Tumors, American Journal of Surgical Pathology 33(1): 50-57.
- Romeo S, Szuhai K, Nishimori I, Ijszenga M, Wijers-Koster P & Hogendoorn PCW (2009), Balanced Rearrangement of Chromosome 5 and 17 in Chondroblastoma: Hints for Its Pathogenesis, Modern Pathology 22: 21A22A.
- Romeo S, Hogendoorn PCW & Dei Tos AP (2009), Benign Cartilaginous Tumors of Bone From Morphology to Somatic and Germ-line Genetics, Advances in Anatomic Pathology 16(5): 307-315.
- Forsyth, R.G.; Boeck, G. de; Baelde, J.J.; Taminiau, A.H.M.; Uyttendaele, D.; Roels, H.; Praet, M.M. & Hogendoorn, P.C.W. (2009), CD33+CD14-Phenotype Is Characteristic of Multinuclear Osteoclast-Like Cells in Giant Cell Tumor of Bone, Journal of Bone and Mineral Research 24(1): 70-77.
- Berghuis D, Verhoeven DHJ, Santos SJ, Buddingh EP, Schaefer KL, Scotlandi K, Egeler RM, Schilham MW, Hogendoorn PCW & Lankester AC (2009), Chemo-Resistant Ewing Sarcoma Is Susceptible to Natural Killer Cell-Mediated Cytotoxicity: Implications for Immunotherapy, Modern Pathology 22: 11A11A.
- Romeo, S.; Debiec-Rychter, M.; Glabbeke, M. van; Paassen, H. van; Comite, P.; Eijk, R. van; Oosting, J.; Verweij, J.; Terrier, P.; Schneider, U.; Sciot, R.; Blay, J.Y.; Hogendoorn, P.C.W. & European Org Res Treatment Canc (2009), Cell Cycle/Apoptosis Molecule Expression Correlates with Imatinib Response in Patients with Advanced Gastrointestinal Stromal Tumors, Clinical Cancer Research 15(12): 4191-4198.
- Rozeman, L.B.; Bruijn, I.H.B. de; Bacchini, P.; Staals, E.L.; Bertoni, F.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2009), Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes, Modern Pathology 22(11): 1489-1498.
- Reichardt P, Hogendoorn PCW, Tamborini E, Loda M, Gronchi A, Poveda A & Schoffski P (2009), Gastrointestinal Stromal Tumors I: Pathology, Pathobiology, Primary Therapy, and Surgical Issues, Seminars in Oncology 36(4): 290-301.
- Moskovszky L, Szuhai K, Krenacs T, Hogendoorn PCW, Szendroi M, Benassi MS, Kopper L, Fule T & Sapi Z (2009), Genomic Instability in Giant Cell Tumor of Bone. A Study of 52 Cases Using DNA Ploidy, Relocalization FISH, and Array-CGH Analysis, Genes, Chromosomes and Cancer 48(6): 468-479.
- Hallor, K.H.; Staaf, J.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Cleton-Jansen, A.M.; Knuutila, S.; Savola, S.; Niini, T.; Brosjo, O.; Bauer, H.C.F.; Steyern, F.V. von; Jonsson, K.; Skorpil, M.; Mandahl, N. & Mertens, F. (2009), Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors, Clinical Cancer Research 15(8): 2685-2694.
- Berghuis D, Verhoeven DHJ, Santos SJ, Buddingh EP, Schaefer KL, Scotlandi K, Egeler RM, Schilham MW, Hogendoorn PCW & Lankester AC (2009), Chemo-Resistant Ewing Sarcoma Is Susceptible to Natural Killer Cell-Mediated Cytotoxicity: Implications for Immunotherapy, Laboratory Investigation 89: 11A11A.
- Giaccone, G.; Rajan, A.; Ruijter, R.; Smit, E.; Groeningen, C. van & Hogendoorn, P.C.W. (2009), Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas, Journal of Thoracic Oncology 4(10): 1270-1273.
- Schrage, Y.M.; Briaire-de Bruijn, I.H.; Miranda, N.F.C.C. de; Oosterwijk, J. van; Taminiau, A.H.M.; Wezel, T. van; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment, Cancer Research 69(15): 6216-6222.
- Ray-Coquard, I.; Cropet, C.; Glabbeke, M. van; Sebban, C.; Cesne, A. le; Judson, I.; Tredan, O.; Verweij, J.; Biron, P.; Labidi, I.; Guastalla, J.P.; Bachelot, T.; Perol, D.; Chabaud, S.; Hogendoorn, P.C.W.; Cassier, P.; Dufresne, A.; Blays, J.Y. & European Org Res & Treatment Canc (2009), Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas, Cancer Research 69(13): 5383-5391.
- van Bezooijen RL, Bronckers AL, Gortzak RA, Hogendoorn PCW, van der Wee-Pals L, Balemans W, Oostenbroek HJ, Van Hul W, Hamersma H, Dikkers FG, Hamdy NAT, Papapoulos SE & Lowik CWGM (2009), Sclerostin in Mineralized Matrices and van Buchem Disease, Journal of Dental Research 88(6): 569-574.
- Beerman H, van Dorst EBL, Kuenen-Boumeester V & Hogendoorn PCW (2009), Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program, Gynecologic Oncology 112(3): 572-576.
- Reijnders, C.M.A.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), The molecular and cellular basis exostosis formation in hereditary multiple exostoses, International Journal of Experimental Pathology 90(2): 190-191.
- Kroep JR, Bovee JVMG, van der Molen AJ, Hogendoorn PCW & Gelderblom H (2009), Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature, Journal of Cutaneous Pathology 36(5): 565-569.
- Schrage, Y.M.; Lam, S.; Jochemsen, A.G.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro, Journal of Cellular and Molecular Medicine 13(9A): 2843-2852.
- Mohseny AB, Szuhai K, Romeo S, Budding EP, Bruyn IBD, de Jong D, van Pel M, Hogendoorn PCW & Cleton-Jansen AM (2009), Homozygous Deletion of CDKN2 in Tumorigenic Mesenchymal Stem Cells: A Key Event for Osteosarcoma Genesis, Modern Pathology 22: 19A19A.
- Romeo S, Szuhai K, Nishimori I, Ijszenga M, Wijers-Koster P & Hogendoorn PCM (2009), Balanced Rearrangement of Chromosome 5 and 17 in Chondroblastoma: Hints for Its Pathogenesis, Laboratory Investigation 89: 21A22A.
- Romeo S, Duim RAJ, Mertens F, De Jong D, Dal Cin P, Debiec-Rychter M, Sciot R, Rosenberg A, Szuhai K & Hogendoorn PCW (2009), Balanced and Unbalanced Rearrangement of Chromosome Arm 6q in Chondromyxoid Fibroma (CMF): Delineation of Breakpoints and Analysis of Candidate Target Genes, Modern Pathology 22: 21A21A.
- Romeo S, Duim RAJ, Mertens F, De Jong D, Dal Cin P, Debiec-Rychter M, Sciot R, Rosenberg A, Szuhai K & Hogendoorn PCW (2009), Balanced and Unbalanced Rearrangement of Chromosome Arm 6q in Chondromyxoid Fibroma (CMF): Delineation of Breakpoints and Analysis of Candidate Target Genes, Laboratory Investigation 89: 21A21A.
- Bechan IG, van Nederveen F, den Broeder B, de Krijger R, Hogendoorn PCW, Egeler RM & Leenen PJM (2009), THE ROLE OF BETA-CATENIN IN THE DEVELOPMENT OF LANGERHANS CELL HISTIOCYTOSIS, Pediatric Blood and Cancer 53(4): 685-685.
- Cleton-Jansen, A.M.; Anninga, J.K.; Briaire-de Bruijn, I.H.; Romeo, S.; Oosting, J.; Egeler, R.M.; Gelderblom, H.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways, British Journal of Cancer 101(11): 1909-1918.
- da Costa CET, Szuhai K, van Eijk R, Hoogeboom M, Sciot R, Mertens F, Bjorgvinsdottir H, Debiec-Rychter M, de Krijger RR & Hogendoorn PCW (2009), No Genomic Aberrations in Langerhans Cell Histiocytosis as Assessed by Diverse Molecular Technologies, Genes, Chromosomes and Cancer 48(3): 239-249.
- Verbeke SL, Bertoni F, Bacchini P, Sciot R, Mertens BJ, Kroon HM, Hogendoorn PC & Bovee JV (2009), Hemangioendothelioma and Angiosarcoma of Bone: Distinct Histological Criteria Predicting Clinical Behavior, Laboratory Investigation 89: 24A24A.
- Verbeke SL, Fletcher CD, Picci P, Daugaard S, Kroon HM, Hogendoorn PC & Bovee JV (2009), Haemangiopericytoma of Bone: Real or Imagined?, Modern Pathology 22: 24A25A.
- LVerbeke S, Fletcher CD, Picci P, Daugaard S, Kroon HM, Hogendoorn PC & Bovee JV (2009), Haemangiopericytoma of Bone: Real or Imagined?, Laboratory Investigation 89: 24A25A.
- Bayley, J.P.; Minderhout, I. van; Hogendoorn, P.C.W.; Cornelisse, C.J.; Wal, A. van der; Prins, F.A.; Teppema, L.; Dahan, A.; Devilee, P. & Taschner, P.E.M. (2009), Sdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma, PLoS ONE 4(11).
- Berghuis D, Verhoeven DHJ, Santos S, Schaefer KL, Scotlandi K, Egeler RM, Gelderblom H, Taminiau A, Hogendoorn PCW & van Tol MJD (2009), Towards NK-cell-mediated Immunotherapy in Ewing Sarcoma: Identification of Molecular Mechanisms, Journal of Pediatric Hematology/Oncology 31(4): 242-242.
- Jansen-Landheer MLEA, Krijnen P, Oostindier MJ, Kloosterman-Boele WM, Noordijk EM, Nooij MA, Steup WH, Taminiau AHM, Vree R, Hogendoorn PCW, Tollenaar RAEM & Gelderblom H (2009), Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study, EJSO - European Journal of Surgical Oncology 35(12): 1326-1332.
- Romeo, S.; Szuhai, K.; Nishimori, I.; Ijszenga, M.; Wijers-Koster, P.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes, BMC Cancer 9.
- Romeo S, Szuhai K, Nishimori I, Ijszenga M, Wijers-Koster P & Hogendoorn PCM (2009), Balanced Rearrangement of Chromosome 5 and 17 in Chondroblastoma: Hints for Its Pathogenesis, Laboratory Investigation 89: 21A22A.
- Giaccone, G.; Rajan, A.; Ruijter, R.; Smit, E.; Groeningen, C. van & Hogendoorn, P.C.W. (2009), Imatinib Mesylate in Patients with WHO B3 Thymomas and Thymic Carcinomas, Journal of Thoracic Oncology 4(10): 1270-1273.
- Mohseny AB, Szuhai K, Romeo S, Budding EP, Bruyn IBD, de Jong D, van Pel M, Hogendoorn PCW & Cleton-Jansen AM (2009), Homozygous Deletion of CDKN2 in Tumorigenic Mesenchymal Stem Cells: A Key Event for Osteosarcoma Genesis, Modern Pathology 22: 19A19A.
- Heyning FH, Hogendoorn PCW, Kramer MHH, Holland CTQ, Dreef E & Jansen PM (2009), Primary lymphoma of bone: extranodal lymphoma with favourable survival independent of germinal centre, post-germinal centre or indeterminate phenotype, Journal of Clinical Pathology 62(9): 820-824.
- Szuhai K, IJszenga M, de Jong D, Karseladze A, Tanke HJ & Hogendoorn PCW (2009), Novel, Cloned Translocation Partner in Ewing Sarcoma Couples Its Function to Oncology, Modern Pathology 22: 23A23A.
- Szuhai K, de Jong J, Bovee JVMG, Jennes I, Wuyts W, Wiweger M, Tanke HJ & Hogendoorn PCW (2009), Somatic Mosaicism Is Causative in EXT1/2 Negative Multiple Osteochondroma Detected by Tiling Resolution Array-CGH, Laboratory Investigation 89: 23A23A.
- Berghuis D, Verhoeven DHJ, Santos SJ, Buddingh EP, Schaefer KL, Scotlandi K, Egeler RM, Schilham MW, Hogendoorn PCW & Lankester AC (2009), Chemo-Resistant Ewing Sarcoma Is Susceptible to Natural Killer Cell-Mediated Cytotoxicity: Implications for Immunotherapy, Modern Pathology 22: 11A11A.
- Berghuis D, Verhoeven DHJ, Santos SJ, Buddingh EP, Schaefer KL, Scotlandi K, Egeler RM, Schilham MW, Hogendoorn PCW & Lankester AC (2009), Chemo-Resistant Ewing Sarcoma Is Susceptible to Natural Killer Cell-Mediated Cytotoxicity: Implications for Immunotherapy, Laboratory Investigation 89: 11A11A.
- Bechan IG, van Nederveen F, den Broeder B, de Krijger R, Hogendoorn PCW, Egeler RM & Leenen PJM (2009), THE ROLE OF BETA-CATENIN IN THE DEVELOPMENT OF LANGERHANS CELL HISTIOCYTOSIS, Pediatric Blood and Cancer 53(4): 685-685.
- Berghuis D, Verhoeven DHJ, Santos S, Schaefer KL, Scotlandi K, Egeler RM, Gelderblom H, Taminiau A, Hogendoorn PCW & van Tol MJD (2009), Towards NK-cell-mediated Immunotherapy in Ewing Sarcoma: Identification of Molecular Mechanisms, Journal of Pediatric Hematology/Oncology 31(4): 242-242.
- Szuhai K, IJszenga M, de Jong D, Karseladze A, Tanke HJ & Hogendoorn PCW (2009), Novel, Cloned Translocation Partner in Ewing Sarcoma Couples Its Function to Oncology, Laboratory Investigation 89: 23A23A.
- Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Bruijn IBD, de Jong D, van Pel M, Hogendoorn PCW & Cleton-Jansen AM (2009), Homozygous Deletion of CDKN2 in Tumorigenic Mesenchymal Stem Cells: A Key Event for Osteosarcoma Genesis, Laboratory Investigation 89: 19A19A.
- Szuhai K, de Jong J, Bovee JVMG, Jennes I, Wuyts W, Wiweger M, Tanke HJ & Hogendoorn PCW (2009), Somatic Mosaicism Is Causative in EXT1/2 Negative Multiple Osteochondroma Detected by Tiling Resolution Array-CGH, Modern Pathology 22: 23A23A.
- Cai YP, Mohseny AB, Karperien M, Zhou GY, Hogendoorn PCW & Cleton-Jansen AM (2009), Activation of Canonical Wnt Signalling Inhibits Proliferation or Promotes Differentiaiton in High-Grade Osteosarcoma, Modern Pathology 22: 345A345A.
- Romeo S, Duim RAJ, Mertens F, De Jong D, Dal Cin P, Debiec-Rychter M, Sciot R, Rosenberg A, Szuhai K & Hogendoorn PCW (2009), Balanced and Unbalanced Rearrangement of Chromosome Arm 6q in Chondromyxoid Fibroma (CMF): Delineation of Breakpoints and Analysis of Candidate Target Genes, Laboratory Investigation 89: 21A21A.
- Cai YP, Mohseny AB, Karperien M, Zhou GY, Hogendoorn PCW & Cleton-Jansen AM (2009), Activation of Canonical Wnt Signalling Inhibits Proliferation or Promotes Differentiaiton in High-Grade Osteosarcoma, Laboratory Investigation 89: 345A345A.
- Romeo S, Szuhai K, Nishimori I, Ijszenga M, Wijers-Koster P & Hogendoorn PCW (2009), Balanced Rearrangement of Chromosome 5 and 17 in Chondroblastoma: Hints for Its Pathogenesis, Modern Pathology 22: 21A22A.
- Romeo S, Duim RAJ, Mertens F, De Jong D, Dal Cin P, Debiec-Rychter M, Sciot R, Rosenberg A, Szuhai K & Hogendoorn PCW (2009), Balanced and Unbalanced Rearrangement of Chromosome Arm 6q in Chondromyxoid Fibroma (CMF): Delineation of Breakpoints and Analysis of Candidate Target Genes, Modern Pathology 22: 21A21A.
- LVerbeke S, Fletcher CD, Picci P, Daugaard S, Kroon HM, Hogendoorn PC & Bovee JV (2009), Haemangiopericytoma of Bone: Real or Imagined?, Laboratory Investigation 89: 24A25A.
- Verbeke SL, Fletcher CD, Picci P, Daugaard S, Kroon HM, Hogendoorn PC & Bovee JV (2009), Haemangiopericytoma of Bone: Real or Imagined?, Modern Pathology 22: 24A25A.
- Verbeke SL, Bertoni F, Bacchini P, Sciot R, Mertens BJ, Kroon HM, Hogendoorn PC & Bovee JV (2009), Hemangioendothelioma and Angiosarcoma of Bone: Distinct Histological Criteria Predicting Clinical Behavior, Laboratory Investigation 89: 24A24A.
- Jansen-Landheer MLEA, Krijnen P, Oostindier MJ, Kloosterman-Boele WM, Noordijk EM, Nooij MA, Steup WH, Taminiau AHM, Vree R, Hogendoorn PCW, Tollenaar RAEM & Gelderblom H (2009), Improved diagnosis and treatment of soft tissue sarcoma patients after implementation of national guidelines: A population-based study, EJSO - European Journal of Surgical Oncology 35(12): 1326-1332.
- Mohseny AB, Szuhai K, Romeo S, Buddingh EP, Briaire-de Bruijn I, de Jong D, van Pel M, Cleton-Jansen AM & Hogendoorn PCW (2009), Osteosarcoma originates from mesenchymal stem cells in consequence of aneuploidization and genomic loss of Cdkn2, Journal of Pathology 219(3): 294-305.
- van Bezooijen RL, Bronckers AL, Gortzak RA, Hogendoorn PCW, van der Wee-Pals L, Balemans W, Oostenbroek HJ, Van Hul W, Hamersma H, Dikkers FG, Hamdy NAT, Papapoulos SE & Lowik CWGM (2009), Sclerostin in Mineralized Matrices and van Buchem Disease, Journal of Dental Research 88(6): 569-574.
- Ray-Coquard, I.; Cropet, C.; Glabbeke, M. van; Sebban, C.; Cesne, A. le; Judson, I.; Tredan, O.; Verweij, J.; Biron, P.; Labidi, I.; Guastalla, J.P.; Bachelot, T.; Perol, D.; Chabaud, S.; Hogendoorn, P.C.W.; Cassier, P.; Dufresne, A.; Blays, J.Y. & European Org Res & Treatment Canc (2009), Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas, Cancer Research 69(13): 5383-5391.
- Beerman H, van Dorst EBL, Kuenen-Boumeester V & Hogendoorn PCW (2009), Superior performance of liquid-based versus conventional cytology in a population-based cervical cancer screening program, Gynecologic Oncology 112(3): 572-576.
- Szuhai, K.; Ijszenga, M.; Jong, D. de; Karseladze, A.; Tanke, H.J. & Hogendoorn, P.C.W. (2009), The NFATc2 Gene Is Involved in a Novel Cloned Translocation in a Ewing Sarcoma Variant That Couples Its Function in Immunology to Oncology, Clinical Cancer Research 15(7): 2259-2268.
- Eefting D, Schrage YM, Geirnaerdt MJA, Le Cessie S, Taminiau AHM, Bovee JVMG & Hogendoorn PCW (2009), Assessment of Interobserver Variability and Histologic Parameters to Improve Reliability in Classification and Grading of Central Cartilaginous Tumors, American Journal of Surgical Pathology 33(1): 50-57.
- Cesne, A. le; Glabbeke, M. van; Verweij, J.; Casali, P.G.; Findlay, M.; Reichardt, P.; Issels, R.; Judson, I.; Schoffski, P.; Leyvraz, S.; Bui, B.; Hogendoorn, P.C.W.; Sciot, R. & Blay, J.Y. (2009), Absence of Progression As Assessed by Response Evaluation Criteria in Solid Tumors Predicts Survival in Advanced GI Stromal Tumors Treated With Imatinib Mesylate: The Intergroup EORTC-ISG-AGITG Phase III Trial, Journal of Clinical Oncology 27(24): 3969-3974.
- Cleton-Jansen, A.M.; Anninga, J.K.; Briaire-de Bruijn, I.H.; Romeo, S.; Oosting, J.; Egeler, R.M.; Gelderblom, H.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways, British Journal of Cancer 101(11): 1909-1918.
- Schrage, Y.M.; Briaire-de Bruijn, I.H.; Miranda, N.F.C.C. de; Oosterwijk, J. van; Taminiau, A.H.M.; Wezel, T. van; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Kinome Profiling of Chondrosarcoma Reveals Src-Pathway Activity and Dasatinib as Option for Treatment, Cancer Research 69(15): 6216-6222.
- Romeo, S.; Debiec-Rychter, M.; Glabbeke, M. van; Paassen, H. van; Comite, P.; Eijk, R. van; Oosting, J.; Verweij, J.; Terrier, P.; Schneider, U.; Sciot, R.; Blay, J.Y.; Hogendoorn, P.C.W. & European Org Res Treatment Canc (2009), Cell Cycle/Apoptosis Molecule Expression Correlates with Imatinib Response in Patients with Advanced Gastrointestinal Stromal Tumors, Clinical Cancer Research 15(12): 4191-4198.
- da Costa CET, Szuhai K, van Eijk R, Hoogeboom M, Sciot R, Mertens F, Bjorgvinsdottir H, Debiec-Rychter M, de Krijger RR & Hogendoorn PCW (2009), No Genomic Aberrations in Langerhans Cell Histiocytosis as Assessed by Diverse Molecular Technologies, Genes, Chromosomes and Cancer 48(3): 239-249.
- Reichardt P, Hogendoorn PCW, Tamborini E, Loda M, Gronchi A, Poveda A & Schoffski P (2009), Gastrointestinal Stromal Tumors I: Pathology, Pathobiology, Primary Therapy, and Surgical Issues, Seminars in Oncology 36(4): 290-301.
- Forsyth, R.G.; Boeck, G. de; Baelde, J.J.; Taminiau, A.H.M.; Uyttendaele, D.; Roels, H.; Praet, M.M. & Hogendoorn, P.C.W. (2009), CD33+CD14-Phenotype Is Characteristic of Multinuclear Osteoclast-Like Cells in Giant Cell Tumor of Bone, Journal of Bone and Mineral Research 24(1): 70-77.
- Willems, S.M.; Mohseny, A.B.; Balog, C.; Sewrajsing, R.; Briaire-de Bruijn, I.H.; Knijnenburg, J.; Cleton-Jansen, A.M.; Sciot, R.; Fletcher, C.D.M.; Deelder, A.M.; Szuhai, K.; Hensbergen, P.J. & Hogendoorn, P.C.W. (2009), Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix, Journal of Cellular and Molecular Medicine 13(7): 1291-1301.
- Hallor, K.H.; Staaf, J.; Bovee, J.V.M.G.; Hogendoorn, P.C.W.; Cleton-Jansen, A.M.; Knuutila, S.; Savola, S.; Niini, T.; Brosjo, O.; Bauer, H.C.F.; Steyern, F.V. von; Jonsson, K.; Skorpil, M.; Mandahl, N. & Mertens, F. (2009), Genomic Profiling of Chondrosarcoma: Chromosomal Patterns in Central and Peripheral Tumors, Clinical Cancer Research 15(8): 2685-2694.
- Hall, P.A.; Poulsom, R.; Coates, P.J.; , M.Q. du; Hogendoom, P.C.W.; Jones, L.J.; Ladanyi, M.; Murray, G.I. & Niedobitek, G. (2009), The Journal of Pathology 2008 Jeremy Jass Prize for Research Excellence in Pathology, Journal of Pathology 219(4): 393-395.
- Boeck, G. de; Forsyth, R.G.; Praet, M. & Hogendoom, P.C.W. (2009), Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms, Journal of Pathology 217(3): 327-344.
- Hall, P.A.; Poulsom, R.; Coates, P.J.; , M.Q. du; Hogendoom, P.C.W.; Jones, L.J.; Ladanyi, M.; Murray, G.I. & Niedobitek, G. (2009), The Journal of Pathology 2008 Jeremy Jass Prize for Research Excellence in Pathology, Journal of Pathology 219(4): 393-395.
- Boeck, G. de; Forsyth, R.G.; Praet, M. & Hogendoom, P.C.W. (2009), Telomere-associated proteins: cross-talk between telomere maintenance and telomere-lengthening mechanisms, Journal of Pathology 217(3): 327-344.
- Reijnders, C.M.A.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), The molecular and cellular basis exostosis formation in hereditary multiple exostoses, International Journal of Experimental Pathology 90(2): 190-191.
- Schrage, Y.M.; Lam, S.; Jochemsen, A.G.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro, Journal of Cellular and Molecular Medicine 13(9A): 2843-2852.
- Bayley, J.P.; Minderhout, I. van; Hogendoorn, P.C.W.; Cornelisse, C.J.; Wal, A. van der; Prins, F.A.; Teppema, L.; Dahan, A.; Devilee, P. & Taschner, P.E.M. (2009), Sdhd and Sdhd/H19 Knockout Mice Do Not Develop Paraganglioma or Pheochromocytoma, PLoS ONE 4(11).
- Romeo S, Hogendoorn PCW & Dei Tos AP (2009), Benign Cartilaginous Tumors of Bone From Morphology to Somatic and Germ-line Genetics, Advances in Anatomic Pathology 16(5): 307-315.
- Moskovszky L, Szuhai K, Krenacs T, Hogendoorn PCW, Szendroi M, Benassi MS, Kopper L, Fule T & Sapi Z (2009), Genomic Instability in Giant Cell Tumor of Bone. A Study of 52 Cases Using DNA Ploidy, Relocalization FISH, and Array-CGH Analysis, Genes, Chromosomes and Cancer 48(6): 468-479.
- Schrage, Y.M.; Hameetman, L.; Szuhai, K.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Aberrant Heparan Sulfate Proteoglycan Localization, Despite Normal Exostosin, in Central Chondrosarcoma, American Journal of Pathology 174(3): 979-988.
- Rozeman, L.B.; Bruijn, I.H.B. de; Bacchini, P.; Staals, E.L.; Bertoni, F.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2009), Dedifferentiated peripheral chondrosarcomas: regulation of EXT-downstream molecules and differentiation-related genes, Modern Pathology 22(11): 1489-1498.
- Kroep JR, Bovee JVMG, van der Molen AJ, Hogendoorn PCW & Gelderblom H (2009), Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature, Journal of Cutaneous Pathology 36(5): 565-569.
- Hensen, E.F.; Goeman, J.J.; Oosting, J.; Mey, A.G.L. van der; Hogendoorn, P.C.W.; Cremers, C.W.R.J.; Devilee, P. & Cornelisse, C.J. (2009), Similar gene expression profiles of sporadic, PGL2-, and SDHD-linked paragangliomas suggest a common pathway to tumorigenesis, BMC Medical Genomics 2.
- Cleton-Jansen, A.M.; Anninga, J.K.; Briaire-de Bruijn, I.H.; Romeo, S.; Oosting, J.; Egeler, R.M.; Gelderblom, H.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways (vol 101, pg 1909, 2009), British Journal of Cancer 101(12): 2064-2064.
- Berghuis, D.; Hooge, A.S.K. de; Santos, S.J.; Horst, D.; Wertz, E.J.; Eggermond, M.C. van; Elsen, P.J. van den; Taminiau, A.H.M.; Ottaviano, L.; Schaefer, K.L.; Dirksen, U.; Hooijberg, E.; Mulder, A.; Melief, C.J.M.; Egeler, R.M.; Schilham, M.W.; Jordanova, E.S.; Hogendoom, P.C.W. & Lankester, A.C. (2009), Reduced human leukocyte antigen expression in advanced-stage Ewing sarcoma: implications for immune recognition, The Journal of Pathology 218(2): 222-231.
- Cleton-Jansen, A.M.; Anninga, J.K.; Briaire-de Bruijn, I.H.; Romeo, S.; Oosting, J.; Egeler, R.M.; Gelderblom, H.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways., British Journal of Cancer 101(11): 1909-18.
- Verbeke, S.L.; Bertoni, F.; Bacchini, P.; Sciot, R.; Mertens, B.J.; Kroon, H.M.; Hogendoora, P.C. & Bovee, J.V. (2009), Hemangioendothelioma and Angiosarcoma of Bone: Distinct Histological Criteria Predicting Clinical Behavior, Modern Pathology 22: 24A24A.
- Kroep, J.R.; Bovee, J.V.M.G.; Molen, A.J. van der; Hogendoorn, P.C.W. & Gelderblom, H. (2009), Extra-abdominal subcutaneous metastasis of a gastrointestinal stromal tumor: report of a case and a review of the literature.
- Schrage, Y.M.; Lam, S.; Jochemsen, A.G.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2009), Central chondrosarcoma progression is associated with pRb pathway alterations: CDK4 down-regulation and p16 overexpression inhibit cell growth in vitro.
- Eefting, D.; Schrage, Y.M.; Geirnaerdt, M.J.A.; Cessie, S. le; Taminiau, A.H.M.; Bovee, J.V.M.G.; Hogendoorn, P.C.W. & EuroBoNeT Consortium (2009), Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors., The American Journal of Surgical Pathology 33(1): 50-7.
- Romeo, S.; Szuhai, K.; Nishimori, I.; Ijszenga, M.; Wijers-Koster, P.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2009), A balanced t(5;17) (p15;q22-23) in chondroblastoma: frequency of the re-arrangement and analysis of the candidate genes., BMC Cancer 9: 393.
- Belghuis D, De Hooge AS, Santos SJ, Jordanova ES, Alblas G, Horst D, Wiertz EJ, Mulder A, Taminian AH, Melief CJ, Hogendoorn PC & Lankesler AC (2008), Patterns and regulation of HLA class I expression in ewing sarcoma: Clinical implications, Laboratory Investigation 88.
- Schlemmer M, Reichardt P, Verweij J, Hartmann JT, Judson I, Thyss A, Hogendoorn PCW, Marreaud S, Van Glabbeke M & Blay JY (2008), Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group, European Journal of Cancer 44(16).
- Gelderblom H, Hogendoorn PCW, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AHM & Bovee JVMG (2008), The clinical approach towards chondrosarcoma, Oncologist 13(3).
- van den Berg H, Kroon HM, Slaar A & Hogendoorn P (2008), Incidence of biopsy-proven bone tumors in children - A report based on the dutch pathology registration "PALGA", Journal of Pediatric Orthopaedics 28(1).
- Hallor, K.H.; Staaf, J.; Jonsson, G.; Heidenblad, M.; Steyern, F.V. von; Bauer, H.C.F.; IJszenga, M.; Hogendoorn, P.C.W.; Mandahl, N.; Szuhai, K. & Mertens, F. (2008), Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation, British Journal of Cancer 98(2).
- Ye, D.; Kraaijeveld, A.O.; Grauss, R.W.; Willems, S.M.; Vark-van der Zee, L.C. van; Jager, S.C.A. de; Jauhiainen, M.; Kuivenhoven, J.A.; Dallinga-Thie, G.M.; Atsma, D.E.; Hogendoorn, P.C.W.; Biessen, E.A.L.; Berkel, T.J.C. van; Jukema, J.W. & Eck, M. van (2008), Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes, Journal of Internal Medicine 264(6).
- Ray-Coquard I, Le Cesne A, Whelan JS, Schoffski P, Bui BN, Verweij J, Marreaud S, Van Glabbeke M, Hogendoorn P & Blay JY (2008), A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens, Oncologist 13(4).
- Edwards JR, Williams K, Kindblom LG, Meis-Kindblom JM, Hogendoorn PCW, Hughes D, Forsyth RG, Jackson D & Athanasou NA (2008), Lymphatics and bone, Human Pathology 39(1).
- van den Berg H, Slaar A, Kroon HM, Taminiau AHM & Hogendoorn P (2008), Results of Diagnostic Review in Pediatric Bone Tumors and Tumorlike Lesions, Journal of Pediatric Orthopaedics 28(5): 561-564.
- Willems SM, Schrage YM, Baelde JJ, Bruijn IBD, Mohseny A, Sciot R, Bovee JVMG & Hogendoorn PCW (2008), Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition, Histopathology 52(4).
- Verhoeven DHJ, de Hooge ASK, Mooiman ECK, Santos SJ, ten Dam MM, Gelderblom H, Melief CJM, Hogendoorn PCW, Egeler RM, van Tol MJD, Schilham MW & Lankester AC (2008), NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways, Molecular Immunology 45(15).
- Boeuf S, Kunz P, Hennig T, Lehner B, Hogendoorn PCW, Bovee JVMG & Richter W (2008), A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma, Journal of Pathology 216(2).
- Verdegaal SHM, Corver WE, Hogendoorn PCW & Taminiau AHM (2008), The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27 AN IN VITRO EXPERIMENT, Journal of Bone and Joint Surgery, British Volume 90B(11).
- Sciot R, Debiec-Rychter M, Daugaard S, Fisher C, Collin F, van Glabbeke M, Verweij J, Blay JY & Hogendoorn PCW (2008), Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate, European Journal of Cancer 44(13).
- Ye, D.; Kraaijeveld, A.O.; Grauss, R.W.; Willems, S.M.; Vark-van der Zee, L.C. van; Jager, S.C.A. de; Jauhiainen, M.; Kuivenhoven, J.A.; Dallinga-Thie, G.M.; Atsma, D.E.; Hogendoorn, P.C.W.; Biessen, E.A.L.; Berkel, T.J.C. van; Jukema, J.W. & Eck, M. van (2008), Reduced leucocyte cholesteryl ester transfer protein expression in acute coronary syndromes, Journal of Internal Medicine 264(6).
- Hallor, K.H.; Staaf, J.; Jonsson, G.; Heidenblad, M.; Steyern, F.V. von; Bauer, H.C.F.; IJszenga, M.; Hogendoorn, P.C.W.; Mandahl, N.; Szuhai, K. & Mertens, F. (2008), Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation, British Journal of Cancer 98(2).
- Belghuis D, De Hooge AS, Santos SJ, Jordanova ES, Alblas G, Horst D, Wiertz EJ, Mulder A, Taminian AH, Melief CJ, Hogendoorn PC & Lankesler AC (2008), Patterns and regulation of HLA class I expression in ewing sarcoma: Clinical implications, Laboratory Investigation 88.
- van den Berg H, Slaar A, Kroon HM, Taminiau AHM & Hogendoorn P (2008), Results of Diagnostic Review in Pediatric Bone Tumors and Tumorlike Lesions, Journal of Pediatric Orthopaedics 28(5): 561-564.
- Gelderblom H, Hogendoorn PCW, Dijkstra SD, van Rijswijk CS, Krol AD, Taminiau AHM & Bovee JVMG (2008), The clinical approach towards chondrosarcoma, Oncologist 13(3).
- van den Berg H, Kroon HM, Slaar A & Hogendoorn P (2008), Incidence of biopsy-proven bone tumors in children - A report based on the dutch pathology registration "PALGA", Journal of Pediatric Orthopaedics 28(1).
- Schlemmer M, Reichardt P, Verweij J, Hartmann JT, Judson I, Thyss A, Hogendoorn PCW, Marreaud S, Van Glabbeke M & Blay JY (2008), Paclitaxel in patients with advanced angiosarcomas of soft tissue: A retrospective study of the EORTC soft tissue and bone sarcoma group, European Journal of Cancer 44(16).
- Edwards JR, Williams K, Kindblom LG, Meis-Kindblom JM, Hogendoorn PCW, Hughes D, Forsyth RG, Jackson D & Athanasou NA (2008), Lymphatics and bone, Human Pathology 39(1).
- Verhoeven DHJ, de Hooge ASK, Mooiman ECK, Santos SJ, ten Dam MM, Gelderblom H, Melief CJM, Hogendoorn PCW, Egeler RM, van Tol MJD, Schilham MW & Lankester AC (2008), NK cells recognize and lyse Ewing sarcoma cells through NKG2D and DNAM-1 receptor dependent pathways, Molecular Immunology 45(15).
- Ray-Coquard I, Le Cesne A, Whelan JS, Schoffski P, Bui BN, Verweij J, Marreaud S, Van Glabbeke M, Hogendoorn P & Blay JY (2008), A phase II study of gefitinib for patients with advanced HER-1 expressing synovial sarcoma refractory to doxorubicin-containing regimens, Oncologist 13(4).
- Boeuf S, Kunz P, Hennig T, Lehner B, Hogendoorn PCW, Bovee JVMG & Richter W (2008), A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma, Journal of Pathology 216(2).
- Verdegaal SHM, Corver WE, Hogendoorn PCW & Taminiau AHM (2008), The cytotoxic effect of phenol and ethanol on the chondrosarcoma-derived cell line OUMS-27 AN IN VITRO EXPERIMENT, Journal of Bone and Joint Surgery, British Volume 90B(11).
- Willems SM, Schrage YM, Baelde JJ, Bruijn IBD, Mohseny A, Sciot R, Bovee JVMG & Hogendoorn PCW (2008), Myxoid tumours of soft tissue: the so-called myxoid extracellular matrix is heterogeneous in composition, Histopathology 52(4).
- Sciot R, Debiec-Rychter M, Daugaard S, Fisher C, Collin F, van Glabbeke M, Verweij J, Blay JY & Hogendoorn PCW (2008), Distribution and prognostic value of histopathologic data and immunohistochemical markers in gastrointestinal stromal tumours (GISTs): An analysis of the EORTC phase III trial of treatment of metastatic GISTs with imatinib mesylate, European Journal of Cancer 44(13).
- Forsyth, R.; Boeck, G. de; Bekaerl, S.; Meyer, T. de; Taminlau, A.; Uyttendaele, D.; Roels, H.; Praet, M. & Hogendoom, P. (2008), Telomere biology in giant cell tumour of bone, The Journal of Pathology 214(5).
- da Costa CET, Egeler RM, Hoogeboorn M, Szuhai K, Forsyth RG, Niesters M, de Krijger RR, Tazi A, Hogendoorn PCW & Annels NE (2007), Differences in telomerase expression by the CD1a(+) cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease, Journal of Pathology 212(2).
- Verbeke SLJ, Bacchini P, Kroon HMH, Hogendoorn PCW & Bovee JVMG (2007), Primary malignant vascular tumours of bone: Immunohistochemical investigation on endothelial phenotype and histopathological correlation, Virchows Archiv 451(2): 151-152.
- Willems S, Schrage Y, Baelde H, Mohseny A, Sciot R, Bovee J & Hogendoorn P (2007), Myxoid soft tissue tumours have a heterogeneous composition of their extracellular matrix: A study on myxofibrosarcoma, intramuscular myxoma and extraskeletal myxoid chondrosarcoma, Virchows Archiv 451(2): 149-149.
- Anninga J, Briaire-De Bruijn IH, Romeo S, Oosting J, Egeler R, Taminiau A, Hogendoorn P & Cleton-Jansen A (2007), Dissecting osteosarcoma genesis by gene expression pathway profiling.
- Heyning, F.H.; Kroon, H.M.J.A.; Hogendoorn, P.C.W.; Taminiau, A.H.M. & Woude, H.J. van der (2007), MR imaging characteristics in primary lymphoma of bone with emphasis on non-aggressive appearance, Skeletal Radiology 36(10).
- Gomes CMF, Welling M, Que I, Henriquez NV, Van der Plujm G, Romeo S, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pouwels E & Cleton-Jansen AM (2007), Molecular imaging of multidrug resistance in an orthotopic model of osteosarcoma, Modern Pathology 20.
- Willems SM, Szuhai K, Hartgrink H, Bovee JVMG, De Schepper A & Hogendoorn PCW (2007), CT-guided, COBRA-FISH-assisted diagnosis of well-differentiated liposarcoma (inflammatory subtype) of the retroperitoneum, Histopathology 51(3).
- Gomes, C.M.F.; Welling, M.; Que, I.; Henriquez, N.V.; Pluijm, G. van der; Romeo, S.; Abrunhosa, A.J.; Botelho, M.F.; Hogendoorn, P.C.W.; Pauwels, E.K.J. & Cleton-Jansen, A.M. (2007), Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using Tc-99m-sestamibi, European Journal of Nuclear Medicine and Molecular Imaging 34(11).
- Schrage YM, Hameetman L, Szuhai K, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2007), EXT and its downstream targets in central chondrosarcoma (CCS), Modern Pathology 20.
- Leahy M, Ray-Coquard I, Verweij J, Le Cesne A, Duffaud F, Hogendoorn PCW, Fowst C, de Balincourt C, di Paola ED, van Glabbeke M, Judson I & Blay JY (2007), Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, European Journal of Cancer 43(2).
- Szuhai K, IJszenga M, Knijnenburg J, Dijkstra S, de Schepper A, Tanke HJ & Hogendoorn PCW (2007), Does parosteal liposarcoma differ from other atypical lipomatous tumors/well-differentiated liposarcomas? A molecular cytogenetic study using combined multicolor COBRA-FISH karyotyping and array-based comparative genomic hybridization, Cancer Genetics and Cytogenetics 176(2).
- Romeo S, Oosting J, Rozeman LB, Hameetman L, Taminiau AHM, Cleton-Jansen AM, Bovee JVMG & Hogendoorn PCW (2007), The role of noncartilage-specific molecules in differentiation of cartilaginous tumors - Lessons from chondroblastoma and chondromyxoid fibroma, Cancer 110(2).
- Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PCW & Blay JY (2007), Phase III trial of two Investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study, Journal of Clinical Oncology 25(21).
- Hameetman, L.; Szuhai, K.; Yavas, A.; Knijnenburg, J.; Duin, M. van; Dekken, H. van; Taminiau, A.H.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2007), The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions, Journal of the National Cancer Institute 99(5).
- Dekker PBD, Kuipers-Dijkshoorn NJ, Baelde HJ, van der Mey AGL, Hogendoorn PCW & Cornelisse CJ (2007), Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism, Human Pathology 38(1).
- Hameetman L, David G, Yavas A, White SJ, Taminiau AHM, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2007), Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas, Journal of Pathology 211(4).
- Anninga JK, Bruijn IHBD, Romeo S, Oosting J, Egeler RM, Taminiau AHM, Hogendoorn PCW & Cleton-Jansen AM (2007), Dissecting osteosarcoma genesis by gene expression pathway profiling, Laboratory Investigation 87.
- Szuhai K, IJszenga M, Tanke HJ, Taminiau AHM, de Schepper A, van Duinen SG, Rosenberg C & Hogendoorn PCW (2007), Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma, Cancer Genetics and Cytogenetics 172(1).
- Hooge, A.S.K. de; Berghuis, D.; Santos, S.J.; Mooiman, E.; Romeo, S.; Kummer, J.A.; Egeler, R.M.; Tol, M.J.D. van; Melief, C.J.M.; Hogendoorn, P.C.W. & Lankester, A.C. (2007), Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways, Clinical Cancer Research 13(1).
- Gomes CMF, Welling M, Que I, Henriquez NV, van der Pluijm G, Romeo S, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pauwels E & Cleton-Jansen AM (2007), Molecular imaging of multidrug resistance in an orthotopic model of osteosarcoma, Laboratory Investigation 87.
- Lewis, I.J.; Nooij, M.A.; Whelan, J.; Sydes, M.R.; Grimer, R.; Hogendoorn, P.C.W.; Memon, M.A.; Weeden, S.; Uscinska, B.M.; Glabbeke, M. van; Kirkpatrick, A.; Hauben, E.I.; Craft, A.W.; Taminiau, A.H.M.; MRC BO06 Collaborators; EORTC 80931 Collaborators & European Osteosarcoma Intergrp (2007), Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup, Journal of the National Cancer Institute 99(2).
- Schrage YM, Hameetman L, Szuhai K, Cleton-Jansen AM, Taminian AHM, Hogendoorn PCW & Bovee JVMG (2007), EXT and its downstream targets in central chondrosarcoma (CCS), Laboratory Investigation 87.
- Costa C, Egeler M, Forsyth R, Szuhai K, Niesters M, de Krijger R, Tati A, Hogendoorn P & Annels N (2007), Differences in telomerase expression by the CD1 a+ cells in langerhans cell histiocytosis reflects the diverse clinical presentation of the disease, Clinical Immunology 123.
- De Schepper AM, Hogendoorn PCW & Bloem JL (2007), Giant cell tumors of the tendon sheath may present radiologically as intrinsic osseous lesions, European Radiology 17(2).
- Lehtonen, H.J.; Makinen, M.J.; Kjuru, M.; Laiho, P.; Herva, R.; Minderhout, I. van; Hogendoorn, P.C.W.; Cornelisse, C.; Devilee, P.; Launonen, V. & Aaltonen, L.A. (2007), Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability, International Journal of Cancer 121(6).
- Bezooijen, R.L. van; DeRuiter, M.C.; Vilain, N.; Monteiro, R.M.; Visser, A.; Wee-Pals, L. van der; Munsteren, C.J. van; Hogendoorn, P.C.W.; Aguet, M.; Mummery, C.L.; Papapoulos, S.E.; Dijke, P. ten & Lowik, C.W.G.M. (2007), SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development, Developmental Dynamics 236(2).
- Costa C, Annels N, Hoogeboom M, Szuhai K, Hogendoorn P & Egeler M (2007), Investigation of potential chromosomal abnormalities in the lesional cells of Langerhans cell histiocytosis, Pediatric Blood and Cancer 48(7).
- Tolar, J.; Nauta, A.J.; Osborn, M.J.; Mortari, A.P.; McElmurry, R.T.; Bell, S.; Xia, L.L.; Zhou, N.; Riddle, M.; Schroeder, T.M.; Westendorf, J.J.; McIvor, R.S.; Hogendoorn, P.C.W.; Szuhai, K.; Oseth, L.; Hirsch, B.; Yant, S.R.; Kay, M.A.; Peister, A.; Prockop, D.J.; Fibbe, W.E. & Blazar, B.R. (2007), Sarcoma derived from cultured mesenchymal stem cells, Stem Cells 25(2).
- Grogan, S.P.; Barbero, A.; Diaz-Romero, J.; Cleton-Jansen, A.M.; Soeder, S.; Whiteside, R.; Hogendoorn, P.C.W.; Farhadi, J.; Aigner, T.; Martin, I. & Mainil-Varlet, P. (2007), Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity, Arthritis and Rheumatism 56(2).
- Romeo S, Oosting J, Rozeman LB, Hameetman L, Taminiau AHM, Cleton-Jansen AM, Bovee JVMG & Hogendoorn PCW (2007), The role of noncartilage-specific molecules in differentiation of cartilaginous tumors - Lessons from chondroblastoma and chondromyxoid fibroma, Cancer 110(2).
- Szuhai K, IJszenga M, Knijnenburg J, Dijkstra S, de Schepper A, Tanke HJ & Hogendoorn PCW (2007), Does parosteal liposarcoma differ from other atypical lipomatous tumors/well-differentiated liposarcomas? A molecular cytogenetic study using combined multicolor COBRA-FISH karyotyping and array-based comparative genomic hybridization, Cancer Genetics and Cytogenetics 176(2).
- Schrage YM, Hameetman L, Szuhai K, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2007), EXT and its downstream targets in central chondrosarcoma (CCS), Modern Pathology 20.
- Anninga JK, Bruijn IHBD, Romeo S, Oosting J, Egeler RM, Taminiau AHM, Hogendoorn PCW & Cleton-Jansen AM (2007), Dissecting osteosarcoma genesis by gene expression pathway profiling, Laboratory Investigation 87.
- Tolar, J.; Nauta, A.J.; Osborn, M.J.; Mortari, A.P.; McElmurry, R.T.; Bell, S.; Xia, L.L.; Zhou, N.; Riddle, M.; Schroeder, T.M.; Westendorf, J.J.; McIvor, R.S.; Hogendoorn, P.C.W.; Szuhai, K.; Oseth, L.; Hirsch, B.; Yant, S.R.; Kay, M.A.; Peister, A.; Prockop, D.J.; Fibbe, W.E. & Blazar, B.R. (2007), Sarcoma derived from cultured mesenchymal stem cells, Stem Cells 25(2).
- Costa C, Egeler M, Forsyth R, Szuhai K, Niesters M, de Krijger R, Tati A, Hogendoorn P & Annels N (2007), Differences in telomerase expression by the CD1 a+ cells in langerhans cell histiocytosis reflects the diverse clinical presentation of the disease, Clinical Immunology 123.
- Costa C, Annels N, Hoogeboom M, Szuhai K, Hogendoorn P & Egeler M (2007), Investigation of potential chromosomal abnormalities in the lesional cells of Langerhans cell histiocytosis, Pediatric Blood and Cancer 48(7).
- Willems S, Schrage Y, Baelde H, Mohseny A, Sciot R, Bovee J & Hogendoorn P (2007), Myxoid soft tissue tumours have a heterogeneous composition of their extracellular matrix: A study on myxofibrosarcoma, intramuscular myxoma and extraskeletal myxoid chondrosarcoma, Virchows Archiv 451(2): 149-149.
- Gomes CMF, Welling M, Que I, Henriquez NV, van der Pluijm G, Romeo S, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pauwels E & Cleton-Jansen AM (2007), Molecular imaging of multidrug resistance in an orthotopic model of osteosarcoma, Laboratory Investigation 87.
- Gomes CMF, Welling M, Que I, Henriquez NV, Van der Plujm G, Romeo S, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pouwels E & Cleton-Jansen AM (2007), Molecular imaging of multidrug resistance in an orthotopic model of osteosarcoma, Modern Pathology 20.
- De Schepper AM, Hogendoorn PCW & Bloem JL (2007), Giant cell tumors of the tendon sheath may present radiologically as intrinsic osseous lesions, European Radiology 17(2).
- Bezooijen, R.L. van; DeRuiter, M.C.; Vilain, N.; Monteiro, R.M.; Visser, A.; Wee-Pals, L. van der; Munsteren, C.J. van; Hogendoorn, P.C.W.; Aguet, M.; Mummery, C.L.; Papapoulos, S.E.; Dijke, P. ten & Lowik, C.W.G.M. (2007), SOST expression is restricted to the great arteries during embryonic and neonatal cardiovascular development, Developmental Dynamics 236(2).
- Schrage YM, Hameetman L, Szuhai K, Cleton-Jansen AM, Taminian AHM, Hogendoorn PCW & Bovee JVMG (2007), EXT and its downstream targets in central chondrosarcoma (CCS), Laboratory Investigation 87.
- Szuhai K, IJszenga M, Tanke HJ, Taminiau AHM, de Schepper A, van Duinen SG, Rosenberg C & Hogendoorn PCW (2007), Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma, Cancer Genetics and Cytogenetics 172(1).
- Lewis, I.J.; Nooij, M.A.; Whelan, J.; Sydes, M.R.; Grimer, R.; Hogendoorn, P.C.W.; Memon, M.A.; Weeden, S.; Uscinska, B.M.; Glabbeke, M. van; Kirkpatrick, A.; Hauben, E.I.; Craft, A.W.; Taminiau, A.H.M.; MRC BO06 Collaborators; EORTC 80931 Collaborators & European Osteosarcoma Intergrp (2007), Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: A randomized phase III trial of the European Osteosarcoma Intergroup, Journal of the National Cancer Institute 99(2).
- Grogan, S.P.; Barbero, A.; Diaz-Romero, J.; Cleton-Jansen, A.M.; Soeder, S.; Whiteside, R.; Hogendoorn, P.C.W.; Farhadi, J.; Aigner, T.; Martin, I. & Mainil-Varlet, P. (2007), Identification of markers to characterize and sort human articular chondrocytes with enhanced in vitro chondrogenic capacity, Arthritis and Rheumatism 56(2).
- Lorigan P, Verweij J, Papai Z, Rodenhuis S, Le Cesne A, Leahy MG, Radford JA, Van Glabbeke MM, Kirkpatrick A, Hogendoorn PCW & Blay JY (2007), Phase III trial of two Investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: A European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group study, Journal of Clinical Oncology 25(21).
- Verbeke SLJ, Bacchini P, Kroon HMH, Hogendoorn PCW & Bovee JVMG (2007), Primary malignant vascular tumours of bone: Immunohistochemical investigation on endothelial phenotype and histopathological correlation, Virchows Archiv 451(2): 151-152.
- Hameetman L, David G, Yavas A, White SJ, Taminiau AHM, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2007), Decreased EXT expression and intracellular accumulation of heparan sulphate proteoglycan in osteochondromas and peripheral chondrosarcomas, Journal of Pathology 211(4).
- Leahy M, Ray-Coquard I, Verweij J, Le Cesne A, Duffaud F, Hogendoorn PCW, Fowst C, de Balincourt C, di Paola ED, van Glabbeke M, Judson I & Blay JY (2007), Brostallicin, an agent with potential activity in metastatic soft tissue sarcoma: A phase II study from the European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group, European Journal of Cancer 43(2).
- Hameetman, L.; Szuhai, K.; Yavas, A.; Knijnenburg, J.; Duin, M. van; Dekken, H. van; Taminiau, A.H.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2007), The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions, Journal of the National Cancer Institute 99(5).
- Willems SM, Szuhai K, Hartgrink H, Bovee JVMG, De Schepper A & Hogendoorn PCW (2007), CT-guided, COBRA-FISH-assisted diagnosis of well-differentiated liposarcoma (inflammatory subtype) of the retroperitoneum, Histopathology 51(3).
- Anninga J, Briaire-De Bruijn IH, Romeo S, Oosting J, Egeler R, Taminiau A, Hogendoorn P & Cleton-Jansen A (2007), Dissecting osteosarcoma genesis by gene expression pathway profiling.
- Hooge, A.S.K. de; Berghuis, D.; Santos, S.J.; Mooiman, E.; Romeo, S.; Kummer, J.A.; Egeler, R.M.; Tol, M.J.D. van; Melief, C.J.M.; Hogendoorn, P.C.W. & Lankester, A.C. (2007), Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways, Clinical Cancer Research 13(1).
- Dekker PBD, Kuipers-Dijkshoorn NJ, Baelde HJ, van der Mey AGL, Hogendoorn PCW & Cornelisse CJ (2007), Basic fibroblast growth factor and fibroblastic growth factor receptor-1 may contribute to head and neck paraganglioma development by an autocrine or paracrine mechanism, Human Pathology 38(1).
- Lehtonen, H.J.; Makinen, M.J.; Kjuru, M.; Laiho, P.; Herva, R.; Minderhout, I. van; Hogendoorn, P.C.W.; Cornelisse, C.; Devilee, P.; Launonen, V. & Aaltonen, L.A. (2007), Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability, International Journal of Cancer 121(6).
- Heyning, F.H.; Kroon, H.M.J.A.; Hogendoorn, P.C.W.; Taminiau, A.H.M. & Woude, H.J. van der (2007), MR imaging characteristics in primary lymphoma of bone with emphasis on non-aggressive appearance, Skeletal Radiology 36(10).
- Gomes, C.M.F.; Welling, M.; Que, I.; Henriquez, N.V.; Pluijm, G. van der; Romeo, S.; Abrunhosa, A.J.; Botelho, M.F.; Hogendoorn, P.C.W.; Pauwels, E.K.J. & Cleton-Jansen, A.M. (2007), Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using Tc-99m-sestamibi, European Journal of Nuclear Medicine and Molecular Imaging 34(11).
- da Costa CET, Egeler RM, Hoogeboorn M, Szuhai K, Forsyth RG, Niesters M, de Krijger RR, Tazi A, Hogendoorn PCW & Annels NE (2007), Differences in telomerase expression by the CD1a(+) cells in Langerhans cell histiocytosis reflect the diverse clinical presentation of the disease, Journal of Pathology 212(2).
- Gomes, C.M.F.; Welling, M.; Que, I.; Henriquez, N.V.; Pluijm, G. van der; Romeo, S.; Abrunhosa, A.J.; Botelho, M.F.; Hogendoorn, P.C.W.; Pauwels, E.K.J. & Cleton-Jansen, A.M. (2007), Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi., European Journal of Nuclear Medicine and Molecular Imaging 34(11): 1793-803.
- Rozeman, L.B.; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2006), Pathology of primary malignant bone and cartilage tumours, International Orthopaedics 30(6).
- Lankester A, de Hooge A, Berghuis D, Santos S, Bots M, Melief K & Hogendoorn P (2006), Expression and functional relevance of cFLIP, PI-9 and caspase 8 in Ewing's sarcoma: Implications for immunotherapy., Clinical Immunology 119: S99S100.
- Oudenhoven LFIJ, Dhondt E, Kahn S, Nieborg A, Kroon HMJ, Hogendoorn PCW, Gielen JL, Bloem JL & De Schepper A (2006), Accuracy of radiography in grading and tissue-specific diagnosis - a study of 200 consecutive bone tumors of the hand, Skeletal Radiology 35(2).
- Gomes CM, Van Paassen HJ, Welling MM, Feitsma RJ, Abrunhosa AJ, Botelho MF, Hogendoorn PC, Pauwels EK & Cleton-Jansen AM (2006), Multidrug resistance activity in human osteosarcoma cell lines and reversal of chemosensitivity, Modern Pathology 19.
- Rozeman, L.B.; Szuhai, K.; Schrage, Y.M.; Rosenberg, C.; Tanke, H.J.; Taminiau, A.H.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2006), Array-comparative genomic hybridization of central chondrosarcoma - Identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations, Cancer 107(2).
- Romeo S, Eyden B, Prins FA, Briaire-de Bruijn IH, Taminiau AHM & Hogendoorn PCW (2006), TGF-beta 1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone, Journal of Pathology 208(1).
- Schrage YM, Szuhai K, Taminian AHM, Hogendoorn PCW & Bovee JVMG (2006), CDK4 amplification in central chondrosarcoma is associated with tumor progression, Modern Pathology 19: 18A18A.
- Gomes CM, Van Paassen HJ, Welling MM, Feitsma RJ, Abrunhosa AJ, Botelho MF, Hogendoorn PC, Pauwels EK & Cleton-Jansen AM (2006), Multidrug resistance activity in human osteosarcoma cell lines and reversal of chemosensitivity, Laboratory Investigation 86.
- Schrage YM, Szuhai K, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2006), CDK4 amplification in central chondrosarcoma is associated with tumor progression, Laboratory Investigation 86: 18A18A.
- Romeo, S. & Hogendoorn, P. (2006), Brachyury and chordoma: the chondroid-chordoid dilemma resolved?, Journal of Pathology 209(2): 143-146.
- Romeo S, Hameetman L, Oosting J, Rozeman LB, Cleton-Jansen AM, Bovee JVMG & Hogendoorn PCW (2006), A differentially expressed gene-set differentiates chondromyxoid fibroma from high-grade central chondrosarcoma, Modern Pathology 19: 17A17A.
- Romeo S, Hameetman L, Oosting J, Rozeman LB, Cleton-Jansen AM, Bovee JVMG & Hogendoorn PCW (2006), A differentially expressed gene-set differentiates chondromyxoid fibroma from high-grade central chondrosarcoma, Laboratory Investigation 86: 17A17A.
- Hyzy MD, Hogendoorn PCW, Bloem JL & De Schepper AM (2006), Chondroid lipoma: findings on radiography and MRI (2006 : 7b), European Radiology 16(10).
- Dhondt E, Oudenhoven L, Khan S, Kroon HM, Hogendoorn PC, Nieborg A, Bloem JL & De Schepper A (2006), Nora's lesion, a distinct radiological entity?, Skeletal Radiology 35(7).
- Nout R, Schoevers W, Putter H, Hogendoorn P, Nooij M, Taminiau A, Anninga J, Noordijk E & Marijnen C (2006), A 25-year single institution experience in the treatment of ewing sarcoma family oftumors (EFT): Havetreatment outcomes improved in this period?, Radiotherapy and Oncology 81: S406S407.
- Gomes CMF, Welling MM, Que I, Henriquez NV, van der Pluijm G, Romeo S, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pauwels EKJ & Cleton-Jansen AM (2006), Molecular imaging of multidrug resistance in an orthotopic model of osteosarcoma, European Journal of Nuclear Medicine and Molecular Imaging 33.
- Hauben EI, Bielack S, Grimer R, Jundt G, Reichardt P, Sydes M, Taminiau AHM & Hogendoorn PCW (2006), Clinico-histologic parameters of osteosarcoma patients with late relapse, European Journal of Cancer 42(4).
- Szuhai K, IJszenga M, Tanke HJ, Rosenberg C & Hogendoorn PCW (2006), Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines, Cancer Genetics and Cytogenetics 166(2).
- Willems, S.M.; Debiec-Rychter, M.; Szuhai, K.; Hogendoorn, P.C.W. & Sciot, R. (2006), Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model, Modern Pathology 19(3).
- Gomes CMF, van Paassen H, Romeo S, Welling MM, Feltsma RIJ, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pauwels E & Cleton-Jansen AM (2006), Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies, Nuclear Medicine and Biology 33(7).
- Hyzy MD, Hogendoorn PCW, Bloem JL & De Schepper AM (2006), Chondroid lipoma: findings on radiography and MRI (2006 : 7b), European Radiology 16(10).
- Oudenhoven LFIJ, Dhondt E, Kahn S, Nieborg A, Kroon HMJ, Hogendoorn PCW, Gielen JL, Bloem JL & De Schepper A (2006), Accuracy of radiography in grading and tissue-specific diagnosis - a study of 200 consecutive bone tumors of the hand, Skeletal Radiology 35(2).
- Romeo, S. & Hogendoorn, P. (2006), Brachyury and chordoma: the chondroid-chordoid dilemma resolved?, Journal of Pathology 209(2): 143-146.
- Romeo S, Hameetman L, Oosting J, Rozeman LB, Cleton-Jansen AM, Bovee JVMG & Hogendoorn PCW (2006), A differentially expressed gene-set differentiates chondromyxoid fibroma from high-grade central chondrosarcoma, Modern Pathology 19: 17A17A.
- Schrage YM, Szuhai K, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2006), CDK4 amplification in central chondrosarcoma is associated with tumor progression, Laboratory Investigation 86: 18A18A.
- Gomes CM, Van Paassen HJ, Welling MM, Feitsma RJ, Abrunhosa AJ, Botelho MF, Hogendoorn PC, Pauwels EK & Cleton-Jansen AM (2006), Multidrug resistance activity in human osteosarcoma cell lines and reversal of chemosensitivity, Modern Pathology 19.
- Hauben EI, Bielack S, Grimer R, Jundt G, Reichardt P, Sydes M, Taminiau AHM & Hogendoorn PCW (2006), Clinico-histologic parameters of osteosarcoma patients with late relapse, European Journal of Cancer 42(4).
- Nout R, Schoevers W, Putter H, Hogendoorn P, Nooij M, Taminiau A, Anninga J, Noordijk E & Marijnen C (2006), A 25-year single institution experience in the treatment of ewing sarcoma family oftumors (EFT): Havetreatment outcomes improved in this period?, Radiotherapy and Oncology 81: S406S407.
- Romeo S, Hameetman L, Oosting J, Rozeman LB, Cleton-Jansen AM, Bovee JVMG & Hogendoorn PCW (2006), A differentially expressed gene-set differentiates chondromyxoid fibroma from high-grade central chondrosarcoma, Laboratory Investigation 86: 17A17A.
- Lankester A, de Hooge A, Berghuis D, Santos S, Bots M, Melief K & Hogendoorn P (2006), Expression and functional relevance of cFLIP, PI-9 and caspase 8 in Ewing's sarcoma: Implications for immunotherapy., Clinical Immunology 119: S99S100.
- Schrage YM, Szuhai K, Taminian AHM, Hogendoorn PCW & Bovee JVMG (2006), CDK4 amplification in central chondrosarcoma is associated with tumor progression, Modern Pathology 19: 18A18A.
- Gomes CMF, Welling MM, Que I, Henriquez NV, van der Pluijm G, Romeo S, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pauwels EKJ & Cleton-Jansen AM (2006), Molecular imaging of multidrug resistance in an orthotopic model of osteosarcoma, European Journal of Nuclear Medicine and Molecular Imaging 33.
- Gomes CMF, van Paassen H, Romeo S, Welling MM, Feltsma RIJ, Abrunhosa AJ, Botelho MF, Hogendoorn PCW, Pauwels E & Cleton-Jansen AM (2006), Multidrug resistance mediated by ABC transporters in osteosarcoma cell lines: mRNA analysis and functional radiotracer studies, Nuclear Medicine and Biology 33(7).
- Gomes CM, Van Paassen HJ, Welling MM, Feitsma RJ, Abrunhosa AJ, Botelho MF, Hogendoorn PC, Pauwels EK & Cleton-Jansen AM (2006), Multidrug resistance activity in human osteosarcoma cell lines and reversal of chemosensitivity, Laboratory Investigation 86.
- Rozeman, L.B.; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2006), Pathology of primary malignant bone and cartilage tumours, International Orthopaedics 30(6).
- Dhondt E, Oudenhoven L, Khan S, Kroon HM, Hogendoorn PC, Nieborg A, Bloem JL & De Schepper A (2006), Nora's lesion, a distinct radiological entity?, Skeletal Radiology 35(7).
- Willems, S.M.; Debiec-Rychter, M.; Szuhai, K.; Hogendoorn, P.C.W. & Sciot, R. (2006), Local recurrence of myxofibrosarcoma is associated with increase in tumour grade and cytogenetic aberrations, suggesting a multistep tumour progression model, Modern Pathology 19(3).
- Rozeman, L.B.; Szuhai, K.; Schrage, Y.M.; Rosenberg, C.; Tanke, H.J.; Taminiau, A.H.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2006), Array-comparative genomic hybridization of central chondrosarcoma - Identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations, Cancer 107(2).
- Szuhai K, IJszenga M, Tanke HJ, Rosenberg C & Hogendoorn PCW (2006), Molecular cytogenetic characterization of four previously established and two newly established Ewing sarcoma cell lines, Cancer Genetics and Cytogenetics 166(2).
- Romeo S, Eyden B, Prins FA, Briaire-de Bruijn IH, Taminiau AHM & Hogendoorn PCW (2006), TGF-beta 1 drives partial myofibroblastic differentiation in chondromyxoid fibroma of bone, Journal of Pathology 208(1).
- Bovee, J.; Hameetman, L.; Kroon, H.M.; Aigner, T. & Hogendoom, P.C.W. (2006), EXT-related pathways are not involved in the pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis, The Journal of Pathology 209(3).
- Hameetman, L.; Rozeman, L.B.; Lombaerts, M.; Oostlng, J.; Taminiau, A.H.M.; Cleton-Jansen, A.M.; Bovee, J.V.M.G. & Hogendoom, P.C.W. (2006), Peripheral chondrosarcoma progression is accompanied by decreased Indian Hedgehog signalling, The Journal of Pathology 209(4).
- Tolar, J.; Nauta, A.J.; Osborn, M.J.; Panoskaltsis-Mortari, A.; McElmurry, R.T.; Bell, S.; Xia, L.; Zhou, N.; Riddle, M.; Schroeder, T.M.; Westendorf, J.J.; McIvor, R.S.; Hogendoom, P.C.W.; Szuhai, K.; Oseth, L.; Hirsch, B.; Yant, S.R.; Kay, M.A.; Peister, A.; Prockop, D.J.; Fibbe, W.E. & Blazar, B.R. (2006), Osteosarcoma derived from cultured mesenchymal stem cells., Blood 108(11).
- Sueters M, Peek AML, Ball LM, Hogendoorn PCW, Scherjon SA, de Keizer RJW & Schalij-Delfos NE (2005), Prenatal detection of orbital rhabdomyosarcoma, Archives of Ophthalmology -New Series- 123(2).
- Hameetman L, Hogendoorn PCW, Kroon HM, Aigner T & Bovee JVMG (2005), EXT-Related pathways are not involved in pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis, Laboratory Investigation 85.
- Hameetman L, Cleton-Jansen AM, Rozeman LB, Lombaerts M, Taminiau AHM, Bovee JVMG & Hogendoorn PCW (2005), Progression of secondary peripheral chondrosarcoma is characterized by downregulation of oxidative phosphrylation genes, Modern Pathology 18: 15A15A.
- Hameetman L, Cleton-Jansen AM, Rozeman LB, Lombaerts M, Taminiau AHM, Bovee JVMG & Hogendoorn P (2005), Progression of secondary peripheral chondrosarcoma is characterized by downregulation of oxidative phosphrylation genes, Laboratory Investigation 85: 15A15A.
- Cleton-Jansen, A.M.; Beerendonk, H.M. van; Baelde, H.J.; Bovee, J.V.G.M.; Karperien, M. & Hogendoorn, P.C.W. (2005), Estrogen signaling is active in cartilaginous tumors: Implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma, Clinical Cancer Research 11(22).
- Hameetman L, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2005), Loss of EXT Expression causes downregulation of IHh signaling in hereditary and solitary osteochondromas, Modern Pathology 18: 15A15A.
- Hameetman L, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2005), Loss of EXTExpression causes downregulation of IHh signaling in hereditary and solitary osteochondromas, Laboratory Investigation 85: 15A15A.
- Cleton-Jansen AM, Van Beerendonk HM, Bovee JV, Szuhai K, Karperien M & Hogendoorn PC (2005), Estrogen signaling is active in chondrosarcoma; Implications for anti-estrogens as treatment of chondrosarcoma, Modern Pathology 18: 12A12A.
- Hauben E, Jundt G, Cleton-Jansen A, Yavas A, Kroon HM, Van Marck E & Hogendoorn PC (2005), Desmoplastic fibroma of bone: An immunohistochemical study on 13 cases including beta-catenin expression and mutational analysis for catenin, Modern Pathology 18.
- Hameetman L, Hogendoorn PCW, Kroon HM, Aigner T & Bovee JVMG (2005), EXT-related pathways are not involved in pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis, Modern Pathology 18.
- Romeo S, Bovee JVMG, Grogan SP, Taminiau AH, Eilers PHC, Cleton-Jansen AM, Mainil-Varlet P & Hogendoorn PCW (2005), Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules, Journal of Pathology 206(2).
- Rozeman LB, Hameetman L, van Wezel T, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), cDNA microarray analysis of conventional central chondrosarcomas identifies genes associated with tumor progression, not related to Ollier disease, Laboratory Investigation 85: 21A22A.
- Schaft, D.W.J. van der; Hillen, F.; Pauwels, P.; Kirschmann, D.A.; Castermans, K.; Egbrink, M.G.A.O.; Tran, M.G.B.; Sciot, R.; Hauben, E.; Hogendoorn, P.C.W.; Delattre, O.; Maxwell, P.H.; Hendrix, M.J.C. & Griffioen, A.W. (2005), Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia, Cancer Research 65(24).
- Nooij MA, Whelan J, Bramwell VHC, Taminiau AT, Cannon S, Hogendoorn PCW, Pringle J, Uscinska BM, Weeden S, Kirkpatrick A, von Glabbeke M & Craft AW (2005), Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study, European Journal of Cancer 41(2).
- van de Kamp JM, van der Smagt JJ, Bos CFA, van Haeringen A, Hogendoorn PCW & Breuning MH (2005), Bifurcation of the femur with tibial agenesis and additional anomalies, American Journal of Medical Genetics Part A 138A(1).
- Hauben EI, Jundt G, Cleton-Jansen AM, Yavas A, Kroon HM, Van Marck E & Hogendoorn PCW (2005), Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin, Human Pathology 36(9).
- Vink, G.R.; White, S.J.; Gabelic, S.; Hogendoorn, P.C.W.; Breuning, M.H. & Bakker, E. (2005), Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations, European Journal of Human Genetics 13(4).
- Rozeman LB, Hameetman L, van Wezel T, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), cDNA microarray analysis of conventional central chondrosarcomas identifies genes associated with tumor progression, not related to Ollier disease, Modern Pathology 18: 21A22A.
- Goettsch, W.G.; Bos, S.D.; Breekveldt-Postma, N.; Casparie, M.; Herings, R.M.C. & Hogendoorn, P.C.W. (2005), Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study, European Journal of Cancer 41(18).
- Rozeman LB, Szuhai K, Bovee JVMG, Rosenberg C, Tanke HJ & Hogendoorn PCW (2005), Array-CGH analysis of conventional central chondrosarcomas points to chromosome 6 and 12 involvement in tumor progression, Laboratory Investigation 85: 21A21A.
- Rozeman LB, Szuhai K, Bovee JVMG, Rosenberg C, Tanke HJ & Hogendoorn PCW (2005), Arrary-CGH analysis of conventional central chondrosarcomas points to chromosome 6 and 12 involvement in tumor progression, Modern Pathology 18: 21A21A.
- Van Glabbeke M, Verweij J, Casali PG, Le Cesne A, Hohenberger P, Ray-Coquard I, Schlemmer M, van Oosterom AT, Goldstein D, Sciot R, Hogendoorn PCW, Brown M, Bertulli R & Judson IR (2005), Initial and late resistance to imatinib in advanced gastrointestinal stromal. tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study, Journal of Clinical Oncology 23(24).
- Rozeman, L.B.; Hameetman, L.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C. & Bovee, J.V.M.G. (2005), Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas, Journal of Pathology 205(4).
- Rozeman LB, Hameetman L, van Wezel T, Taminiau AHM, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade, Journal of Pathology 207(1).
- Blay, J.Y.; Bonvalot, S.; Casali, P.; Choi, H.; Debiec-Richter, M.; Tos, A.P. dei; Emile, J.F.; Gronchi, A.; Hogendoorn, P.C.W.; Joensuu, H.; Cesne, A. le; Mac Clure, J.; Maurel, J.; Nupponen, N.; Ray-Coquard, I.; Reichardt, P.; Sciot, R.; Stroobants, S.; Glabbeke, M. van; Oosterom, A. van; Demetri, G.D. & GIST Consensus Meeting Panelists (2005), Consensus meeting for the management of gastrointestinal stromal tumors - Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO, Annals of Oncology 16(4).
- Costa, C.E.T. da; Annels, N.E.; Faaij, C.M.J.M.; Forsyth, R.G.; Hogendoorn, P.C.W. & Egeler, R.M. (2005), Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis, Journal of Experimental Medicine 201(5).
- Bovee JVMG, Cleton-Jansen AM, Taminiau AHM & Hogendoorn PCW (2005), Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment, Lancet Oncology 6(8).
- Nicholls BM, Bredius RGM, Hamdy NAT, Gerritsen EJA, Lankester AC, Hogendoorn PCW, Nesbitt SA, Horton MA & Flanagan AM (2005), Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor, Journal of Bone and Mineral Research 20(12).
- Hauben E, Jundt G, Cleton-Jansen A, Yavas A, Kroon HM, Van Marck E & Hogendoorn PC (2005), Desmoplastic fibroma of bone: An immunohistochemical study on 13 cases including beta-catenin expression and mutational analysis for beta-catenin, Laboratory Investigation 85.
- Hameetman L, Kok P, Eilers PHC, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting, Virchows Archiv 446(4).
- van Roggen JFG, van Unnik JAM, Briaire-de Bruijn IH & Hogendoorn PCW (2005), Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up, Virchows Archiv 446(2).
- van de Kamp JM, van der Smagt JJ, Bos CFA, van Haeringen A, Hogendoorn PCW & Breuning MH (2005), Bifurcation of the femur with tibial agenesis and additional anomalies, American Journal of Medical Genetics Part A 138A(1).
- Nooij MA, Whelan J, Bramwell VHC, Taminiau AT, Cannon S, Hogendoorn PCW, Pringle J, Uscinska BM, Weeden S, Kirkpatrick A, von Glabbeke M & Craft AW (2005), Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study, European Journal of Cancer 41(2).
- Schaft, D.W.J. van der; Hillen, F.; Pauwels, P.; Kirschmann, D.A.; Castermans, K.; Egbrink, M.G.A.O.; Tran, M.G.B.; Sciot, R.; Hauben, E.; Hogendoorn, P.C.W.; Delattre, O.; Maxwell, P.H.; Hendrix, M.J.C. & Griffioen, A.W. (2005), Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia, Cancer Research 65(24).
- Hameetman L, Cleton-Jansen AM, Rozeman LB, Lombaerts M, Taminiau AHM, Bovee JVMG & Hogendoorn PCW (2005), Progression of secondary peripheral chondrosarcoma is characterized by downregulation of oxidative phosphrylation genes, Modern Pathology 18: 15A15A.
- Hameetman L, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2005), Loss of EXT Expression causes downregulation of IHh signaling in hereditary and solitary osteochondromas, Modern Pathology 18: 15A15A.
- Rozeman LB, Szuhai K, Bovee JVMG, Rosenberg C, Tanke HJ & Hogendoorn PCW (2005), Arrary-CGH analysis of conventional central chondrosarcomas points to chromosome 6 and 12 involvement in tumor progression, Modern Pathology 18: 21A21A.
- Hameetman L, Cleton-Jansen AM, Taminiau AHM, Hogendoorn PCW & Bovee JVMG (2005), Loss of EXTExpression causes downregulation of IHh signaling in hereditary and solitary osteochondromas, Laboratory Investigation 85: 15A15A.
- Rozeman LB, Hameetman L, van Wezel T, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), cDNA microarray analysis of conventional central chondrosarcomas identifies genes associated with tumor progression, not related to Ollier disease, Laboratory Investigation 85: 21A22A.
- Rozeman LB, Hameetman L, van Wezel T, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), cDNA microarray analysis of conventional central chondrosarcomas identifies genes associated with tumor progression, not related to Ollier disease, Modern Pathology 18: 21A22A.
- Rozeman LB, Szuhai K, Bovee JVMG, Rosenberg C, Tanke HJ & Hogendoorn PCW (2005), Array-CGH analysis of conventional central chondrosarcomas points to chromosome 6 and 12 involvement in tumor progression, Laboratory Investigation 85: 21A21A.
- Cleton-Jansen AM, Van Beerendonk HM, Bovee JV, Szuhai K, Karperien M & Hogendoorn PC (2005), Estrogen signaling is active in chondrosarcoma; Implications for anti-estrogens as treatment of chondrosarcoma, Modern Pathology 18: 12A12A.
- Hameetman L, Cleton-Jansen AM, Rozeman LB, Lombaerts M, Taminiau AHM, Bovee JVMG & Hogendoorn P (2005), Progression of secondary peripheral chondrosarcoma is characterized by downregulation of oxidative phosphrylation genes, Laboratory Investigation 85: 15A15A.
- Hauben E, Jundt G, Cleton-Jansen A, Yavas A, Kroon HM, Van Marck E & Hogendoorn PC (2005), Desmoplastic fibroma of bone: An immunohistochemical study on 13 cases including beta-catenin expression and mutational analysis for catenin, Modern Pathology 18.
- Hameetman L, Hogendoorn PCW, Kroon HM, Aigner T & Bovee JVMG (2005), EXT-related pathways are not involved in pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis, Modern Pathology 18.
- Costa, C.E.T. da; Annels, N.E.; Faaij, C.M.J.M.; Forsyth, R.G.; Hogendoorn, P.C.W. & Egeler, R.M. (2005), Presence of osteoclast-like multinucleated giant cells in the bone and nonostotic lesions of Langerhans cell histiocytosis, Journal of Experimental Medicine 201(5).
- Hameetman L, Hogendoorn PCW, Kroon HM, Aigner T & Bovee JVMG (2005), EXT-Related pathways are not involved in pathogenesis of dysplasia epiphysealis hemimelica and metachondromatosis, Laboratory Investigation 85.
- Hauben E, Jundt G, Cleton-Jansen A, Yavas A, Kroon HM, Van Marck E & Hogendoorn PC (2005), Desmoplastic fibroma of bone: An immunohistochemical study on 13 cases including beta-catenin expression and mutational analysis for beta-catenin, Laboratory Investigation 85.
- Sueters M, Peek AML, Ball LM, Hogendoorn PCW, Scherjon SA, de Keizer RJW & Schalij-Delfos NE (2005), Prenatal detection of orbital rhabdomyosarcoma, Archives of Ophthalmology -New Series- 123(2).
- Van Glabbeke M, Verweij J, Casali PG, Le Cesne A, Hohenberger P, Ray-Coquard I, Schlemmer M, van Oosterom AT, Goldstein D, Sciot R, Hogendoorn PCW, Brown M, Bertulli R & Judson IR (2005), Initial and late resistance to imatinib in advanced gastrointestinal stromal. tumors are predicted by different prognostic factors: A European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study, Journal of Clinical Oncology 23(24).
- Blay, J.Y.; Bonvalot, S.; Casali, P.; Choi, H.; Debiec-Richter, M.; Tos, A.P. dei; Emile, J.F.; Gronchi, A.; Hogendoorn, P.C.W.; Joensuu, H.; Cesne, A. le; Mac Clure, J.; Maurel, J.; Nupponen, N.; Ray-Coquard, I.; Reichardt, P.; Sciot, R.; Stroobants, S.; Glabbeke, M. van; Oosterom, A. van; Demetri, G.D. & GIST Consensus Meeting Panelists (2005), Consensus meeting for the management of gastrointestinal stromal tumors - Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO, Annals of Oncology 16(4).
- Goettsch, W.G.; Bos, S.D.; Breekveldt-Postma, N.; Casparie, M.; Herings, R.M.C. & Hogendoorn, P.C.W. (2005), Incidence of gastrointestinal stromal tumours is underestimated: Results of a nation-wide study, European Journal of Cancer 41(18).
- Bovee JVMG, Cleton-Jansen AM, Taminiau AHM & Hogendoorn PCW (2005), Emerging pathways in the development of chondrosarcoma of bone and implications for targeted treatment, Lancet Oncology 6(8).
- van Roggen JFG, van Unnik JAM, Briaire-de Bruijn IH & Hogendoorn PCW (2005), Aggressive angiomyxoma: a clinicopathological and immunohistochemical study of 11 cases with long-term follow-up, Virchows Archiv 446(2).
- Rozeman, L.B.; Hameetman, L.; Cleton-Jansen, A.M.; Taminiau, A.H.M.; Hogendoorn, P.C. & Bovee, J.V.M.G. (2005), Absence of IHH and retention of PTHrP signalling in enchondromas and central chondrosarcomas, Journal of Pathology 205(4).
- Vink, G.R.; White, S.J.; Gabelic, S.; Hogendoorn, P.C.W.; Breuning, M.H. & Bakker, E. (2005), Mutation screening of EXT1 and EXT2 by direct sequence analysis and MLPA in patients with multiple osteochondromas: splice site mutations and exonic deletions account for more than half of the mutations, European Journal of Human Genetics 13(4).
- Hameetman L, Kok P, Eilers PHC, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), The use of Bcl-2 and PTHLH immunohistochemistry in the diagnosis of peripheral chondrosarcoma in a clinicopathological setting, Virchows Archiv 446(4).
- Hauben EI, Jundt G, Cleton-Jansen AM, Yavas A, Kroon HM, Van Marck E & Hogendoorn PCW (2005), Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin, Human Pathology 36(9).
- Cleton-Jansen, A.M.; Beerendonk, H.M. van; Baelde, H.J.; Bovee, J.V.G.M.; Karperien, M. & Hogendoorn, P.C.W. (2005), Estrogen signaling is active in cartilaginous tumors: Implications for antiestrogen therapy as treatment option of metastasized or irresectable chondrosarcoma, Clinical Cancer Research 11(22).
- Rozeman LB, Hameetman L, van Wezel T, Taminiau AHM, Cleton-Jansen AM, Hogendoorn PCW & Bovee JVMG (2005), cDNA expression profiling of chondrosarcomas: Ollier disease resembles solitary tumours and alteration in genes coding for components of energy metabolism occurs with increasing grade, Journal of Pathology 207(1).
- Romeo S, Bovee JVMG, Grogan SP, Taminiau AH, Eilers PHC, Cleton-Jansen AM, Mainil-Varlet P & Hogendoorn PCW (2005), Chondromyxoid fibroma resembles in vitro chondrogenesis, but differs in expression of signalling molecules, Journal of Pathology 206(2).
- Nicholls BM, Bredius RGM, Hamdy NAT, Gerritsen EJA, Lankester AC, Hogendoorn PCW, Nesbitt SA, Horton MA & Flanagan AM (2005), Limited rescue of osteoclast-poor osteopetrosis after successful engraftment by cord blood from an unrelated donor, Journal of Bone and Mineral Research 20(12).
- Hogendoorn, P.C.W.; Geel, A.N. van; Wyrdeman, H.K.; Seynaeve, C.; Bongaerts, A.H.H. & Molenaar, W.M. (2005), Richtlijn Diagnostiek bij wekedelentumoren en behandeling van wekedelensarcomen (herziening) , Nederlands Tijdschrift voor Geneeskunde 149(17).
- Schaefer, K.L.; Brachwitz, K.; Wai, D.H.; Braun, Y.; Diallo, R.; Korsching, E.; Eisenacher, M.; Voss, R.; Valen, F. van; Baer, C.; Selle, B.; Spahn, L.; Liao, S.K.; Lee, K.A.W.; Hogendoorn, P.C.W.; Reifenberger, G.; Gabbert, H.E. & Poremba, C. (2004), Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3, Cancer Research 64(10).
- Anninga JK, van de Vijver MJ, Cleton-Jansen AM, Kristel PMP, Taminiau AHM, Nooij M, Egeler RM & Hogendoorn PCW (2004), Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas, European Journal of Cancer 40(7).
- Hensen, E.F.; Jordanova, E.S.; Minderhout, I.J.H.M. van; Hogendoorn, P.C.W.; Taschner, P.E.M.; Mey, A.G.L. van der; Devilee, P. & Cornelisse, C.J. (2004), Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families, Oncogene 23(23).
- Romeo S, Bovee JVMG, Jadnanansing NAA, Taminiau AHM & Hogendoorn PCW (2004), Expression of cartilage growth plate signalling molecules in chondroblastoma, Journal of Pathology 202(1).
- Van der Woude HJ, Hazelbag HM, Bloem JL, Taminiau AHM & Hogendoorn PCW (2004), MRI of adamantinoma of long bones in correlation with histopathology, American Journal of Roentgenology 183(6).
- Rozeman, L.B.; Sangiorgi, L.; Briaire-de Bruijn, I.H.; Mainil-Varlet, P.; Bertoni, F.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2004), Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C, Human Mutation 24(6).
- Blay JY, Le Cesne A, Verweij J, Scurr M, Seynaeve C, Bonvalot S, Hogendoorn P, Jimeno J, Evrard V, van Glabbeke M & Judson I (2004), A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours, European Journal of Cancer 40(9).
- Lindeman, J.H.N.; Hanemaaijer, R.; Mulder, A.; Dijkstra, S.; Szuhai, K.; Bromme, D.; Verheijen, J.H. & Hogendoorn, P.C.W. (2004), Cathepsin K is the principal protease in giant cell tumor of bone, American Journal of Pathology 165(2).
- Cleton-Jansen, A.M.; Timmerman, M.C.; Vijver, M.J. van de; Asperen, C.J. van; Kroon, H.M.; Eilers, P.H. & Hogendoorn, P.C. (2004), A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient, Laboratory Investigation 84(2).
- Hazelbag, H.M.; Szuhai, K.; Tanke, H.J.; Rosenberg, C. & Hogendoorn, P.C.W. (2004), Primary synovial sarcoma of the heart: a cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH of a case with a complex karyotype, Modern Pathology 17(11).
- van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW, Taminiau AHM, van Coevorden F, Zwinderman AH, Pope TL & Bloem JL (2004), Soft-tissue tumors: Value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy, Radiology 233(2).
- Szuhai K, Knijnenburg J, Ijszenga M, Tanke HJ, Baatenburg RJ, de Jong RJB, Dekker PBD, Rosenberg C & Hogendoorn PCW (2004), Multicolor fluorescence in situ hybridization analysis of a synovial sarcoma of the larynx with a t(X;18)(p11.2;q11.2) and trisomy-2 and trisomy-8, Cancer Genetics and Cytogenetics 153(1).
- Kornaat PR, Doornbos J, van der Molen AJ, Kloppenburg M, Nelissen RG, Hogendoorn PCW & Bloem JL (2004), Magnetic resonance imaging of knee cartilage using a water selective balanced steady-state free precession sequence, Journal of Magnetic Resonance Imaging 20(5).
- Hogendoorn PCW, Collin F, Daugaard S, Dei Tos AP, Fisher C, Schneider U & Sciot R (2004), Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment, European Journal of Cancer 40(11).
- Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PCW, Van Glabbeke M, Bertulli R & Judson I (2004), Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial, Lancet 364(9440).
- Egeler RM, Annels NE & Hogendoorn PCW (2004), Commentary - Langerhans cell histiocytosis: A pathologic combination of oncogenesis and immune dysregulation, Pediatric Blood and Cancer 42(5).
- van Beerendonk HM, Rozeman LB, Taminiau AH, Sciot R, Bovee JVMG, Cleton-Jansen AM & Hogendoorn PC (2004), Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression, Journal of Pathology 202(3).
- Cleton-Jansen, A.M.; Timmerman, M.C.; Vijver, M.J. van de; Asperen, C.J. van; Kroon, H.M.; Eilers, P.H. & Hogendoorn, P.C. (2004), A distinct phenotype characterizes tumors from a putative genetic trait involving chondrosarcoma and breast cancer occurring in the same patient, Laboratory Investigation 84(2).
- Szuhai K, Knijnenburg J, Ijszenga M, Tanke HJ, Baatenburg RJ, de Jong RJB, Dekker PBD, Rosenberg C & Hogendoorn PCW (2004), Multicolor fluorescence in situ hybridization analysis of a synovial sarcoma of the larynx with a t(X;18)(p11.2;q11.2) and trisomy-2 and trisomy-8, Cancer Genetics and Cytogenetics 153(1).
- Egeler RM, Annels NE & Hogendoorn PCW (2004), Commentary - Langerhans cell histiocytosis: A pathologic combination of oncogenesis and immune dysregulation, Pediatric Blood and Cancer 42(5).
- Lindeman, J.H.N.; Hanemaaijer, R.; Mulder, A.; Dijkstra, S.; Szuhai, K.; Bromme, D.; Verheijen, J.H. & Hogendoorn, P.C.W. (2004), Cathepsin K is the principal protease in giant cell tumor of bone, American Journal of Pathology 165(2).
- Verweij J, Casali PG, Zalcberg J, LeCesne A, Reichardt P, Blay JY, Issels R, van Oosterom A, Hogendoorn PCW, Van Glabbeke M, Bertulli R & Judson I (2004), Progression-free survival in gastrointestinal stromal tumours with high-dose imatinib: randomised trial, Lancet 364(9440).
- van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW, Taminiau AHM, van Coevorden F, Zwinderman AH, Pope TL & Bloem JL (2004), Soft-tissue tumors: Value of static and dynamic gadopentetate dimeglumine-enhanced MR imaging in prediction of malignancy, Radiology 233(2).
- Hensen, E.F.; Jordanova, E.S.; Minderhout, I.J.H.M. van; Hogendoorn, P.C.W.; Taschner, P.E.M.; Mey, A.G.L. van der; Devilee, P. & Cornelisse, C.J. (2004), Somatic loss of maternal chromosome 11 causes parent-of-origin-dependent inheritance in SDHD-linked paraganglioma and phaeochromocytoma families, Oncogene 23(23).
- Kornaat PR, Doornbos J, van der Molen AJ, Kloppenburg M, Nelissen RG, Hogendoorn PCW & Bloem JL (2004), Magnetic resonance imaging of knee cartilage using a water selective balanced steady-state free precession sequence, Journal of Magnetic Resonance Imaging 20(5).
- Schaefer, K.L.; Brachwitz, K.; Wai, D.H.; Braun, Y.; Diallo, R.; Korsching, E.; Eisenacher, M.; Voss, R.; Valen, F. van; Baer, C.; Selle, B.; Spahn, L.; Liao, S.K.; Lee, K.A.W.; Hogendoorn, P.C.W.; Reifenberger, G.; Gabbert, H.E. & Poremba, C. (2004), Expression profiling of t(12;22) positive clear cell sarcoma of soft tissue cell lines reveals characteristic up-regulation of potential new marker genes including ERBB3, Cancer Research 64(10).
- van Beerendonk HM, Rozeman LB, Taminiau AH, Sciot R, Bovee JVMG, Cleton-Jansen AM & Hogendoorn PC (2004), Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression, Journal of Pathology 202(3).
- Anninga JK, van de Vijver MJ, Cleton-Jansen AM, Kristel PMP, Taminiau AHM, Nooij M, Egeler RM & Hogendoorn PCW (2004), Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas, European Journal of Cancer 40(7).
- Van der Woude HJ, Hazelbag HM, Bloem JL, Taminiau AHM & Hogendoorn PCW (2004), MRI of adamantinoma of long bones in correlation with histopathology, American Journal of Roentgenology 183(6).
- Blay JY, Le Cesne A, Verweij J, Scurr M, Seynaeve C, Bonvalot S, Hogendoorn P, Jimeno J, Evrard V, van Glabbeke M & Judson I (2004), A phase II study of ET-743/trabectedin ('Yondelis') for patients with advanced gastrointestinal stromal tumours, European Journal of Cancer 40(9).
- Hazelbag, H.M.; Szuhai, K.; Tanke, H.J.; Rosenberg, C. & Hogendoorn, P.C.W. (2004), Primary synovial sarcoma of the heart: a cytogenetic and molecular genetic analysis combining RT-PCR and COBRA-FISH of a case with a complex karyotype, Modern Pathology 17(11).
- Rozeman, L.B.; Sangiorgi, L.; Briaire-de Bruijn, I.H.; Mainil-Varlet, P.; Bertoni, F.; Cleton-Jansen, A.M.; Hogendoorn, P.C.W. & Bovee, J.V.M.G. (2004), Enchondromatosis (Ollier disease, Maffucci syndrome) is not caused by the PTHR1 mutation p.R150C, Human Mutation 24(6).
- Romeo S, Bovee JVMG, Jadnanansing NAA, Taminiau AHM & Hogendoorn PCW (2004), Expression of cartilage growth plate signalling molecules in chondroblastoma, Journal of Pathology 202(1).
- Hogendoorn PCW, Collin F, Daugaard S, Dei Tos AP, Fisher C, Schneider U & Sciot R (2004), Changing concepts in the pathological basis of soft tissue and bone sarcoma treatment, European Journal of Cancer 40(11).
- Dekker, P.B.D.; Corver, W.E.; Hogendoom, P.C.W.; Mey, A.G.L. van der & Cornelisse, C.J. (2004), Multiparameter DNA flow-sorting demonstrates diploidy and SDHD wild-type gene retention in the sustentacular cell compartment of head and neck paragangliomas: chief cells are the only neoplastic component, The Journal of Pathology 202(4).
- Laman JD, Leenen PJM, Annels NE, Hogendoorn PCW & Egeler RM (2003), Langerhans-cell histiocytosis 'insight into DC biology', Trends in Immunology 24(4).
- Dekker PBD, Kuipers-Dijkshoorn N, Hogendoorn PCW, Van der Mey AGL & Cornelisse CJ (2003), G(2)M arrest, blocked apoptosis, and low growth fraction may explain indolent behavior of head and neck paragangliomas, Human Pathology 34(7).
- Hauben, E.I.; Arends, J.; Vandenbroucke, J.P.; Asperen, C.J. van; Marck, E. van & Hogendoorn, P.C.W. (2003), Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma, European Journal of Human Genetics 11(8).
- Verweij J, van Oosterom A, Blay JY, Judson I, Rodenhuis S, van der Graaf W, Radford J, Le Cesne A, Hogendoorn PCW, di Paola ED, Brown M & Nielsen OS (2003), Imatinib mesylate (STI-571 Glivec (R), Gleevec (TM)) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study, European Journal of Cancer 39(14).
- Egeler RM, Laman JD, Leenen PJM, Annels NE & Hogendoorn PCW (2003), Response to Fadeel and Henter: Langerhans cell histiocytosis: a combination of carcinogenesis and inflammation, Trends in Immunology 24(8).
- van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW, Peterse JL, van Coevorden F, Taminiau AHM, Tollenaar RAEM, Kroon BBR & Bloem JL (2003), Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results, European Radiology 13(8).
- Hazelbag HM, Laforga JB, Roels HJL & Hogendoorn PCW (2003), Dedifferentiated adamantinoma with revertant mesenchymal phenotype, American Journal of Surgical Pathology 27(12).
- Dekker PBD, Hogendoorn PCW, Kuipers-Dijkshoorn N, Prins FA, van Duinen SG, Taschner PEM, van der Mey AGL & Cornelisse CJ (2003), SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology, Journal of Pathology 201(3).
- Hogendoorn PCW (2003), Pathology of soft tissue sarcomas with emphasis on molecular diagnostic techniques, EJC Supplements 1(6).
- Annels, N.E.; Costa, C.E.T. da; Prins, F.A.; Willemze, A.; Hogendoorn, P.C.W. & Egeler, R.M. (2003), Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis, Journal of Experimental Medicine 197(10).
- Hogendoorn PCW (2003), Pathology of soft tissue sarcomas with emphasis on molecular diagnostic techniques, EJC Supplements 1(6).
- Dekker PBD, Kuipers-Dijkshoorn N, Hogendoorn PCW, Van der Mey AGL & Cornelisse CJ (2003), G(2)M arrest, blocked apoptosis, and low growth fraction may explain indolent behavior of head and neck paragangliomas, Human Pathology 34(7).
- Verweij J, van Oosterom A, Blay JY, Judson I, Rodenhuis S, van der Graaf W, Radford J, Le Cesne A, Hogendoorn PCW, di Paola ED, Brown M & Nielsen OS (2003), Imatinib mesylate (STI-571 Glivec (R), Gleevec (TM)) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target: Results from an EORTC Soft Tissue and Bone Sarcoma Group phase II study, European Journal of Cancer 39(14).
- Dekker PBD, Hogendoorn PCW, Kuipers-Dijkshoorn N, Prins FA, van Duinen SG, Taschner PEM, van der Mey AGL & Cornelisse CJ (2003), SDHD mutations in head and neck paragangliomas result in destabilization of complex II in the mitochondrial respiratory chain with loss of enzymatic activity and abnormal mitochondrial morphology, Journal of Pathology 201(3).
- Annels, N.E.; Costa, C.E.T. da; Prins, F.A.; Willemze, A.; Hogendoorn, P.C.W. & Egeler, R.M. (2003), Aberrant chemokine receptor expression and chemokine production by Langerhans cells underlies the pathogenesis of Langerhans cell histiocytosis, Journal of Experimental Medicine 197(10).
- Laman JD, Leenen PJM, Annels NE, Hogendoorn PCW & Egeler RM (2003), Langerhans-cell histiocytosis 'insight into DC biology', Trends in Immunology 24(4).
- van Rijswijk CSP, Geirnaerdt MJA, Hogendoorn PCW, Peterse JL, van Coevorden F, Taminiau AHM, Tollenaar RAEM, Kroon BBR & Bloem JL (2003), Dynamic contrast-enhanced MR imaging in monitoring response to isolated limb perfusion in high-grade soft tissue sarcoma: initial results, European Radiology 13(8).
- Hauben, E.I.; Arends, J.; Vandenbroucke, J.P.; Asperen, C.J. van; Marck, E. van & Hogendoorn, P.C.W. (2003), Multiple primary malignancies in osteosarcoma patients. Incidence and predictive value of osteosarcoma subtype for cancer syndromes related with osteosarcoma, European Journal of Human Genetics 11(8).
- Hazelbag HM, Laforga JB, Roels HJL & Hogendoorn PCW (2003), Dedifferentiated adamantinoma with revertant mesenchymal phenotype, American Journal of Surgical Pathology 27(12).
- Egeler RM, Laman JD, Leenen PJM, Annels NE & Hogendoorn PCW (2003), Response to Fadeel and Henter: Langerhans cell histiocytosis: a combination of carcinogenesis and inflammation, Trends in Immunology 24(8).
- van Dartel M, Cornelissen PWA, Redeker S, Tarkkanen M, Knuutila S, Hogendoorn PCW, Westerveld A, Gomes I, Bras J & Hulsebos TJM (2002), Amplification of 17p11.2 similar to p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma, Cancer Genetics and Cytogenetics 139(2).
- Schouten B, Egeler RM, Leenen PJM, Taminiau AHM, van den Broek LJCM & Hogendoorn PCW (2002), Expression of cell cycle-related gene products in Langerhans cell histiocytosis, Journal of Pediatric Hematology/Oncology 24(9).
- Kok P, Hogendoorn PCW, van den Broek LJCM & Bovee JVMG (2002), Bcl-2 expression as a diagnostic marker to identify malignant progression of osteochondroma, Modern Pathology 15(1): 17A17A.
- Kok P, Hogendoorn PCW, van den Broek LJCM & Bovee JVMG (2002), Bcl-2 expression as a diagnostic marker to identify malignant progression of osteochondroma, Laboratory Investigation 82(1): 17A17A.
- Pauwels P, Debiec-Rychter M, Sciot R, Vlasveld T, den Butter B, Hagemeijer A & Hogendoorn PCW (2002), Clear cell sarcoma of the stomach, Histopathology 41(6).
- Pinto CH, Taminiau AHM, Vanderschueren G, Hogendoorn PCW, Bloem JL & Obermann WR (2002), Perspective. Technical considerations in CT-guided radiofrequency thermal ablation of osteoid osteoma: tricks of the trade., American Journal of Roentgenology 179(6).
- Svancarova L, Blay JY, Judson IR, van Hoesel QGCM, van Oosterom AT, le Cesne A, Keizer HJ, Hermans C, van Glabbeke M, Verweij J, Hogendoorn PCW & Nielsen OS (2002), Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group, European Journal of Cancer 38(4).
- Bovee, J.V.M.G.; Sakkers, R.J.B.; Geirnaerdt, M.J.A.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2002), Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses, Journal of Clinical Pathology 55(3).
- Deijkers RLM, Bloem RM, Hogendoorn PCW, Verlaan JJ, Kroon HM & Taminiau AHM (2002), Hemicortical allograft reconstruction after resection of low-grade malignant bone tumours, Journal of Bone and Joint Surgery, British Volume 84B(7).
- Rijswijk, C.S.P. van; Kunz, P.; Hogendoorn, P.C.W.; Taminiau, A.H.M.; Doornbos, J. & Bloem, J.L. (2002), Diffusion-weighted MRI in the characterization of soft-tissue tumors, Journal of Magnetic Resonance Imaging 15(3).
- Hauben EI, Weeden S, Pringle J, Van Marck EA & Hogendoorn PCW (2002), Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup, European Journal of Cancer 38(9).
- Janssen, J.P.; Egmont-Petersen, M.; Hendriks, E.A.; Reinders, M.J.T.; Geest, R.J. van der; Hogendoorn, P.C.W. & Reiber, J.H.C. (2002), Scale-invariant segmentation of dynamic contrast-enhanced perfusion MR images with inherent scale selection, Journal of Visualization and Computer Animation 13(1).
- Kok P, Hogendoorn PCW, van den Broek LJCM & Bovee JVMG (2002), Bcl-2 expression as a diagnostic marker to identify malignant progression of osteochondroma, Modern Pathology 15(1): 17A17A.
- Kok P, Hogendoorn PCW, van den Broek LJCM & Bovee JVMG (2002), Bcl-2 expression as a diagnostic marker to identify malignant progression of osteochondroma, Laboratory Investigation 82(1): 17A17A.
- Schouten B, Egeler RM, Leenen PJM, Taminiau AHM, van den Broek LJCM & Hogendoorn PCW (2002), Expression of cell cycle-related gene products in Langerhans cell histiocytosis, Journal of Pediatric Hematology/Oncology 24(9).
- Pinto CH, Taminiau AHM, Vanderschueren G, Hogendoorn PCW, Bloem JL & Obermann WR (2002), Perspective. Technical considerations in CT-guided radiofrequency thermal ablation of osteoid osteoma: tricks of the trade., American Journal of Roentgenology 179(6).
- Rijswijk, C.S.P. van; Kunz, P.; Hogendoorn, P.C.W.; Taminiau, A.H.M.; Doornbos, J. & Bloem, J.L. (2002), Diffusion-weighted MRI in the characterization of soft-tissue tumors, Journal of Magnetic Resonance Imaging 15(3).
- Janssen, J.P.; Egmont-Petersen, M.; Hendriks, E.A.; Reinders, M.J.T.; Geest, R.J. van der; Hogendoorn, P.C.W. & Reiber, J.H.C. (2002), Scale-invariant segmentation of dynamic contrast-enhanced perfusion MR images with inherent scale selection, Journal of Visualization and Computer Animation 13(1).
- Svancarova L, Blay JY, Judson IR, van Hoesel QGCM, van Oosterom AT, le Cesne A, Keizer HJ, Hermans C, van Glabbeke M, Verweij J, Hogendoorn PCW & Nielsen OS (2002), Gemcitabine in advanced adult soft-tissue sarcomas. A phase II study of the EORTC Soft Tissue and Bone Sarcoma Group, European Journal of Cancer 38(4).
- Hauben EI, Weeden S, Pringle J, Van Marck EA & Hogendoorn PCW (2002), Does the histological subtype of high-grade central osteosarcoma influence the response to treatment with chemotherapy and does it affect overall survival? A study on 570 patients of two consecutive trials of the European Osteosarcoma Intergroup, European Journal of Cancer 38(9).
- van Dartel M, Cornelissen PWA, Redeker S, Tarkkanen M, Knuutila S, Hogendoorn PCW, Westerveld A, Gomes I, Bras J & Hulsebos TJM (2002), Amplification of 17p11.2 similar to p12, including PMP22, TOP3A, and MAPK7, in high-grade osteosarcoma, Cancer Genetics and Cytogenetics 139(2).
- Bovee, J.V.M.G.; Sakkers, R.J.B.; Geirnaerdt, M.J.A.; Taminiau, A.H.M. & Hogendoorn, P.C.W. (2002), Intermediate grade osteosarcoma and chondrosarcoma arising in an osteochondroma. A case report of a patient with hereditary multiple exostoses, Journal of Clinical Pathology 55(3).
- Pauwels P, Debiec-Rychter M, Sciot R, Vlasveld T, den Butter B, Hagemeijer A & Hogendoorn PCW (2002), Clear cell sarcoma of the stomach, Histopathology 41(6).
- Deijkers RLM, Bloem RM, Hogendoorn PCW, Verlaan JJ, Kroon HM & Taminiau AHM (2002), Hemicortical allograft reconstruction after resection of low-grade malignant bone tumours, Journal of Bone and Joint Surgery, British Volume 84B(7).
- Bovee JVMG, van den Broek LJCM, Cleton-Jansen AM & Hogendoorn PCW (2001), Upregulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma, Journal of Pathology 193: 1A1A.
- Bovee JVMG, Sciot R, Cin PD, Debiec-Rychter M, van Zelderen-Bhola SL, Cornelisse CJ & Hogendoorn PCW (2001), Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: A cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes, Diagnostic Molecular Pathology 10(4).
- Hazelbag HM & Hogendoorn PC (2001), Adamantinoma of long bones: a clinicopathological review and its relationship with osteofibrous dysplasia, Annales de Pathologie 21(6).
- Rijswijk, C.S.P. van; Lieng, J.G.S.T.A.; Kroon, H.M. & Hogendoorn, P.C.W. (2001), Retroperitoneal extraskeletal osteosarcoma, Journal of Clinical Pathology 54(1).
- Ronday, H.K.; Laan, W.H. van der; Tak, P.P.; Roos, J.A.D.M. de; Bank, R.A.; TeKoppele, J.M.; Froelich, C.J.; Hack, C.E.; Hogendoorn, P.C.W.; Breedveld, F.C. & Verheijen, J.H. (2001), Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis, Rheumatology 40(1).
- Roggen, J.F.G. van; Velthuysen, M.L.F. van & Hogendoorn, P.C.W. (2001), The histopathological differential diagnosis of gastrointestinal stromal tumours, Journal of Clinical Pathology 54(2).
- van Rijswijk CSP, Hogendoorn PCW, Taminiau AHM & Bloem JL (2001), Synovial sarcoma: dynamic contrast-enhanced MR imaging features, Skeletal Radiology 30(1).
- Langezaal, S.M.; Roggen, J.F.G. van; Cleton-Jansen, A.M.; Baelde, J.J. & Hogendoorn, P.C.W. (2001), Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts), British Journal of Cancer 84(4).
- Nelissen, R.G.H.H. & Hogendoorn, P.C.W. (2001), Retain or sacrifice the posterior cruciate ligament in total knee arthroplasty? A histopathological study of the cruciate ligament in osteoarthritic and rheumatoid disease, Journal of Clinical Pathology 54(5).
- Hauben, E.; Broek, L.C.J.M. van den; Marck, E. van & Hogendoorn, P.C.W. (2001), Adamantinoma-like Ewing's sarcoma and Ewing's-like adamantinoma. The t(11;22), t(21;22) status, Journal of Pathology 195(2).
- Baelde, H.J.; Cleton-Jansen, A.M.; Beerendonk, H. van; Namba, M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2001), High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma, Journal of Clinical Pathology 54(10).
- Bovee JVMG, van den Broek LJCM, Cleton-Jansen AM & Hogendoorn PCW (2001), Upregulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma, Journal of Pathology 193: 1A1A.
- Hauben, E.; Broek, L.C.J.M. van den; Marck, E. van & Hogendoorn, P.C.W. (2001), Adamantinoma-like Ewing's sarcoma and Ewing's-like adamantinoma. The t(11;22), t(21;22) status, Journal of Pathology 195(2).
- Ronday, H.K.; Laan, W.H. van der; Tak, P.P.; Roos, J.A.D.M. de; Bank, R.A.; TeKoppele, J.M.; Froelich, C.J.; Hack, C.E.; Hogendoorn, P.C.W.; Breedveld, F.C. & Verheijen, J.H. (2001), Human granzyme B mediates cartilage proteoglycan degradation and is expressed at the invasive front of the synovium in rheumatoid arthritis, Rheumatology 40(1).
- Baelde, H.J.; Cleton-Jansen, A.M.; Beerendonk, H. van; Namba, M.; Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2001), High quality RNA isolation from tumours with low cellularity and high extracellular matrix component for cDNA microarrays: application to chondrosarcoma, Journal of Clinical Pathology 54(10).
- Nelissen, R.G.H.H. & Hogendoorn, P.C.W. (2001), Retain or sacrifice the posterior cruciate ligament in total knee arthroplasty? A histopathological study of the cruciate ligament in osteoarthritic and rheumatoid disease, Journal of Clinical Pathology 54(5).
- Hazelbag HM & Hogendoorn PC (2001), Adamantinoma of long bones: a clinicopathological review and its relationship with osteofibrous dysplasia, Annales de Pathologie 21(6).
- Bovee JVMG, Sciot R, Cin PD, Debiec-Rychter M, van Zelderen-Bhola SL, Cornelisse CJ & Hogendoorn PCW (2001), Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: A cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes, Diagnostic Molecular Pathology 10(4).
- Roggen, J.F.G. van; Velthuysen, M.L.F. van & Hogendoorn, P.C.W. (2001), The histopathological differential diagnosis of gastrointestinal stromal tumours, Journal of Clinical Pathology 54(2).
- Langezaal, S.M.; Roggen, J.F.G. van; Cleton-Jansen, A.M.; Baelde, J.J. & Hogendoorn, P.C.W. (2001), Malignant melanoma is genetically distinct from clear cell sarcoma of tendons and aponeurosis (malignant melanoma of soft parts), British Journal of Cancer 84(4).
- van Rijswijk CSP, Hogendoorn PCW, Taminiau AHM & Bloem JL (2001), Synovial sarcoma: dynamic contrast-enhanced MR imaging features, Skeletal Radiology 30(1).
- Rijswijk, C.S.P. van; Lieng, J.G.S.T.A.; Kroon, H.M. & Hogendoorn, P.C.W. (2001), Retroperitoneal extraskeletal osteosarcoma, Journal of Clinical Pathology 54(1).
- Odink, A.E.; Asperen, C.J. van; Vandenbroucke, J.P.; Cleton-Jansen, A.M. & Hogendoom, P.C.W. (2001), An association between cartilaginous tumours and breast cancer in the national pathology registration in The Netherlands points towards a possible genetic trait, The Journal of Pathology 193(2).
- Bovee, J.V.M.G.; Broek, L.J.C.M. van den; Cleton-Jansen, A.M. & Hogendoom, P.C.W. (2001), Chondrosarcoma is not characterized by detectable telomerase activity, The Journal of Pathology 193(3).
- Bloem JL, van der Woude HJ, Geirnaerdt MJA, Taminiau AHM, Hogendoorn PCW & van Rijswijk CSP (2000), Bone tumors.
- Geirnaerdt MJA, Hogendoorn PCW, Bloem JL, Taminiau AHM & van der Woude HJ (2000), Cartilaginous tumors: Fast contrast-enhanced MR imaging.
- Bovee, J.V.M.G.; Broek, L.J.C.M. van den; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2000), Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma, Laboratory Investigation 80(12).
- Egmont-Petersen M, Hogendoorn PCW, van der Geest RJ, Vrooman HA, van der Woude HJ, Janssen JP, Bloem JL & Reiber JHC (2000), Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling.
- Bovee JVMG, van Roggen JFG, Cleton-Jansen AM, Taminiau AHM, van der Woude HJ & Hogendoorn PCW (2000), Malignant progression in multiple enchondromatosis (Ollier's disease): An autopsy-based molecular genetic study, Human Pathology 31(10).
- Bovee, J.V.M.G.; Royen, M. van; Bardoel, A.F.J.; Rosenberg, C.; Cornelisse, C.J.; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2000), Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma, American Journal of Pathology 157(5).
- Plusje LGJM, Bastiaens M, Chang A & Hogendoorn PCW (2000), Infantile-type digital fibromatosis tumour in an adult, British Journal of Dermatology 143(5).
- Beuckeleer, L.H. de; Schepper, A.M. de; Vandevenne, J.E.; Bloem, J.L.; Davies, A.M.; Oudkerk, M.; Hauben, E.; Marck, E. van; Somville, J.; Vanel, D.; Steinbach, L.S.; Guinebretiere, J.M.; Hogendoorn, P.C.W.; Mooi, W.J.; Verstraete, K.; Zaloudek, C. & Jones, H. (2000), MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review, Skeletal Radiology 29(4).
- van Roggen JF, Bovee JVMG, van der Woude HJ & Hogendoorn PCW (2000), An update of diagnostic strategies using molecular genetic and magnetic resonance imaging techniques for musculoskeletal tumors.
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2000), Re. Review Article entitled 'The neoplastic pathogenesis of solitary and multiple osteochondromas'.
- Bovee, J.V.M.G.; Broek, L.J.C.M. van den; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2000), Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma, Laboratory Investigation 80(12).
- Egmont-Petersen M, Hogendoorn PCW, van der Geest RJ, Vrooman HA, van der Woude HJ, Janssen JP, Bloem JL & Reiber JHC (2000), Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling.
- Geirnaerdt MJA, Hogendoorn PCW, Bloem JL, Taminiau AHM & van der Woude HJ (2000), Cartilaginous tumors: Fast contrast-enhanced MR imaging.
- Bovee, J.V.M.G.; Royen, M. van; Bardoel, A.F.J.; Rosenberg, C.; Cornelisse, C.J.; Cleton-Jansen, A.M. & Hogendoorn, P.C.W. (2000), Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma, American Journal of Pathology 157(5).
- Beuckeleer, L.H. de; Schepper, A.M. de; Vandevenne, J.E.; Bloem, J.L.; Davies, A.M.; Oudkerk, M.; Hauben, E.; Marck, E. van; Somville, J.; Vanel, D.; Steinbach, L.S.; Guinebretiere, J.M.; Hogendoorn, P.C.W.; Mooi, W.J.; Verstraete, K.; Zaloudek, C. & Jones, H. (2000), MR imaging of clear cell sarcoma (malignant melanoma of the soft parts): a multicenter correlative MRI-pathology study of 21 cases and literature review, Skeletal Radiology 29(4).
- Bloem JL, van der Woude HJ, Geirnaerdt MJA, Taminiau AHM, Hogendoorn PCW & van Rijswijk CSP (2000), Bone tumors.
- Bovee JVMG, van Roggen JFG, Cleton-Jansen AM, Taminiau AHM, van der Woude HJ & Hogendoorn PCW (2000), Malignant progression in multiple enchondromatosis (Ollier's disease): An autopsy-based molecular genetic study, Human Pathology 31(10).
- van Roggen JF, Bovee JVMG, van der Woude HJ & Hogendoorn PCW (2000), An update of diagnostic strategies using molecular genetic and magnetic resonance imaging techniques for musculoskeletal tumors.
- Bovee, J.V.M.G. & Hogendoorn, P.C.W. (2000), Re. Review Article entitled 'The neoplastic pathogenesis of solitary and multiple osteochondromas'.
- Plusje LGJM, Bastiaens M, Chang A & Hogendoorn PCW (2000), Infantile-type digital fibromatosis tumour in an adult, British Journal of Dermatology 143(5).
- TAK, P.P.; VISSER, L.G.; HOOGKAMPKORSTANJE, J.A.A.; KLUINNELEMANS, J.C.; HOGENDOORN, P.C.W.; KLUIN, P.M.; BARZA, M.; DEKONING, J. & VANFURTH, R. (1992), UNUSUAL MANIFESTATIONS OF YERSINIA-ENTEROCOLITICA INFECTIONS DIAGNOSED USING NOVEL METHODS, Clinical Infectious Diseases 15(4): 645-649.
- Member Advisory Board
- Adjunct Professor in Pathology
- Lid Raad van Toezicht
- Voorzitter
- Visiting Professor in Sarcoma Pathology
- Visiting Professor of Pathology